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Poor skeletal health results from aging and metabolic diseases such as obesity and 
diabetes and involves impaired homeostatic balance between marrow osteogenesis and 
adipogenesis. Tissue engineering provides researchers with the ability to generate 
improved, highly controlled and tailorable in vitro model systems to better understand 
mechanisms of homeostasis, disease, and healing and regeneration. Model systems that 
allow assembly of modules of MSCs, osteoblasts, and adipocytes in a number of 
configurations to engage in signaling crosstalk offer the potential to study integrative 
physiological aspects and complex interactions in the face of changes in local and 
systemic microenvironments. Thus, the overall goal of this dissertation was to examine 
integrative physiological aspects between MSCs, osteoblasts, and adipocytes that exist 
within the marrow microenvironment. 
  To investigate the effects of intercellular signaling in different 
microenvironmental contexts, methods were developed to photolithographically pattern 
and assemble cell-laden PEG-based hydrogels with high spatial fidelity and tissue-scale 
thickness for long-term 3D co-culture of multiple cell types. This platform was applied to 
study effects of crosstalk between MSCs, osteoblasts and adipocytes on markers of 
differentiation in each cell type. Additionally, responses of MSCs to systemic 
perturbations in glucose concentration were modulated by mono-, co-, and tri-culture 
with these cell types in a model of diabetes-induced skeletal disease. Together, these 
studies provided valuable insight into unique and differential effects of intercellular 
signaling within the niche environment of MSCs and their terminally differentiated 
 xxvi 
progeny during homeostatic and pathological states, and offer opportunities further study 









1.1  Motivation 
Osteopenia and osteoporosis are the most common metabolic disorders of bone 
formation and remodeling that are exceedingly prevalent in young and adult populations, 
affecting 200 million individuals worldwide [1, 2].  They constitute the most common cause 
of fractures (> 1.5 million/year) in the United States [3, 4].  These fractures lead to more than 
500,000 hospitalizations, over 800,000 emergency room encounters, more than 2.6 million 
physician office visits, and the placement of nearly 180,000 individuals into nursing homes 
[4]. Caring for these fractures is expensive: annual direct care expenditures for osteoporotic 
fractures range from $12-18 billion/year and indirect costs (e.g., lost productivity for patients 
and caregivers) likely add billions more to this figure [4, 5]. By 2020, one in two Americans 
over age 50 is expected to have or be at risk of developing osteoporosis of the hip; even more 
will be at risk of developing osteoporosis at any site in the skeleton [4, 5]. Available 
treatment options are supportive rather than curative and oftentimes are associated with 
persistent patient morbidity, further fractures, and eventually mortality [5, 6]. 
Primary causes of osteoporosis include age and estrogen deficiency arising from 
menopause, while secondary osteoporosis can result as a consequence of disorders of 
energy metabolism such as anorexia nervosa, obesity, and diabetes mellitus [7-11] that 
are accompanied by their own exorbitantly high prevalence, costs, and morbidities [12-
17]. These individuals experience varying degrees of an imbalance between bone 
deposition and bone resorption, resulting in progressive loss of bone mineral density and 
skeletal fragility. These changes are accompanied by excess marrow adipogenesis beyond 
that which develops during the peak time of bone acquisition. Osteoblasts and adipocytes 
together represent the result of divergent, reciprocally regulated differentiation programs 
of a common multipotent precursor within the marrow stroma: mesenchymal stem cells 
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(MSCs). Previous research suggests that there is paracrine signaling between osteoblasts 
and adipocytes in vivo that may affect these divergent, reciprocally regulated MSC 
differentiation programs [2, 10, 18]. Additionally, elegant work in mouse models has 
demonstrated that there exists a significant integrative crosstalk between bone and energy 
metabolisms controlled through neural and endocrine mechanisms and that osteoblasts 
and adipocytes participate in this crosstalk through secretion of soluble mediators [19-
27]. 
However, due to a dearth of in vitro models to study effects of multidirectional 
crosstalk between MSCs, osteoblasts, and adipocytes, it is not clear to what extent 
paracrine signaling from nearby cells may direct differentiation and stemness properties 
of multipotent MSCs, particularly in the context of diseases that result in excess 
adipogenesis and impaired osteogenesis. This lack of knowledge hinders the development 
of systemic therapies to regulate formation of adipose stores, restore normal metabolic 
functions and glucose homeostasis, and rescue the normal osteopoietic environment that 
balances bone deposition with resorption. Additionally, this hampers the ability to 
harness the healing potential of endogenous MSCs for treating a variety of 
musculoskeletal injuries. MSC lineage allocation along with neural and endocrine 
homeostatic control of their differentiated counterparts balances the process of bone 
deposition and energy storage as fat to support an energy-intensive remodeling process. 
Examining the interplay between MSCs, osteoblasts, and adipocytes is therefore crucial 
to understanding the pathophysiology of osteoporosis and metabolic disorders and 
development of targeted systemic molecular and cytotherapies. 
1.2  Research Objectives and Specific Aims 
Thus, the goal of this project is to design and implement a 3D in vitro tri-culture 
system to examine integrative physiological aspects between multiple cell types that exist 
within the marrow microenvironment. This research will elucidate the roles of osteoblasts 
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and adipocytes in priming MSC fate and simultaneously evaluate the temporal effects of 
MSCs on osteoblast-adipocyte crosstalk. This project will use PEG-based hydrogels as a 
3D scaffolding platform to model a portion of the marrow microenvironment and study 
aspects of the integrative MSC, osteoblast, and adipocyte interactions that may govern 
bone metabolism. The rationale for this project is that by patterning and laminating 
hydrogel modules containing different cell types into a single structure, this system may 
be used simultaneously to interrogate paracrine signaling effects of multiple cell types on 
each other and retain the ability to separate cells after the tri-culture period for analyses 
of individual cell types. The central hypothesis of this work is that this tri-culture system 
will allow us to demonstrate how MSC lineage allocation and differentiation are affected 
by osteoblasts and adipocytes, and how MSCs in turn are affected by their neighboring 
cell types in response to pathophysiological levels of glucose as a model for diabetes. 
This hypothesis will be investigated in the following three specific aims: 
Hypothesis I: 3D laminated hydrogel modules will facilitate culture of multiple cell 
types in tandem for a specified time, after which cell types may be isolated and separately 
analyzed for genotypic and phenotypic characteristics. 
Specific Aim I: Design and develop methods for photopatterning cell-laden, 3D hydrogel 
constructs for spatially controlled long term co-culture and subsequent separation of 
multiple cell types. 
 Spatiotemporally controlled co-culture in three-dimensional (3D) environments that 
appropriately mimic in vivo tissue architecture is a highly desirable goal in studies of stem 
cell physiology (e.g. proliferation, matrix production, and tissue repair) and in enhancing the 
development of novel stem cell-based clinical therapies for a variety of ailments. Current 
technologies that enable co-culture of two cell types largely rely on 2D culture that does not 
adequately recreate the native tissue environment or allow separation of the two cell 
populations for further downstream culture and analytical assays. Therefore, the objective of 
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this aim was to develop techniques to accomplish photopatterning, cell encapsulation, and 3D 
co-culture, and selective on-demand separation of different populations of cells post-culture.  
The rationale for this aim was that successful completion of the proposed experiments would 
lead to a vastly improved technological platform for studying the effects of soluble factors on 
cell fate and physiology of multiple cell types simultaneously. 
 
The general goals of this aim were: 1) to design photopatternable polymer systems 
for cell encapsulation, requiring optimizing chemistry of the materials, processing conditions, 
as well as the overall design of the encapsulation scheme; 2) to design cytocompatible cell-
laden constructs that enable long-term (2-3 wks) co-culture of multiple cell populations; and 
3) to design a selective enzyme-degradable system where each population of cells could be 
easily separated after co-culture for detailed gene expression and phenotypic analyses (see 
Aims II and III). At the completion of Aim I, we were able to pattern, with high fidelity and 
resolution, specifically designed co-culture constructs.  Furthermore, our process maintained 
cell viability, was compatible with established microscopy, histology, and other techniques 
for characterization, and permitted successful release of cell populations from the construct.  
Such results are important because this technology was further applied in Aims II and III to 
improve understanding of how 3D co-culture of MSCs, osteoblasts, and adipocytes affects 
changes in clonogenicity and plasticity of MSCs and their derivatives with time along with 
differential responses to each other under systemic alterations in glucose concentration. 
Hypothesis II: MSCs will contribute to osteoblast and adipocyte populations through 
lineage allocation and differentiation that are biased by the relative amount of each cell 
type in the tri-culture construct over weeks of long term culture. 
Specific Aim II: Assess gene expression and histological markers of differentiation in 
MSCs and their derivatives with time in response to differential amounts of osteoblasts 
and adipocytes in co-culture or tri-culture settings. 
Design of optimal MSC-based treatment strategies for osteoporosis and other 
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diseases of bone remodeling have been hampered by a lack of knowledge of how MSCs 
interact with resident osteoblasts and adipocytes (either prior to their harvest for ex vivo 
expansion and modification, or after their transplantation into the bone marrow cavity).  
MSCs must maintain their propensity to regenerate an adequate osteopoietic environment 
through sufficient and appropriate lineage allocation and differentiation to restore absent 
osteoblast function. Additionally, this requires continued maintenance of self-renewal and 
plasticity of MSCs in the face of a dynamic niche that contains osteoblasts and adipocytes 
supplying regulatory cues that encourage their differentiation.  Thus, the objective of this 
Aim was to determine how co- and tri- culture of MSCs with osteoblasts and/or adipocytes 
differentially affects gene expression of markers of mesenchymal lineage specification in 
MSCs, osteoblasts, and adipocytes in response to prolonged co- and tri-culture. 
To attain this objective, we used an experimental approach centered on the 
micropatterned hydrogel layering system developed in Aim I combined with quantitative 
multivariate statistical analysis methods (principle component analysis and partial least 
squares discriminant analysis).  The rationale for this Aim was that successful completion of 
the proposed study would contribute important knowledge about effects of soluble signals 
derived from MSCs, osteoblasts, and adipocytes on each others’ level of lineage commitment 
and differentiation.  The acquisition of such knowledge is critical to determining optimal 
dosage and timing of MSC-based treatments for osteoporosis and other diseases of bone 
remodeling, as well as the design of carrier materials that modulate the MSC niche to 
produce the desired differentiation outcomes. At the completion of Aim II, hydrogel 
constructs demonstrating various amounts of MSC lineage commitment in the absence of 
complete differentiation were produced depending on the culture configuration. Multivariate 
analysis of the entire gene expression data set enabled us to distinguish differential responses 
in each encapsulated cell type to its co- or tri-culture condition over the course of 18 days. 
Additionally, histological markers of differentiation were uniquely affected in osteoblasts and 
MSCs by the co- or tri-culture condition applied.  Such results are important because the 
location and extent of changes in osteoblastic or adipocytic gene expression provided key 
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first information about the effect of the presence of multiple cell types and the role of soluble 
factors on elements of the MSC niche within the bone marrow and MSC contributions to 
marrow osteogenesis and adipogenesis.  This information may be used to direct future MSC-
based approaches to encourage trabecular bone formation and appropriate bone remodeling 
through improved knowledge about how MSCs and their placement relative to native 
osteoblasts and adipocytes affect tissue formation from all three cell types. These results 
could also be extended to create model systems to study the roles of stem and progenitor cells 
in disease pathophysiology, as studied in Aim III. 
Hypothesis III: Each culture environment will produce a unique response by MSCs to 
glucose perturbation, and in particular that cultures containing adipocytes will produce 
the most detrimental effects on cell viability and clonogenicity since they produce pro-
inflammatory cytokines and oxidative stress in response to hyperglycemia. 
Specific Aim III: Assess differential modulation of gene expression, cell viability, and 
clonogenicity of MSCs with time in response to systemic alterations in glucose under 
mono-, co-, and tri-culture settings with osteoblasts and adipocytes. 
 Design of appropriate therapies, whether molecular or cellular in nature, that 
effectively target a dysregulation system of energy metabolism and bone remodeling 
have been hampered by a lack of knowledge of how MSCs, osteoblasts, and adipocytes 
work in concert to absorb and respond to systemic perturbations of glucose. The role of 
each cell type in cell- and non-cell autonomous responses to normal and pathological 
fluctuations is difficult to elucidate using traditional in vitro models systems. Thus, the 
objective of this Aim was to determine how mono-, co-, and tri-culture of MSCs, 
osteoblasts, and/or adipocytes differently affects each others’ gene expression and fate 
(cell viability and MSC clonogenicity) in response to normal and pathological levels of 
systemically administered glucose. 
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 To attain this objective, we used the same experimental approach centered on the 
micropatterned hydrogel layering system developed in Aim I and evaluated in Aim II 
combined with quantitative multivariate statistical analysis methods to correlate 
treatments (culture type and glucose condition) with gene expression responses, and 
further correlate these outcomes with functional responses (cell viability and MSC 
clonogenicity). At the completion of Aim III, MSCs displayed different genotypic and 
cell fate responses governed predominantly by the neighboring cell types when 
responding to perturbations in glucose levels, rather than a singular, monotonic response 
to glucose level regardless of culture type. Such results are important because they 
conclusively demonstrated that the microenvironment sensed by the MSCs dictates their 
response and validated this platform as an approach for studying the systems level 
behavior of multiple cell types in response to physiological and disease states. 
1.3 Significance and Scientific Contributions 
The dissertation research described herein provides critical insight into the effects 
of crosstalk between MSCs, osteoblasts, and adipocytes in multiple environments. The 
use of a modular tri-culture system, in which the biomaterial niche of each cell type may 
be tightly controlled through the addition of adhesion and degradable biofunctionalities, 
permits explicit control of cellular behaviors and simultaneously enables dissecting the 
effects on each cell type through its separability after culture. Developing techniques for 
lamination of each hydrogel module of cells to form an integrated construct enabled the 
exchange of soluble signals between each cell type and generated unique responses 
depending on the composition of the modules. The addition of degradable moieties 
patterned within specific modules enabled isolation of specific cell populations for 
further phenotypic studies. This integrated platform provides an essential tool for 
studying the behavior that emerges from the interacting encapsulated cells and allows for 
additional perturbation of the tailored microenvironment by exogenously added stimuli 
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during any point in the culture to elicit different responses. While evaluated herein with 
MSCs, osteoblasts, and adipocytes, these functions readily facilitate the application of 
this platform to multicellular co-culture to model a host of different tissues. 
This research is innovative because this versatile platform allows for the study of 
integrative physiological and pathophysiological processes governing the lifelong process 
of continuous bone remodeling and its interdependence with energy metabolism. 
Simultaneous co- and tri-culture of MSCs, osteoblasts, and adipocytes has yet to be 
examined in such a controlled manner in a physiologically representative, 3D model 
system, despite the suggested interplay between all three cell types in the bone marrow 
microenvironment and within the context of communicating with multiple other tissues 
and organs. This work is significant because it elucidates the contributions of diffusible 
biomolecular cues from neighboring terminally differentiated cells on stem cell fate 
decisions together with stem cell contributions to terminally differentiated cell function. 
Additionally, it represents a first attempt to use a controlled 3D environment to 
understand how soluble factors influence systems-level interactions between multiple cell 
types such as those present during bone deposition and remodeling in the marrow 
microenvironment. The development of such precisely-controlled test platforms is of 
critical importance in furthering basic understanding of how progenitor cells interact with 
native cells to effect normal physiological processes, disease pathogenesis, and tissue 
healing.  Knowledge derived from both crosstalk aspects described in these studies will 
inform further studies of MSC niche characteristics. Therefore, in the future, we expect 
results from these studies to lead to improved rational design of molecular, biomaterial, 
stem cell and combination regenerative therapies for the prevention and treatment of 




BACKGROUND AND LITERATURE REVIEW 
2.1 Overview 
 This chapter summarizes the literature relevant to the work completed in this 
dissertation. It begins with a summary of mesenchymal stem cell biology, including their 
discovery, self-renewal and clonogenicity, differentiation potential, plasticity, and in 
particular focuses on the reciprocally regulated differentiation pathways of osteogenesis 
and adipogenesis relevant to the work to be described in later chapters. This is followed 
by an introduction into recent literature detailing how bone remodeling in vertebrate 
organisms is inextricably coupled with energy metabolism, including: physiological 
observations supporting their co-dependence and homeostatic control, clinical 
consequences of dysregulation within this multi-organ system, knowledge gained on key 
mechanisms of its control from animal models, and the possible role that mesenchymal 
stem cells play in these integrated processes. It then delves into literature concerning 
contemporarily available, physiologically relevant in vitro model systems based on three-
dimensional hydrogels developed for tissue engineering and regenerative medicine that 
may be applied towards gaining a deeper understanding of the effects of mono-, co-, and 
tri-culture of MSCs, osteoblasts, and adipocytes on each others’ behavior and response as 
a system to environmental perturbations. Subsequently, current experimental results from 
conventional monolayer and 2D co-culture of MSCs, osteoblasts and/or adipocytes are 
reviewed. Finally, an introduction to systems biological approaches to understanding cell 
fate decision processes and the current state of their application towards tissue 
engineering is discussed. 
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2.2  Mesenchymal Stem Cells and Their Fate 
2.2.1 Self-Renewal and Clonogenicity 
Through a seminal series of experiments in which bone marrow fragments or 
bone marrow stromal cells were transplanted into ectopic sites outside of the bone 
medullary cavity to reconstitute haematopoiesis,[28] Tavassoli and Crosby discovered the 
formation of an ectopic “ossicle” mimicking and reconstituting the haematopoietic and 
adventitial architecture of the marrow cavity. In a series of seminal experiments 
thereafter, Friedenstein et al. assigned this osteogenic potential first to non-
haematopoietic, adherent stromal cells able to form single cell-derived colonies when 
grown in culture at low density [29, 30]. This was later followed by the observation that 
heterotopic transplants of cell strains originating from a single clonogenic cell could 
generate a variety of skeletal tissues (including bone, fat, cartilage, and fibroblasts) [31, 
32]. These experiments proved multipotency of single clonogenic bone marrow stromal 
cells, and their ability to generate differentiated phenotypes [33-43]. Several 





marrow stromal cells comprise the colony-forming adventitial reticular cells within bone 
marrow and self-renew in vivo through serial transplantation experiments [44-47]. 
MSCs are of great interest for cell-based therapies because they can be easily 
isolated and expanded in vitro with a high rate of proliferation without phenotypic 
changes before lineage-specific differentiation [48, 49]. MSCs are endowed with 
clonogenic capacity when plated at extremely low density (1-2 cells/cm
2
) in vitro as 
evidenced by their ability to generate colony-forming unit-fibroblasts (CFU-F) for up to 
at least 4 passages without spontaneous differentiation and maintenance of normal 
karyotype and telomerase activity [35, 50-56]. The high proliferation rate of stem cells 
combined with the ability of these cells to remain in an undifferentiated state can result in 
a dramatic increase in the expansion of total cells while in culture, making it relatively 
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easy to produce enough cells to fill large tissue defects for clinical applications [48, 49, 
57, 58]. 
2.2.2 Differentiation Potential and Plasticity 
MSCs are endowed with the ability to differentiate into elements of the skeletal 
system including bone, cartilage, fat, muscle, fibroblasts and stromal cells supportive of a 
reticular vascular network and haematopoiesis [42, 59]. Through in vitro experiments, 
MSCs have been derived into: osteoblasts, which are responsible for depositing collagen 
type I remodeling it and mineralizing it to form new bone tissue and regulating energy 
metabolism in concert with adipocytes (Section 2.3.3); chondrocytes, which synthesize 
collagen type II and proteoglycans and aggrecan that form cartilaginous tissues; 
adipocytes, which convert glucose to triglycerides to store it for future metabolic 
demands and also participate in regulating energy metabolism (Section 2.3.3); fibroblasts, 
which deposit various forms of extracellular matrix and form the cellular units of 
connective tissues such as tendons and ligaments; and stromal or perivascular cells that 
stabilize vascular networks and regulate the haematopoietic stem cell (HSC) niche in 
bone marrow [42-44, 59]. Cell fate and differentiation of stem cells into these many 
phenotypes is affected by interactions between both biochemical and mechanical factors 
(Figure 2.1; [48, 49, 57, 58, 60-73]). Another integral property of MSCs is their in vitro 
plasticity (yet to be observed in vivo), characterized by the ability to acquire a phenotype 
of a more differentiated derivative under a defined set of culture conditions [74], 
followed by reversion to their original phenotype long after removal of those conditions, 
and application of a different set to produce another phenotype [39, 56, 75, 76]. A 
potential mechanism for this plasticity, similar to that present in haematopoietic stem 
cells (HSCs), is that MSCs express a subset of genes associated with the differentiation 
pathways to which they commit; differentiation along a given pathway is thus 
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characterized by increased expression of marker genes associated with this pathway and 
the decreased expression of genes related to other lineages [39, 77]. 
2.2.3 Reciprocally Regulated Programs of Osteogenesis and Adipogenesis 
The phenomena of differentiation potential and plasticity of MSCs are perhaps 
most readily discerned from examining the reciprocally regulated differentiation 
programs of adipogenesis and osteogenesis in cultures of MSCs: both RUNX2 and 
PPARγ master transcriptional regulators are present in low levels in undifferentiated 
cells, and differentiation towards one lineage completely suppresses genes associated 
with the other lineage [10, 18, 78]. Differentiation towards either pathway is regulated by 
a complex set of paracrine signals, including BMPs, Wnts, PPARγ ligands, 
corticosteroids, and growth factors [18, 79, 80] – all derived from or regulated by cells in 
the neighboring niche environment including osteoblasts, adipocytes, HSCs, and 
endothelial cells [38, 47, 80, 81]. Additionally MSC differentiation into either adipocytes 
or osteoblasts corresponds to unique intracellular redox profiles [82], and each cell type 
can further modify their extracellular redox environment [83] to be more oxidizing 
(adipocytes) or reducing (osteoblasts) – suggesting that differentiation into specific 
phenotypes is likely also regulated by redox states that are permissive to a specific 
developmental process. Importantly, the pathogenesis of osteoporosis represents a 
significant imbalance between these reciprocally regulated differentiation programs, with 
the production of excess marrow adipose tissue at the expense of osteoblasts that deposit 
new bone in the face of osteoclast resorption [2, 3, 8, 10, 11, 78, 80, 84-86]. These 
regulatory mechanisms are summarized in Figure 2.1. 
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Figure 2.1. A number of regulators control MSC fate. Adapted from [87]with 
permission. 
 
2.3  Co-Dependence and Homeostatic Control of Bone Remodeling and Energy 
Metabolism 
2.3.1 Physiological Observations  
Several physiological observations suggest that bone remodeling and energy 
metabolism are co-dependent and homeostatically regulated [3, 10, 88, 89]. Bone 
resorption by osteoclasts (derived from the macrophage lineage of HSCs) and deposition 
by osteoblasts occur in a balanced manner to maintain bone mass and quality and occur 
nearly constantly during adulthood [90, 91]. This serves to support the many functions of 
bone, including: maintaining blood calcium levels, providing mechanical support to soft 
tissues and points of contact to initiate and constrain muscle movement, supporting 
haematopoiesis, and protection of several solid organs (e.g. brain, spinal cord, heart, 
lungs). All of these demands correspond with molecular and mechanical sources of 
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regulatory feedback controls to couple bone deposition with resorption to facilitate 
homeostatic bone remodeling. Homeostatic failure results in numerous pathologies as 
described below (Section 2.3.2). This constant remodeling activity constitutes a 
significant metabolic demand and requires a constant supply of energy [24]. Indeed, 
marrow fat is non-existent at birth and immediately begins accumulating rapidly during 
the time of peak bone acquisition [3, 10, 78, 92-94]. Due to the need to promote 
longitudinal bone growth in children and adolescents and as the result of repeated loading 
and occasional injury that produces macro- and microdamage (i.e. fractures), an 
enormous energetic cost is associated with the daily destruction of bone by osteoclasts 
and the de novo bone formation to replace what has been resorbed. A purported function 
of marrow adipocytes is to provide an energy source for these catabolic and anabolic 
processes [10, 78, 95]. Otherwise, vertebrate mobility cannot be preserved [96] and 
thereby this function can be considered not as a mere particularity of vertebrate 
physiology but as a survival function for this branch of evolution. These observations 
together illustrate the essential need for there to be conserved mechanisms for both co-
dependence and co-regulation of energy metabolism and skeletal remodeling in 
vertebrate organisms.  
2.3.2 Clinical Correlates of Energy Metabolism with Skeletal Health 
2.3.2.1 Anorexia Nervosa 
Abnormities in fat metabolism associated with extreme under- (anorexia nervosa) 
and over-nutrition (obesity) in animal models and humans enable a global consideration 
of the relationship between fat and bone [4, 11]. Anorexia nervosa is characterized by 
self-induced starvation that leads to severe decreases in body fat and muscle mass among 
other physiological abnormalities such as impairment of insulin-stimulated glucose 
disposal, failure of nonoxidative glucose metabolism, and increased levels of adiponectin 
[11, 97, 98]. Together these lead to profound osteopenia and osteoporosis in adolescents 
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and adults, with some notable differences [97, 99-101]. In adults, observation of 
decreased markers of osteogenesis coupled with increased markers of resorption have 
been described, leading to the hypothesis that low osteoblast and high osteoclast activity 
are responsible for rapid and profound bone loss. By contrast, adolescents show a 
generalized reduction in bone turnover markers. Bone formation is markedly reduced, 
whereas bone resorption is increased with a paradoxical increase in marrow fat [102-
106]. Weight recovery causes increases in bone formation and decreases in bone 
resorption [107-109]. In sum, the skeletal components of this disease are directly related 
to changes in body composition and energy metabolism. 
2.3.2.2 Overweight and Obesity 
Body weight represents an important risk factor for vertebral and hip fractures 
since it impacts both bone turnover and bone density [7, 94, 110], yet there is a 
controversy over whether this is in fact protective or detrimental for skeletal health. 
Confirming results observed in patients with low body mass index (BMI; e.g. anorexia 
nervosa, see Section 2.3.2.1 above), a recent meta-analysis clearly indicated that high 
body mass index is protective against total fractures, osteoporotic fractures and hip 
fractures and is seen equally in men and women [111]. Those long-standing observations 
imply that adipose tissue not only insulates the skeleton but may also exert an increased 
mechanical load to cortical elements of the bone that provides a cue for more bone 
deposition [112]. This would seem to indicate that overweight and obese individuals are 
protected from low bone mineral density and bone quality. Additionally, adipose tissue 
produces leptin (see Section 2.3.3) that may directly stimulate bone formation [26, 27]. 
However, several cohort studies have indicated that when fat and lean masses are 
measured with dual-energy X-ray absorptiometry (DXA), fat mass alone was found to be 
a significant risk factor for hip fractures in adults [113-115] and numerous areas of 
fracture in children [116]. During ageing, menopause and glucocorticoid therapy, fat 
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mass is increased or redistributed from subcutaneous to visceral depots at a time when 
bone mass is declining [7]. In addition, a recent clinical investigation showed an 
association between metabolic syndrome (i.e. visceral obesity, high glucose, high 
triglycerides, hypertension and low high-density lipoprotein; all linked to insulin 
resistance) and osteoporotic non-vertebral fractures [117]. Another series of 
investigations have demonstrated that marrow fat positively correlated with increased 
visceral fat in obese women and that this is also associated with poor bone quality and 
osteoporosis [86, 118]. Potential mechanisms for reduction of bone quality (rather than 
density) by excess fat include adipocytic production of pro-inflammatory cytokines that 
impair bone formation [119], stimulation of resorption and activation of PPARγ in MSCs 
by fatty acids (see Section 2.2.3; ref. [7]), and leptin-mediated inhibition of bone 
formation and activation of resorption via the sympathetic nervous system (see Section 
2.3.3; ref. [26, 27, 120]). Together, these results suggest that there is a significant yet 
complex interaction between obesity and skeletal health. 
2.3.2.3 Diabetes Mellitus 
Dysregulation of glucose metabolism as a consequence of diabetes mellitus (DM) 
also has adverse orthopaedic consequences. Both Type I and Type II diabetes mellitus 
(T1DM and T2DM, respectively) are associated with an increased risk of osteoporotic 
fractures [121-123]. Bone formation and osteoblast function are impaired with patients 
with T1DM, while bone mineral density is increased but bone quality is reduced in 
patients with T2DM. This is coupled with an increased infiltration of fat in the bone 
marrow cavity [7]. Together these consequences are worsened in patients with poorer 
glycemic control [124]. Notably, the two types of DM are associated with different 
insulin phenotypes. Whereas there is a complete absence of insulin in T1DM that is 
supplemented pharmacologically, T2DM is characterized by insulin resistance. As insulin 
is a central regulator of bone-fat crosstalk (see Section 2.3.3), this could have profound 
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implications for the differences in pathological sequelae between Type I and Type II DM. 
Additionally, pharmacological treatments of T2DM also differentially affect the balance 
of osteogenesis versus adipogenesis by targeting Runx2 and PPARγ2, respectively [125]. 
Glitazones are PPARγ2 ligands, which activate adipogenesis in MSCs and suppress 
osteogenesis by indirectly inhibiting Runx2 expression [125]. Metformin stimulates 
osteoblastic differentiation of MSCs through transactivation of Runx2. Further, 
gestational diabetes during pregnancy in expectant mothers results in poor skeletal 
growth and bone mineral quality in postnatal infants [126-128]. The mechanisms of 
pathogenesis of osteopenia and osteoporosis secondary to DM are poorly understood as 
research has focused on a few in vitro studies and correlation with serum biomarkers 
[125]. Elevated levels of glucose induce apoptosis and replicative senescence in MSCs 
and reduce their colony formation and osteogenic capacity [129-132]. In immortalized 
osteoblastic cell lines, exposure to high glucose decreases proliferative capacity, 
mineralization and osteocalcin responses to parathyroid hormone (PTH) and Vitamin D 
administration, dysregulates collagen I synthesis, and leads to decreased expression of 
differentiation markers [133-136]. In murine 3T3-L1 adipocytes, high glucose 
administration leads to decreased insulin sensitivity, triglyceride storage dysregulation, 
production of reactive oxygen species (ROS) and pro-inflammatory cytokines, and 
decreased adiponectin secretion [137-139]. 
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2.3.3 Knowledge of Feedback Loops Gained from Mechanistic Studies in Animal 
Models 
 
Figure 2.2. Several distinct intercellular signaling networks that link bone and fat. 
Adapted from [9] with permission. 
Elegant experimental studies in mice have confirmed that several homeostatic 
feedback loops exist between adipocytes and osteoblasts to regulate bone remodeling and 
energy metabolism. Adipocytes secrete adipokine hormones in addition to their fat 
storage and release functions [140-143]. Leptin secreted by adipocytes acts on 
serotonergic neurons in the brainstem, which synapse in the hypothalamus and increase 
sympathetic output, causing increased catecholamine signaling to β2 adrenergic receptors 
on osteoblasts, decreasing their proliferation and stimulating osteoclast-mediated 
resorption [120, 144, 145]. Leptin, via the same pathway, also reduces bioactivity of 
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osteoblast-derived osteocalcin (bone γ-carboxyglutamate (gla) protein) via positive 
regulation of a γ-carboxylase that increases carboxylation of its glutamic acid residues 
and enhances its binding and retention to bone mineral hydroxyapatite [23]. Bioactive 
(uncarboxylated) osteocalcin: 1) induces pancreatic β-cell proliferation and insulin 
secretion; and 2) increases adiponectin secretion by adipocytes, which serves to enhance 
insulin sensitivity in target cells (adipocytes, myocytes, and hepatocytes) [25, 146]. 
Insulin signaling, in turn: 1) stimulates osteoblast differentiation and osteocalcin 
expression [147]; and 2) decreases osteoprotegerin expression in a FOXO1-dependent 
manner, promoting bone resorption and acidification of bone extracellular matrix (ECM) 
by osteoclasts that decarboxylates and releases osteocalcin [22]. Notably, dysregulation 
of one or more of these pathways may manifest clinically as a metabolic disorder (e.g. 
anorexia nervosa, overweight and obesity, and diabetes mellitus; see Section 2.3.2) that 
secondarily lead to the osteopenia and eventually osteoporosis after chronic illness. 
2.3.4 Potential Roles of MSCs 
This evidence clearly supports the existence of an interplay that exists between 
osteoblasts and adipocytes within the bone marrow niche. Critically, evidence that MSCs 
may play an integral role in this process is beginning to accumulate in the literature [10, 
78]. As described in Section 2.2.3, MSCs are a source of both osteoblasts and adipocytes, 
and the balance of their lineage allocation to either cell type is regulated by a complex 
network of pleiotropic, interdependent, and antagonistic cues (see Figures 2.1 and 2.2; [2, 
7, 8, 10, 11, 18, 78-86]). Osteopenia and osteoporosis, whether primarily induced by age 
or menopause or secondarily induced by anorexia nervosa, obesity, or diabetes, are 
accompanied by increased fatty infiltration of bone marrow that suggests an imbalance of 
this lineage allocation and an altered (perhaps detrimental) microenvironment [10, 78, 86, 
95, 106, 118, 148-153]. In vitro studies have confirmed that human and murine MSCs 
express leptin receptor [154-156] and are responsive to leptin, both through enhanced 
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proliferation and differentiation into the osteoblastic lineage [155, 156], as well as 
through inhibition of MSC differentiation into adipocytes [154, 156]. Additionally, a 
population of nestin-expressing MSCs in the bone marrow of mice simultaneously 
contribute to skeletal formation, provide cues for maintenance of haematopoietic stem 
cell localization and mobilization, and alter their proliferative and osteoblast 
differentiation responses to direct neural (sympathetic) and hormonal (G-CSF and PTH) 
stimulation [47, 157, 158]. 
2.4 Patterning of Hydrogels and Encapsulated Cells 
2.4.1 Hydrogels as Biomaterials for Modeling Microenvironments 
 Given the plethora of complex questions that arise in stem cell research, 
increasingly complicated model systems are required to fully capture the biological 
events that are occurring as these cells interact with their local microenvironment. In vitro 
systems that achieve spatially and temporally controlled interactions between stem and 
native cells would yield improved understanding of cellular functions that induce healing 
in vivo. To provide relevant test beds for regenerative medicine therapies, such in vitro 
systems should mimic 3D tissue architecture as closely as possible, given that cellular 
responses can vary substantially from 2D culture [159]. Toward this end, the use of three-
dimensional (3D) hydrogel biomaterials as cell carriers has enabled researchers to 
address many complex questions regarding the role of specific niche components and 
architecture in regulating the dynamic responses of stem cells to well-defined model 
microenvironments [160, 161]. Hydrogels are 3D networks composed of chemically or 
physically crosslinked, hydrophilic, polymer chains that absorb large quantities of water 
while remaining insoluble in aqueous media [162-166]. Specifically, hydrogels are 
appealing for biological applications due to their cytocompatibility [167-170], 
mechanical properties similar to many soft tissues [169, 171], and high water content 
which allows for the formation of thick constructs (up to 1.5–2 mm) with viable cells 
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embedded throughout the gel and free diffusion of soluble factors between encapsulated 
cells [164, 165, 172, 173]. The 3D biomimetic microenvironment provided by patterned 
hydrogels may allow for the probing of stem cell response to external stimuli in a well-
defined and observable manner and is therefore an excellent candidate for building 
controlled model systems [65, 72, 174-176]. 
2.4.1.1 Candidate Hydrogel Materials 
Hydrogels may be prepared from natural or synthetic polymers using various 
methods discussed later in this section [177, 178].  Hydrogels can be derived from natural 
polymers such as collagen, hyaluronic acid (HA), fibrin, alginate, agarose, and chitosan 
[179].  Many natural polymers, such as collagen, HA, and fibrin, have been used in tissue 
engineering applications because they are either components of or have macromolecular 
properties similar to the natural ECM [171, 174, 180-182].  Alternatively, alginate, 
agarose, and chitosan are hydrophilic, linear polysaccharides derived from marine algae 
sources or crustaceans [183, 184].  Another naturally derived gel, Matrigel™, is derived 
from soluble basement membrane extract of mouse tumors [185].  Various natural 
polymers have specific utilities and properties based on their origin and composition 
[174, 186], including inherent biodegradability and biologically recognizable moieties 
that support cellular activities [164, 186]. 
Synthetic hydrogels are appealing for tissue engineering due to the amount of 
control scientists have over structure, such as cross-linking density, and tailored 
properties, such as biodegradation, mechanical strength, and chemical and biological 
response to stimuli [174, 186].  Synthetic polymers such as poly(ethylene glycol) (PEG) 
[187] and other PEG-based polymers [188, 189], or poly(vinyl alcohol) can be 
reproducibly produced with specific molecular weights, block structures, degradable 
linkages, and cross-linking moieties [190].  These features can be individually modulated 
to affect gel formation dynamics, cross-linking density, and mechanical and degradation 
properties of the material.  Hydrogels made from synthetic polymers like PEG do not 
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possess the inherent bioactive properties of gels made from natural polymers.  However, 
they do have well-defined structures and are versatile templates for subsequent 
modifications that yield tailorable degradability and functionality [164, 174]. 
2.4.1.2 PEG-Based Hydrogels and Their Functionalization 
Poly(ethylene glycol) (PEG) is a non-adhesive synthetic material that is highly 
resistant to protein adsorption, making it an especially attractive material for allowing 
freely diffusing cell-derived signals to be transported between encapsulated cells [191-
193]. PEG’s mechanical and biochemical properties can be easily modified for a variety 
of tissue engineering applications [194-196]. As such, PEG-based materials provide a 
template upon which additional bioactive functionality can be specifically tailored into 
the hydrogel formulation. Functional peptides such as the adhesive peptides glycine-
arginine-glycine-aspartic acid-serine (GRGDS) and tyrosine-isoleucine-glycine-serine-
arginine (YIGSR) and growth factors including TGF-β, bFGF, and VEGF have been 
tethered into PEG networks to modulate cell response [197-201]. PEG hydrogels have 
been extensively investigated for bone, cartilage, vascular, and neural engineering [196, 
201-207]. Collectively, these studies have demonstrated the ability of biofunctionalized 
PEG hydrogels to support viability, spreading, proliferation and ECM deposition by 
multiple cell types, directed differentiation of stem cells, and more complex functions 
such as endothelial tubulogenesis, vascular infiltration, and neurite extension. 
Biodegradable hydrogels have been favored for biomedical applications since 
they degrade in clinically relevant time-scales under relatively mild conditions, thus 
eliminating the need for additional surgeries to recover implanted gels and allowing for 
progressive replacement of the biomaterial by native or regenerated tissue [165, 186, 208, 
209]. They are advantageous for in vitro applications because they facilitate cell 
spreading, proliferation, migration and deposition of extracellular matrix to better mimic 
native tissue environments [209, 210]. Currently, the fabrication and modeling of 
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hydrolytically degradable hydrogels [209, 211, 212] are well developed and the synthesis 
and utilization of synthetic gels incorporating biological moieties for enzymatic 
degradation are under investigation [209, 213, 214]. While hydrogels made from natural 
polymers are often enzymatically degraded, synthetic hydrogels containing biological 
moieties often offer more controlled degradation rates due to their tunable 
physicochemical properties [164]. Hydrolytically labile components have been added into 
PEG networks to control degradation [203, 215], and enzymatically degradable peptides 
have also been incorporated within PEG hydrogels for cell-mediated degradation [216-
218]. More recently, novel photodegradable groups have been investigated as a means to 
degrade PEG networks on demand in the presence of ultraviolet (UV) light [219-221]. 
These methods have been designed with the ability to elicit a cellular response (e.g. 
migration, spreading, and proliferation) in vitro or to eventually fully degrade via 
hydrolysis or cell-mediated enzymes in an in vivo setting to promote regeneration. None 
have been employed thus far for cell retrieval. 
2.4.2 Micropatterning of Hydrogels and Encapsulated Cells 
2.4.2.1 Gelation Mechanisms 
Several modes of crosslinking PEG-based hydrogels have been developed, 
including free-radical crosslinking of conjugated acrylate groups (e.g. with PEG-
diacrylate, PEG-DA), where polymerization occurs through a chain-growth mechanism 
that involves chain transfer of the radical to a free double bond on another acrylate group 
[222]. Commonly used radical initiators include the thermodynamically driven 
combination of ammonium persulfate (APS) and tetramethylethylenediamine (TEMED) 
redox initiators, as well as the photosensitive Irgacure 2959 (I-2959 or D-2959; [223-
226]). Both of these techniques lend unique capabilities for spatially and temporally 
controlled patterning of hydrogels and the cells encapsulated within them and are 
accompanied by differences in resolution and fidelity in the geometries produced. 
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Thermally induced free radical polymerization is particularly advantageous for 
micromolding applications and producing large constructs since polymerization occurs 
homogeneously throughout the bulk material. Photo-induced free radical polymerization 
(photo-polymerization) is uniquely suited to photo- and stereolithographic approaches, 
offers temporal control of polymerization due to the short half life of light-induced 
radicals, and produces components that can be assembled post-encapsulation and 
manipulation. The cytotoxicity of several redox and photointiating systems has been 
examined and it was determined that redox-initiating system toxicities are dependent, in 
part, on the pH of the initiator [227] while photoinitiator system toxicities are based upon 
initiator chemistry and concentration [228, 229].  Additionally, radical concentration and 
length of cell exposure to radicals and UV light has significant effects on cell viability 
[229, 230]. Use of these initiation systems in microscale patterning has thus far been 
limited because of oxygen free radicals that may potentially hinder the cross-linking 
reaction by quenching activated photoinitiator or terminating polymer free radicals 
prematurely [231-233]. 
Alternative step-growth crosslinking mechanisms, including Michael-type 
addition and “click” chemistry, have been utilized for crosslinking of PEG-based 
materials, and these techniques can also be used together with chain-growth initiators for 
sequential or mixed-mode crosslinking reactions to provide orthogonal modes of 
crosslinking for further spatial control [222, 234-237]. An attractive feature of these 
cross-linking mechanisms is that they do not require additional components like initiators 
[238]. Studies utilizing these cross-linking mechanisms verified that the conditions 
required for chemical cross-linking do not adversely affect cells; however, gelation rates 
are typically slower compared to radical chain polymerizations, and the addition of 
catalysts may negate the ability of these systems to maintain cell viability during the 
encapsulation process [168, 234-237]. 
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2.4.2.2 Patterning Methodologies 
  Novel micropatterning techniques have been adapted to pattern hydrogel 
biomaterials with different cells or ligands at the microscale in an effort to probe the 
basic mechanisms of cell interactions with their surrounding microenvironments. These 
include extracellular matrix components, physical contacts with neighboring cells, and 
the presence of soluble paracrine signals. 
 In photolithography, a photomask containing opaque patterns is placed over a 
macromer solution containing a photo-initiator and then exposed to UV light to initiate 
free radical polymerization [173, 239, 240].  Only the hydrogel precursor solution that is 
exposed to the UV light through the transparent regions of the photomask will crosslink 
to create hydrogels [73, 241]. Photolithography is versatile since can be used with a 
variety of multifunctional macromers [173, 242] and can be adapted for utilization in 
other lithographic techniques such as laser scanning lithography [243, 244] and stop-flow 
lithography [245, 246] as well as micromolding techniques [247]. A trade-off exists 
between pattern resolution and the sample thickness (i.e. large sample thicknesses 
sacrifice resolution and result in a loss of feature fidelity) [173, 230, 248]. 
Laser-scanning lithography (LSL) employs a laser-scanning confocal microscope 
to pattern photosensitive materials in a static reservoir [243, 249]. This technique 
facilitates accurate alignment of successive exposures, achieves resolution on the scale of 
microns, and allows control over laser type, power, and pixel exposure time [244]. 
However, LSL exposes the sample “pixel-by-pixel”, and therefore is a serial technique 
and generally low throughput. A variation of LSL, known as optofluidic maskless 
lithography (OFML) uses programmable exposure patterns with spatial light modulators 
instead of traditional photomasks and the continuous flow of photosensive polymer 
within microfluidic devices to supply the nonpolymerized material into the 
photopatternable region [250]. This method also takes advantage of 
microelectromechanical systems (MEMS)-based high-speed SLMs to dynamically 
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control the shape of polymerized microparticles and to improve the throughput, which is 
especially attractive when generating a large number of constructs [250-252].  However, 
OFML often necessitates complex programs for changing materials on the fly and 
expensive setup equipment. 
  Micromolding is another useful technique for forming micropatterned hydrogels 
that often utilizes a micropatterned master that determines hydrogel shape to mold 
replicas for repeated fabrication [253-256].  The advantages of the micromolding 
technique are that it is relatively inexpensive, high-throughput, easy to perform, and the 
fidelity is well-controlled [254, 255, 257].  The spatial resolution of micromolding 
technique can be high, but is significantly dependent on the aspect ratio of the structure 
(width to depth), the cross-linking chemistry of the gel, and the resolution of the 
technique used to make the master.  In general, it is possible to pattern structures with a 
resolution on the order of a cell. However, the difficult of extracting fabricated gels 
increases as their size becomes smaller, and a new master has to be fabricated each time a 
new pattern is designed. Additionally, assembling and laminating molded gels into 
hierarchical structures to mimic tissues is difficult to do manually and therefore non-
trivial [253-257]. 
2.4.2.3. Applications of Micropatterning Techniques 
Several techniques such as surface patterning, micromolding, and 
dielectrophoresis have been used to pattern structures in gels [62, 258, 259]. 
Photopatternable polymers [260-267], in combination with patterning techniques for cell 
encapsulation [268-271], offer a promising potential solution to further understand these 
mechanisms.  Photopatterning techniques have enabled researchers to precisely define 
ECM density and type, as well as cellular locations, proximity to each other, and cell 
density [270, 272-276]. Bhatia and colleagues have demonstrated a combined multiphase 
photo- and electo-patterning technique for precisely patterning different cell types in 
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isolation or in clusters within hydrogels at 50-500 µm resolution with high cell viability 
[258, 277], and demonstrated that 3D spatial information encoded by cell density affects 
chondrocyte variably affects chondrocyte differentiation and matrix production [259], 
Khetan and Burdick have applied a sequential crosslinking process whereby the 
presentation of protease-degradable peptides and adhesive ligands with hyaluronic acid 
hydrogels are spatially controlled in three dimensions to control cell outgrowth from 
chick aortic arches and dictate MSC fate decisions in mixed differentiation media by 
controlling cell spreading [64], Stereolithography, an additive process using light-curable 
photopolymer solution and a computer-guided laser to polymerize components layer-by-
layer, has facilitated patterning of multiple layers of cells in three dimensions [249, 278, 
279]. A multilayer photolithography scheme, using a mask to spatially control light 
penetration and photocuring, has been developed by Tsang et al to pattern hepatocyte 
cultures, showing that cells in three-dimensional culture better mimic in vivo functions 
[271]. Another innovative patterning system from Maeda et al creates 3D multi-
compartmental alginate particles through the use of centrifuge-based micro-droplet 
formation from a multi-barreled capillary tube [280].  
Recently, several approaches have been developed that employ microfluidic 
devices in combination with these photopatterning techniques to engineer more high-
throughput polymerization of microscale, cell-laden hydrogel particles [233, 281-288]. 
Doyle et al have developed stop-flow lithography (SFL) techniques that rely on the 
projection of a photomask upon a focal plane with a microfluidic channel that is filled 
with a photopolymerizable polymer solution [285-288]. Features of the photocross-linked 
particles made using SFL such as size, shape, swelling behavior, and composition can be 
tailored independently through mask selection, optical exposure intensity, and polymer 
composition.  Furthermore, SFL may take advantage of laminar flow regimes in 
microfluidic devices to co-flow unique polymer combinations in adjacent streams without 
mixing and patterning across these streams to fabricate single particles with several 
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orthogonal chemistries. Stroock et al have combined fluid delivery and molding 
techniques to create pattern microfluidic scaffolds in alginate for uniform delivery of 
solutes through a bulk scaffold and controlled delivery of solutes to different regions 
within the bulk hydrogel [289]. This technique was later expanded for patterning co-
cultures of endothelial and perivascular cells surrounding a microvascular network within 
bulk collagen gels that allowed perfusion of whole blood to generate a model of 
angiogenesis and thrombosis [290]. Günther and colleagues  contributed another recent 
innovation by developing a multilayer microfluidic platform that enables one-step, 
continuous formation of “mosaic” hydrogels [291]. This device enables a secondary 
biopolymer with potentially orthogonal chemistries and carrying different molecular, 
colloidal, or cellular contents to be dynamically incorporated and patterned within a 
flowing biopolymer sheet prior to crosslinking. This could be used to encode and 
preserve gradients and precise spatial localization of cells and biomolecules since the 
alginate base material can be ionically crosslinked as it exits the device. These studies 
demonstrate that micropatterning techniques applied to photopatternable biomaterials are 
very attractive ways of fabricating well-defined co-culture systems, and that it is feasible 
to tailor the chemistry of the gel for a variety of applications. However, to date, precision 
systems for photopatterning hydrogels have not been developed for long term (~ weeks) 
co-culture of cells in constructs of tissue-scale thickness (> 1 mm thick, or on the order of 
> 100 cells thick). 
2.5 Co-Cultures to Examine Interactions between MSCs, Osteoblasts, and 
Adipocytes 
2.5.1 Studies with Conditioned Medium 
Conditioned medium systems, in which the cell culture medium from one cell 
type is used to incubate another cell type, have been useful in identifying soluble factors 
involved in MSC trophic signaling effects on other cell types [292-295]. In particular, in 
 29 
a study by Maxson and Burg [296], murine MSCs undergoing osteogenic differentiation 
increased alkaline phosphatase production in response to adipocyte-conditioned medium. 
Conversely, MSCs undergoing adipogenic differentiation demonstrated increased 
triglyceride production and enlarged lipid vesicles in response to osteoblast-conditioned 
medium. Importantly, this study demonstrated that conditioned medium (one-way 
signaling) from osteoblasts and adipocytes enhanced each others’ differentiation, 
supporting the co-dependence results discussed above (Section 2.3).  
2.5.2 Co-Culture of Two Cell Types 
To elucidate the effects of two-way crosstalk, several two-dimensional (2D) co-
culture systems allow co-culture of two cells types separated by a semi-permeable 
membrane (e.g. transwell) to allow diffusion of soluble signals between cell populations 
while preventing direct cell-cell contact. Critically, these systems rely on monolayer 
culture on separable inserts to enable separation and examination of cell population after 
the co-culture period, an attribute that is currently lacking in analogous 3D co-culture 
systems. 
Current studies have examined the effects of co-culture of osteoblasts and MSCs 
in transwell systems [294, 297, 298] or in direct contact with each other [297]. In one 
study, murine osteoblasts co-cultured with MSCs in a transwell system showed no 
change in proliferation or gene expression over 3 weeks in dexamethasone-free medium 
[297]. The co-cultured MSCs, however, demonstrated increased expression of Runx2, 
Osx, Opn, and Ibsp after 3 weeks and demonstrated significantly enhanced mineralization 
compared to MSC-only controls. Similarly, human MSCs co-cultured with human 
osteoblasts (1:2 ratio) in a transwell system exhibited upregulation in IBSP, LEPR, ALPL, 
and BGLAP after 14 days [294]. Increased secretion of Wnt by osteoblasts was observed 
with a concomitant increase in β-catenin and TCF/LEF1 levels, and downstream effectors 
of Wnt in MSCs cultured indirectly with osteoblasts [297, 298].  These results both 
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indicate that paracrine signals from osteoblasts can induce MSCs into a more osteogenic 
phenotype by upregulating both early and late bone markers over time. 
To date, strikingly few studies have been conducted to examine the effects of co-
culture with adipocytes on MSC function [299, 300] and none have examined how MSCs 
influence adipocytes. This is likely attributable, in part, to the difficulty in culturing 
plated adipocytes that fail to maintain plate attachment after accumulating significant 
amounts of intracellular lipid stores. Transwell co-culture of human MSC-derived 
adipocytes with undifferentiated human MSCs led to increased expression of PPARG2 
and LEP with a concomitant decrease in COL1A2 and no change in RUNX2 or ALPL 
expression after 48 hours [299]. In the same study [299], MSC-derived osteoblasts 
demonstrated increased PPARG2, LEP, and LPL expression coupled with increased 
ALPL expression and activity and decreased BGLAP expression after 48 h in co-culture 
with MSC-derived adipocytes. Another study demonstrated decreased proliferation (
3
[H]-
thymidine incorporation) of human osteoblasts but not MSCs in the presence of 
adipocytes after 20 hours of co-culture [300], with this decrease attributable to ligation of 
PPARγ with poly-unsaturated fatty acids and concomitant lower mineralization and 
expression of ALPL, OSX, BGLAP, and RUNX2 [301-305]. While these studies indicate 
that soluble factors produced by each cell type affect cell function and differentiation of 
each other, there is currently no systematic means to examine these effects in all three 
cell populations simultaneously in 3D culture. 
2.6 Approaches Using Systems Biology to Understand Cell Fate and Applications to 
Tissue Engineering 
 Systems biology integrates multivariate molecular-level measurement and 
modeling approaches to seek a deep quantitative understanding of complex biological 
processes [306]. Methods for high-throughput, multivariate analyses of high-content data 
currently have yielded systems-level information of complex cellular processes at or 
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close to a single-cell level. This includes quantifying the abundances and activities of 
molecular components involved in gene expression, metabolism, and signal transduction 
[307-309]. Often this collected information is subjected to data-driven modeling of cell 
signaling and behavioral phenotypes using a wide spectrum of computational modeling 
approaches, such as differential equation-based physiochemical models [310], principle 
component analysis (PCA) and partial least-squares regression (PLS/PLSR) [311-315], 
decision trees [316-318], and Bayesian networks [319, 320]. With respect to resolution 
and prediction of stem cell differentiation, Platt et al compared multi-pathway kinase 
signatures using PLSR to discover states of the kinase signaling network during stages of 
osteoblastic differentiation of MSCs [321]. Single cell expression profiling of blastocyst-
stage embryonic cells in combination with PCA revealed three molecularly defined cell 
populations and elucidated their developmental progression as the blastocyst further 
developed into an embryo [322]. Multi-dimensional scaling has also been used to extract 
and process cytoskeletal features from imaging data during MSC culture in 
differentiation medium to forecast osteogenic versus adipogenic lineage commitment 
within 24 hours, well before histological stains showed evidence of differentiation [63]. 
 Systems-level models of tissues require experimental data of activities of a 
plethora signaling molecules and responses of multiple cells across a diverse combination 
of treatments, perturbations, and time points. This is due to the fact that tissue functions 
are attributed to complex interactions between the numerous components of a cell and 
interactions between cells in a tissue that form a network, rather than individual 
molecules [306, 323, 324]. To illustrate the advantages of such systems, Kirouac et al 
cultured non-adherent blood progenitors (haematopoietic stem cells, or HSCs) under 
defined conditions that were differentially supportive of blood stem cell growth via non-
stem cell autonomous mechanisms [325]. Using a combination of high-throughput 
molecular profiling, database and literature mining, and mechanistic modeling, they 
demonstrated that specific secreted factor-mediated intercellular communication 
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networks regulated HSC fate decisions and reconstructed the intracellular signaling 
network in an attempt to link extracellular signals with intracellular pathway activation. 
The study of these intercellular networks was facilitated by the ability to isolate cell 
populations and secreted factors from liquid culture due to the non-adherent nature of 
HSCs. Further work to elucidate the structure of these networks and perturb them is less 
prevalent in the literature for adherent stem cells and their progeny due to the inability to 
isolate individual cell populations from 3D scaffolds typically employed for tissue 
engineering. This has so far been studied in two-dimensional (2D) cultures of endothelial 
cells as data regarding their growth, network formation, and signaling are readily 
amenable to methods used in standard cell culture [326, 327]. 
2.7 Summary 
 In conclusion, many technical hurdles remain in optimizing model systems, 
generating novel analysis techniques, and understanding the biological interplay between 
MSCs, osteoblasts, and adipocytes and its relevance to homeostatic processes and 
dysregulation of bone and energy metabolism. Integration of information and tools from 
each of these scientific areas is key to informing, developing, and interpreting the work 








3.1  Introduction 
 Stem cells are attractive for a plethora of regenerative medicine applications due 
to their presence in many tissues of the body and capacity for proliferation and 
differentiation along multiple lineages [328, 329]. Realizing their full potential for 
clinical application requires understanding the myriad of molecular mechanisms 
underlying fate determination, especially those that result from interactions with native 
tissues, for which a paucity of information currently exists. This knowledge will facilitate 
integration of stem cells and biomaterials to form a controlled tissue architecture that 
guides cellular differentiation, extracellular matrix (ECM) production, tissue 
organization, and optimal integration with the host to restore normal function [323, 330-
332]. In vitro systems that achieve spatially and temporally controlled interactions 
between stem and native cells would yield improved understanding of cellular functions 
that induce healing in vivo – particularly in the formation and preservation of complex 
interfaces that exist between different tissues and implanted biomaterials. Such in vitro 
systems should mimic 3D tissue architecture as closely as possible, given that cellular 
responses can vary substantially from 2D culture [159], to provide relevant test beds for 
regenerative medicine therapies. This necessitates thick, tissue-scale biomaterial 
constructs that are patterned with high fidelity and precision. 
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 Toward this end, hydrogel-based biomaterials offer tunable three-dimensional 
(3D) environments, hydration that resembles native tissue, and polymer network 
configurations that mimic mechanical and molecular transport properties of native 
ECM.[275, 333] Use of hydrogel carriers has consequently enabled researchers to 
address many complex questions regarding the role of specific niche components and 
architecture in regulating the dynamic responses of stem cells to well-defined model 
microenvironments [160, 161, 333]. Of these, synthetic poly(ethylene glycol) (PEG)-
based hydrogels are widely utilized for their cytocompatibility, intrinsic resistance to 
protein adsorption and cell adhesion, and their chemical versatility [334, 335]. Among 
others, oligo(poly(ethylene glycol) fumarate) (OPF) hydrogels have been explored as cell 
carriers for promoting structural and functional regeneration of injured orthopaedic 
tissues [336-339]. Prior work has demonstrated that OPF cross-linked with PEG-
diacrylate (PEG-DA) is cytocompatible in vitro [339], minimally immunogenic in vivo 
[337], biodegradable via ester hydrolysis [336], and customizable via tethering of 
bioactive molecules [340] in a manner similar to other PEG-based hydrogels, validating it 
as a potentially useful biomaterial for tissue engineering applications. Importantly for the 
prospect of co-culturing multiple diverse cell types, robust and mechanically stable 
interfaces can be created by laminating several OPF:PEG-DA hydrogels together [341]. 
Novel micropatterning techniques have been adapted to control the microscale 
architecture of hydrogels with different cells or ligands. This allows researchers to probe 
the cell-microenvironment interactions with extracellular matrix components and 
neighboring cells through physical contacts and soluble paracrine signals. In particular, 
photopatternable polymers [264], in combination with patterning techniques for cell 
encapsulation [259, 273, 274, 342], enable precise definitions of ECM density and type, 
as well as cellular location, proximity, and density. A multilayer photolithography 
scheme, using a mask to spatially control light penetration and photopolymerization, has 
been developed to pattern hepatocyte cultures, showing that cells in 3D culture better 
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mimic in vivo functions [343]. Recently, several approaches have been developed that 
employ microfluidic devices in combination with these photopatterning techniques to 
engineer more high-throughput polymerization of cell-laden hydrogel microstructures on 
the order of 100 μm [233, 246, 344]. However, to date, micropatterned hydrogel systems 
have not been developed for long term (~ weeks) co-culture of cells in constructs of 
tissue-scale thickness (> 1 mm thick). 
In response, we describe in this study a novel, facile photolithographic patterning 
scheme for generating and assembling thicker (> 1 mm), spatially controlled hydrogel 
constructs with high fidelity and minimal alteration in standard photo-crosslinking 
chemistry. Gel size was characterized before and after gels reached equilibrium swelling, 
and cell-laden gels were successfully laminated together into templated patterns. 
Following calibration of the system, we spatially patterned primary isolates of 
tendon/ligament fibroblasts and marrow stromal cells in a single, 1.5-mm thick construct 
as a co-culture model for interrogating stem cell interactions with injured 
tendon/ligament tissue. The patterning technique developed in this proof-of-concept 
study helps maximize diffusion between cells while maintaining spatial segregation and 
may later be used in combination with other materials to also examine the roles of 
migration or cell-cell contact in tissue formation. Importantly, these experiments 
demonstrate maintenance of cell viability for two primary-isolated cell types (bovine 
marrow stromal cells and tendon/ligament fibroblasts) over culture times relevant for 
tracking biological phenomena (up to 14 days). Accordingly, this work represents a 
simple enabling platform at the convergence of biomaterials and micropatterning that 
facilitates development of in vitro biological model systems that may further inform 
stem-cell based therapies for a variety of clinical applications. 
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3.2  Materials and Methods 
3.2.1 Polymer Synthesis and Characterization 
 OPF was synthesized as previously described [345]. Briefly, 50 g of 
poly(ethylene glycol) (PEG; nominal Mn = 10 kDa; Sigma-Aldrich) was dried by 
azeotropic distillation in toluene (Sigma-Aldrich). The dried PEG was dissolved in 320 
mL anhydrous dichloromethane (DCM; Fisher Scientific). Fumaryl chloride (FuCl; 
distilled before use; Sigma-Aldrich) and triethylamine (TEA; Sigma-Aldrich), in a molar 
ratio 1:0.9 PEG:FuCl and 2:1 TEA:FuCl, were simultaneously added dropwise to the 
PEG solution at ~0 °C over 5 h under nitrogen while the reaction was vigorously stirred. 
After addition of FuCl and TEA, the solution was continuously stirred for 48 h at 25 °C 
under nitrogen. Upon completion of the reaction, the solvent was removed by 
evaporation, and the residue was dissolved in 1 L of warm ethyl acetate (Fisher). Then, 
TEA-HCl salt was removed by filtration. The OPF was re-crystallized twice in ethyl 
acetate and washed twice in ethyl ether (Fisher). The resulting powder was vacuum dried 
at <5 mmHg and stored in a sealed container at -20 °C until further use.  
 PEG-DA was prepared as previously described [278] by combining 0.1 mmol/mL 
dry PEG (MW 3400 Da; Fluka), 0.4 mmol/mL acryloyl chloride, and 0.2 mmol/mL 
triethylamine in anhydrous DCM and stirring under nitrogen overnight. The resulting 
solution was washed with 2 M K2CO3 and separated into aqueous and DCM phases to 
remove HCl. The DCM phase was subsequently dried with anhydrous MgSO4, and PEG-
DA was precipitated in diethyl ether, filtered, and dried under vacuum. PEG-DA was 
stored in a sealed container protected from light at -20 °C until further use. 
After synthesis, the OPF and PEG-DA were characterized via gel permeation 
chromatography (GPC). A GPC system (Prominence LC-20AD, CTO-20AC, SIL-20A, 
CBM-20A, DUG-20A; Shimadzu) equipped with a refractive index detector (RID-20A; 
Shimadzu) was used to determine the molecular weights of both the PEG starting 
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material and the resulting OPF and PEG-DA polymers. The polymer samples were 
dissolved in chloroform, filtered (0.45 µm filter; Whatman) and injected into a column 
(50-100,000 Da range; Waters) at a flow rate of 1 mL/min. Molecular weights were 
determined from elution time based on a calibration curve generated from PEG standards 
(seven standards ranging in molecular weights from 1,400 – 73,500 Da; Waters). 
Samples were run in triplicate. 
3.2.2 Device Fabrication 
Photopatterning experiments were performed in a microfluidic device fabricated 
from polydimethylsiloxane (PDMS, Dow Corning Sylgard 184; Essex-Brownwell Inc) 
using micromolding [346].
 
Devices consisted of a 2 mm-thick rectangular chamber with 
three inlet and three outlet channels for efficient delivery and removal of macromer 
solution (Figure 3.1A). Briefly, a poly(urethane) master was fabricated using established 
techniques [347]. We fabricated PDMS devices by curing the device layer (10:1 
base:curing agent ratio) over the master at 70 °C for 2 h, peeling the PDMS off the mold 
and cutting individual devices to size, and subsequently bonding each to a separate cover 
glass using oxygen plasma treatment [348]. Medical grade platinum-cured silicone micro 
tubing (BB518-12, Scientific Commodities) was used for fluidic connections. Holes for 
fluidic connections were punched to a size determined by the outer diameter of the 
tubing, and the tubing was connected to the device via type 304 90°-angled stainless steel 
tubes (21 gauge; Small Parts). Luer lock dispensing needles (21 gauge; McMaster-Carr) 
were attached to the opposite ends of the tubing for eventual connection to syringes 
containing macromer solution. A contact-bonded, overlying PDMS enclosure was 




3.2.3 Calibration of Photopatterning Method 
Hydrogel constructs were photopatterned from macromer solutions containing 
OPF and PEG-DA a 50:50 in ratio by weight with 75% initial water content and 0.05% 
D2959 photoinitiator in phosphate buffered saline (PBS; Invitrogen). A series of 
photomasks containing polygonal features ranging from 1000 – 3000 µm in size were 
used to pattern hydrogels. Devices were either equilibrated with an N2 atmosphere or left 
in ambient air prior to loading the polymer solution (Figure 3.1). For devices equilibrated 
with N2, gas was initially delivered for a minimum of 30 min to the interior of the device 
via the inlet ports and subsequently delivered within a PDMS enclosure during 
crosslinking (Figures 3.1B,D). The photomask was aligned and the polymer solution 
injected and allowed to cross-link under exposure to ~10.5 mW/cm
2
 of 365 nm light (as 
measured before passing through the cover glass and mask; ~7 mW/cm
2
 of light passes 
through the glass and mask layers to reach the polymer solution) for 12 or 20 min (Figure 
3.1B). The dimensions of the hydrogels immediately after crosslinking and after reaching 
equilibrium swelling were measured using a stereomicroscope (MZ16F; Leica) and 
ImageJ software (version 1.43n; NIH). 
3.2.4 Cell Harvest and Isolation 
Fibroblasts were isolated from the cruciate ligaments and patellar tendons of 
immature bovine knee joints (Research 87). Briefly, excess tissue was removed and the 
joint capsule was transferred to a cell culture hood, where the ligaments and tendons were 
removed in a sterile fashion. The tissue was digested in a solution containing Dulbecco’s 
modified Eagle’s medium (DMEM), 5 μg/mL penicillin, 5 μg/mL streptomycin, 10 
μg/mL neomycin (PSN; Invitrogen), 10 μl/mL kanamycin (Mediatech), 1 μl/mL 
gentamicin (Mediatech), 1 μl/mL fungizone (Invitrogen) and 0.4% collagenase II (w/v) 
(Invitrogen) for 48 h, at which point the solution was filtered through a cell strainer with 
nylon mesh lining (80 μm pores; Small Parts). The harvested cells were resuspended in 
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DMEM, counted on a hemocytometer, and cyropreserved in liquid nitrogen in DMEM 
containing 20% fetal bovine serum (FBS; Hyclone, Logan, UT) and 10% dimethyl 
sulfoxide (DMSO; Sigma–Aldrich) for storage until use in cell culture experiments. 
Bone marrow stromal cells (MSCs) were isolated from the femora and tibiae of 
immature bovine hindlimbs (Research 87). Briefly, excess tissue was removed and the 
bones transferred to a cell culture hood, where they were sawed open in a sterile fashion. 
Bone marrow was removed and mixed with sterile PBS containing 1x 
Antibiotic/Antimycotic solution (A/A; Mediatech). The suspension was progressively 
filtered to dissociate or remove insoluble debris and centrifuged at 300 g for 15 minutes. 
The pelleted fraction was collected and red blood cells were lysed with 4% acetic acid. 
Remaining cells were plated at 1.6 × 10
6
 cells/mL and incubated at 37 °C for 30 min. 
Non-adherent cells were collected and plated in tissue culture flasks and cultured to 
confluency in DMEM containing 1 g/L glucose and L-glutamine (Mediatech) and 
supplemented with 10% FBS and 1% A/A. Cells were subsequently lifted using 0.05% 
Trypsin/0.53 mM EDTA (Mediatech), resuspended in DMEM containing 20% FBS, 10% 
DMSO, and 1% A/A, and cryopreserved in liquid nitrogen until further use in cell culture 
experiments. 
3.2.5 Cell Patterning and Co-Culture 
 Prior to encapsulation, tendon/ligament fibroblasts were thawed and plated at 2 × 
10
6
 cells/flask in growth medium containing DMEM, 10% FBS, 1% non-essential amino 
acids (NEAA; Mediatech), 1% HEPES (Mediatech), 1% A/A, and 50 μg/mL ascorbate 
(Sigma–Aldrich), with medium changes every 2 days. MSCs were thawed and plated at 1 
× 10
6
 cells/flask in growth medium containing DMEM, 10% FBS, 1% A/A, and 1 ng/mL 
basic fibroblast growth factor (bFGF; Peprotech), with medium changes every 2 days. 
Cells were grown to near confluency and lifted using 0.05% Trypsin/0.53 mM EDTA at 
passage 2 for encapsulation experiments. To distinguish the two cell populations during 
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co-culture experiments, fibroblasts and MSCs were differentially stained with 
CellTracker Orange CMRA and CellTracker Green CMFDA reagents (Invitrogen), 
respectively, according to manufacturer’s recommendations at one day prior to 
encapsulation. Briefly, cells were washed twice with sterile PBS and incubated with 
serum-free medium containing 10 µM CellTracker at 37 °C for 45 minutes. After 
incubation, medium containing unincorporated fluorophore was rinsed twice with sterile 
PBS and replaced with normal cell culture medium. 
 These cells were subsequently patterned into 3×5 arrays of 1.5 mm-squares with 
alternating cell types using sequential photo-crosslinking steps inside microfluidic 
devices. Completely assembled devices were sterilized using an autoclave prior to use. 
Sterilized devices were equilibrated with an N2 atmosphere for a minimum of 30 minutes 
prior to loading the polymer solution. Macromer solutions containing OPF and PEG-DA 
in a 1:1 ratio were dissolved in PBS at 90% initial water content and filter sterilized using 
13 mm-diameter syringe filters (0.2 µm pore size; Fisher Scientific). Sterile photoinitiator 
(0.05% D2959 in PBS) was subsequently mixed into the macromer solution. Cells were 
resuspended in macromer solution at a concentration of 10×10
6
 cells/mL. Prior to loading 
the device, each solution containing cells was filtered through nylon mesh with 80-μm 
pores to dissociate or remove any remaining large aggregates of cells. The first 
suspension containing one cell type was delivered into the device and patterned into 1.5-
mm cubic hydrogel blocks using 365 nm UV light for 12 min (Figure 3.3A). The 
remaining uncross-linked cell solution was washed out of the device using macromer 
solution containing no cells. A second suspension containing another cell type was 
delivered into the device and laminated to existing blocks using the same crosslinking 
parameters through the use of a second photomask. Cells patterned during the first round 
of crosslinking were protected from a second dose of UV light by overlying dark areas 
present on the second photomask. Alignment marks were included on the masks and 
device to allow for registration of laminated gels. Array constructs were extracted from 
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the PDMS devices using a scalpel and placed in 6-well tissue culture plates with 5 mL of 
DMEM containing 10% FBS, 1% NEAA, 1% HEPES, 1% A/A, 50 μg/mL ascorbate, and 
1 ng/mL bFGF. 
3.2.6 Image Analysis of Cell Patterning 
Image analysis was performed to reveal interfaces between different cell 
populations after the gel constructs reached equilibrium swelling (~24 h). Gels were 
rinsed for 45 minutes in sterile PBS to remove media, and constructs containing stained 
cells were imaged at 5x and 10x magnification on a laser-scanning confocal microscope 
(LSM 510/NLO; Zeiss). A total of 15 overlapping images were acquired for each gel 
throughout its entire thickness (~2000 μm) at 10-µm intervals. Images were analyzed 
using ImageJ software. The separate slices of each z-series were examined to verify the 
absence of an overlap between green- and red-stained cell populations. The images were 
then processed to provide single images demonstrating a non-overlapping interface 
between adjacent cell populations. To accomplish this, the green and red channels were 
merged for each image slice in the z-series, and then the entire z-series was projected 
onto a single plane using a standard deviation-based algorithm. Separate images were 
then stitched together to provide an overall view of the entire construct. 
3.2.7 Cell Viability Assessment 
 A separate set of studies was conducted to assess the effects of this 
photopatterning technique on cell viability in OPF/PEG-DA gels over a 14-day period. A 
series of 3×5 hydrogel arrays were fabricated using same methodology as described 
above and containing homogeneous populations of either fibroblasts or MSCs. Patterned 
hydrogel arrays were subsequently cultured for various time periods in culture medium 
appropriate for the specific cell type as detailed above, with media changes every 2 days.  
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3.2.7.1 LIVE/DEAD Assay 
Hydrogel constructs (n = 2) were analyzed on days 1, 7, and 14 using a 
LIVE/DEAD assay (Invitrogen) as a qualitative indicator of cell viability. Constructs 
were rinsed in sterile PBS at 37 °C and subsequently incubated in staining solution (1 µM 
calcein AM, 1 µM ethidium homodimer-1 in sterile PBS) for 30 minutes at 37 °C. After a 
second PBS rinse to remove excess dye, stained constructs were imaged with confocal 
microscopy. For each construct, 4-5 images were collected from different sections of the 
gel (stack depth = 0 – 800 µm; 10-µm intervals). 
3.2.7.2 PicoGreen dsDNA Assay 
DNA content was quantitatively assessed as a measure of cell content over time 
using the Quant-iT PicoGreen dsDNA Assay kit (Invitrogen) per manufacturer’s 
instructions [349]. Hydrogel constructs (n = 4) were collected on days 1, 7, and 14 and 
rinsed in PBS to remove media. Their wet weights were recorded and the gels were 
homogenized with a pellet grinder. Samples were mixed with 750 µL of dH2O were 
subjected to three cycles of freeze/thawing at -80 °C and ultrasonication at room 
temperature to promote cell lysis. Fluorescence of each sample was read at 485/525 nm 
excitation/emission using a plate reader (SpectraMax M2e; Molecular Devices, 
Sunnyvale, CA) and the amount of DNA per sample was determined using a standard 
curve using standards from the kit. 
3.2.8 Statistical Analysis and Multivariate Modeling 
 All measurements were compared using ANOVA and Tukey's post hoc test (p ≤ 
0.05) performed with Minitab (version 15.1.30.0; Minitab). Linear regression was 
performed to determine the correlation between mask size and the size of the resulting 




3.3.1 Characterization of Patterning Fidelity and Calibration of Gel Size 
We show that three-dimensional gels with a variety of shapes could be easily and 
reproducibly patterned using inexpensive, easily fabricated, disposable microfluidic 
devices (Figure 3.1A). Feature shapes in the xy plane roughly resembled those of the 
applied photomask for straight edges as well as concave and convex corners and arcs 
(Figure 3.1C, top view). When cross-linked under ambient conditions, these gels 
exhibited somewhat sloped side profiles and shallow thicknesses ≤ 1 mm despite 
relatively long crosslinking times (20 min), indicating incomplete polymerization of the 
hydrogel throughout its entire depth (Figure 3.1C, side view). Alternatively, efforts to 
pattern hydrogels in devices equilibrated in an atmosphere of N2 gas (Figure 3.1D) 
yielded improved results: shape features such as edges and corners were more sharply 
defined; overall hydrogel thickness was visibly greater, exceeding 1 mm for multiple 
feature types, and side faces of the gels were noticeably straighter and less sloped for the 
same crosslinking time of 20 min (Figure 3.1E). 
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Figure 3.1. OPF hydrogels can be photolithographically patterned into a variety of 
three-dimensional shapes in a controllable, high fidelity manner at the micron to 
millimeter scale. (A) 3D rendering of an inexpensive microfluidic device used for 
hydrogel photopatterning that consists of a replica-molded PDMS chamber with 
inlet and outlet ports that is plasma-bonded to a cover glass. Inset: photograph of an 
assembled device. (B) Schematic depicting a technique for simple photolithographic 
patterning hydrogels within the microfluidic device. Gel precursor solution is 
injected into the device, and patterning is accomplished by applying a photomask to 
the glass side of the device followed by crosslinking the exposed gel using a 365-nm 
UV source. (C) Multiple shapes including straight edges, concave or convex corners, 
and arcs may be generated with high fidelity. Photomicrographs illustrate top and 
side views, arrows indicate sloped walls. Insets: photomask applied for each 
patterned hydrogel. Scale bar = 1 mm. (D) Scheme depicting process of device 
equilibration in an inert N2 atmosphere to improve photo-polymerization and 
patterning fidelity. The microfluidic device is purged with N2 gas for 30 minutes 
prior to crosslinking, after which N2 is delivered to the PDMS enclosure during 
loading of macromer solution and subsequent crosslinking. (E) Pattern registration, 
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gel thickness, and side profiles are improved with photopolymerization in a N2 
atmosphere when applying the same photomask. Scale bar = 1000 µm. Figure 3.1 
continued. 
 This photopatterning technique was readily characterized and calibrated by photo-
crosslinking hydrogel blocks using masks with square sizes ranging from 0.9 – 3 mm and 
measuring gel dimensions before and after swelling. Gels cross-linked under N2 had 
widths that more closely adhered to the size of features designed into photomask, in sharp 
contrast to gels cross-linked in ambient air, which were consistently lower than the mask 
size (Figure 3.2A). For smaller feature sizes (< 2 mm), hydrogels patterned under 
nitrogen exhibited widths significantly greater than those cross-linked in ambient air, 
indicating that employing a N2 environment enables higher fidelity patterning at small 
feature sizes. Even more pronounced are the significant differences in initial gel thickness 
observed between gels cross-linked in these two environments. For large features 
approaching 3 mm in width, gels photo-crosslinked in ambient air barely approached 1 
mm in thickness (Figure 3.2B, white bars). Conversely, gel thickness exceeded 1 mm for 
all mask sizes tested using our nitrogen atmosphere system, surpassing 1.5 mm in 
thickness for larger gel widths (Figure 3.2B, grey bars). As a consequence of this novel 
crosslinking environment, a larger aspect ratios (thickness:width) could be achieved: 0.49 
– 1.19 under nitrogen vs. 0.33 – 0.51 under ambient conditions. Gel thickness and thus 
aspect ratio could be further tuned by adjusting crosslinking time, device chamber 
thickness, or initial polymer concentration (data not shown). Gels patterned in a nitrogen 
atmosphere exhibited a lower relative increase in thickness upon swelling than ambient 
air counterparts (Figure 3.2C). 
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Figure 3.2. Patterning fidelity of OPF hydrogels is enhanced under a nitrogen 
atmosphere, enabling fabrication of constructs with highly tunable aspect ratios. (A) 
Performing photopolymerization in a N2 atmosphere reproducibly generates gel 
widths closer to the size of the applied photomask, particularly at low mask sizes, 
allowing facile calibration of this photopatterning method. (B) Gel thickness before 
swelling significantly increases under a N2 atmosphere. (C) Gel width and thickness 
increase proportionally after swelling, though the extent of this increase differs 
depending on the crosslinking environment, indicating different degrees of 
crosslinking. [n = 3; mean ± s.d. for all experiments. * = significant when compared 
to same mask size without N2, p ≤ 0.05] 
3.3.2 Lamination of Multiple Gels Containing Different Cell Types 
 Monolithic, laminated hydrogel modules containing segregated cell types were 
generated through serial photopatterning within the same microfluidic device as 
described in the methods and depicted in Figure 3.3A. Using this procedure facilitated the 
creation of a templated 3×5 array pattern of adjacent gels that were well-aligned and 
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remained laminated together after reaching equilibrium swelling within 24 h (Figure 
3.3B, left). Differential staining of MSCs and fibroblasts encapsulated in alternating 
blocks revealed excellent patterning fidelity and segregation of cell populations 
throughout the entire 2-mm thickness of the gel as demonstrated through confocal 
microscopy image stacks projected onto a single plane (Figures 3.3B,C). Well-defined, 
high-fidelity interfaces including corners and straight edges existed between the two 
encapsulated cell populations, and there was negligible intermixing within the thick gels 
(Figure 3.3C). The uniformity of this pattern throughout the entire depth of the gel array 
was verified by longitudinally or transversely sectioning the construct and imaging these 




Figure 3.3. Spatially controlled, tissue scale co-culture of multiple cell types can be 
realized through serial photo-crosslinking and lamination of hydrogels into 
templated patterns. (A) Schematic illustrating serial photopatterning steps utilized 
in the fabrication of a hydrogel construct for co-culture of multiple cell types. (B) 
Left, a photograph of a 3×5 hydrogel array after swelling for 24 h. Right, a stitched, 
flattened confocal image of a portion of the array containing alternating marrow 
stromal cell (green) and tendon/ligament fibroblast (red) populations. Each cell type 
is segregated within well-defined laminated hydrogel modules that remain well-
bonded during culture. Inset: photomasks applied during each step. Scale bar = 
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1000 µm. (C) Flattened confocal image stacks (top view) of straight and cornered 
interfaces between the two cell populations demonstrate a clear interface between 
them that is preserved throughout the entire depth of the acquired stack. Scale bar 
= 100 μm. (D) Confocal images of hydrogel array cross-sections (longitudinal, left 
and transverse, right) providing further evidence that the interface between the two 
populations of cells is consistent through the entire gel thickness. Scale bar = 100 
µm. Figure 3.3 continued. 
3.3.3 Cell Viability during Long-Term Culture 
 Cell viability was qualitatively and quantitatively assessed for 3×5 hydrogel array 
constructs containing homogenous cell populations (either MSCs or fibroblasts only) 
following their extraction from microfluidic devices and culture over two weeks in their 
respective media. LIVE/DEAD assay of intact gels on days 1, 7, and 14 consistently 
revealed predominately live cells throughout the entire gel thickness when imaged with 
confocal microscopy [primary bovine tendon/ligament fibroblasts (Figure 3.4A, left); 
primary bovine marrow stromal cells (Figure 3.4A, right)]. A separate set of samples was 
analyzed for DNA content as an indicator of cell number over the two-week culture 
period (Figure 3.4B). Relative to day 1, gels containing fibroblasts exhibited a small yet 
significant decrease in DNA content at day 14, while gels with MSCs showed a slight 
significant decrease at day 7. No difference was observed between MSCs on day 14 
versus day 7. 
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Figure 3.4. Primary tendon/ligament fibroblasts and marrow stromal cells remain 
viable during long-term culture after photopatterning. (A) Confocal images of 
encapsulated tendon/ligament fibroblasts (left) and marrow stromal cells (right) 
within a serially photopatterned 3×5 hydrogel array after 1 and 14 d in culture 
stained with LIVE/DEAD reveal predominately viable cells at each time point. Scale 
bar = 100 μm. (B) Assaying for DNA content of these constructs demonstrates a 
small but statistically significant decrease over the 14-day culture period [* = 
significantly different from same cell type on day 1, p ≤ 0.05]. 
 
3.4 Discussion 
 This work presents a novel photolithographic technique for spatially controlling 
hydrogel network formation that facilitates patterning of multiple cell types into three-
dimensional hydrogel constructs of greater than 1 mm thick. Size and shape of hydrogel 
features within each construct may be reproducibly tuned and controlled through simple 
alterations in the photomask and implementation of a nitrogen atmosphere during the 
photo-crosslinking procedure (Figure 3.1). The feature sizes used to calibrate the system 
(Figure 3.2A) and the resulting gel thicknesses (Figure 3.2B) and aspect ratios 
demonstrate the versatility of this technique for patterning gels at multiple size scales. We 
 51 
postulate that the success of this technique in improving patterning fidelity and gel size 
characteristics derives from limiting the presence of oxygen free radicals that may 
potentially hinder the polymerization reaction by quenching activated photoinitiator or 
terminating polymer free radicals prematurely [231-233]. Previously, photopatterning 
hydrogels under ambient air limited the ability to generate hydrogels with features 
smaller than 1 mm and with reasonable fidelity (Figures 3.1 and 3.2), possibly due to the 
presence of oxygen at the PDMS interface into the crosslinking area; a smaller gel also 
has an increased surface area-to-volume ratio, making it more vulnerable to such surface 
dependent effects. Using PDMS devices resulted in shape features with significantly 
more rounded corners that did not adequately correlate with the shape of the photomask 
and side walls that were dramatically sloped and shallow (Figure 3.1C), but using 
nitrogen purging improved the fidelity significantly (Figure 3.1E). Furthermore, data 
demonstrating greater increase in gel thickness during swelling in gels that were cross-
linked under ambient air (Figure 3.2C) also points to a lower degree of crosslinking in 
those samples. 
 With less oxygen in the system under this novel approach, hydrogels could be 
consistently photopatterned to thicknesses approaching 2 mm with shape features that 
accurately reflected the photomask (Figures 3.1 and 3.2). Gel thickness resulting from 
crosslinking in this environment is thus primarily limited by the concentration and molar 
absorptivity of the polymer solution, the kinetic efficiency of the free radical initiation 
and propogation reactions, and the length of the polymer chains and their cross-linkers 
[350-353]. Previous efforts by other groups have demonstrated enhanced patterning 
fidelity at the microscale by altering the chemistry of the free radical polymerization 
through the use of higher concentrations of photoinitiators, the addition of short length 
cross-linkers, and the use of shorter polymer chains in an effort to induce crosslinking on 
much shorter timescales for much smaller gels [233, 245, 354]. While each of these 
potential modifications may result in improved crosslinking and fidelity of hydrogels, 
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these enhancements may be delivered at the expense of cell viability, especially for 
culturing primary cell types over long periods of time [350]. Free-radical photoinitiators 
and short length cross-linkers are cytotoxic at high concentrations [229, 350], and the low 
network mesh size that results from using low molecular weight polymers may impose 
harmful physical constraints on encapsulated cells due to their lower water content and a 
mesh size that may limit diffusion of macromolecules [355-357]. Without altering any of 
these chemical parameters and instead crosslinking under a nitrogen atmosphere, we 
simultaneously avoid these potential detriments and potentially reduce the presence of 
cytotoxic oxygen free-radicals [358]. 
 In addition to patterning of individual gels, this facile photolithographic scheme 
may be sequentially employed in the generation of multiple laminated, spatially defined 
hydrogel domains that consistently remain adherent at their interface despite the internal 
stresses generated while the gels reach equilibrium swelling (Figure 3.3B). This serial 
crosslinking process may be performed multiple times in situ within the same 
microfluidic device and enables the spatially controlled segregation of multiple cell types 
within the same laminated hydrogel construct (Figure 3.3A,B). This work demonstrates 
that this cell patterning occurs with high fidelity and with interfacial uniformity 
throughout the entire gel thickness. Confocal microscopy consistently demonstrated 
negligible overlap between two cell populations in different areas and at different depths 
within the overall hydrogel construct (Figures 3.3B-D). Consequently, these templated 
hydrogel constructs enable tissue-scale co-culture between two or more cell types in 
defined spatial locales and orientations.  
 Additionally, cell viability for two different types of primary cells, 
tendon/ligament fibroblasts and marrow stromal cells, is largely preserved for at least two 
weeks of cell culture in the laminated constructs developed in this study (Figure 3.4). 
This is possible despite the presence of UV light, the use of free-radical polymerization, 
and the low oxygen concentration present during crosslinking, all of which could have 
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been potentially harmful to the non-immortalized cell lines used in this study. Slow 
declines were observed in DNA content over time for both cell types after two weeks in 
culture (Figure 3.4B), similar to previous observations with cells encapsulated in non-
patterned OPF:PEG-DA gels crosslinked in ambient air [359]. This response may be 
attributable to the specific cell source studied or the seeding density. At each time point 
evaluated in this study, remaining cells appeared predominately viable (Figure 3.4A); it is 
conceivable that additional modifications of the hydrogels to provide additional adhesion 
or degradation sites may be required in future studies to provide a more optimal 
microenvironment that would enhance cellularity during long-term culture in OPF 
hydrogels. 
3.5 Conclusions 
 In this study, we focused on design, characterization, and preliminary in vitro 
evaluation of a novel tissue-scale, hydrogel-based scaffold for long-term, three-
dimensional co-culture of multiple primary cell types with excellent spatial control. 
Hydrogels were successfully photopatterned into well-defined shapes at 1-2 mm 
thicknesses using a modified photolithographic process in simple, inexpensive 
microfluidic devices equilibrated in a nitrogen atmosphere to enhance crosslinking. 
Shape fidelity was maintained throughout the entire thickness of the construct, and this 
system was easily calibrated to allow for the production of hydrogels with tunable sizes 
and shapes depending on user specifications. Separate hydrogel modules were 
successfully laminated together with robust, well-defined interfaces, and this process 
enabled encapsulation and spatially controlled orientation of multiple cell types in 
monolithic arrays. Cell viability of sensitive primary cell isolates, namely 
tendon/ligament fibroblasts and marrow stromal cells, was successfully demonstrated for 
up to two weeks in culture in gel arrays photopatterned using this process. The system 
developed here establishes a proof of concept for examining MSC-based therapies for 
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tendon/ligament tissue regenerative medicine strategies. Additionally, this system may be 
extended to a variety of stem-cell types to inform basic science studies of interactions 
between multiple cell types in stem-cell mediated healing, as well as to improve design of 
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4.1  Introduction 
 An improved understanding of the multiple and complex molecular mechanisms 
underlying stem cell fate determination, especially those that result from interactions with 
native tissues, is an important prerequisite for designing and implementing cytotherapies 
involving stem cells [176, 323]. As test beds, in vitro systems with spatially and 
temporally controlled stem and native cell interactions can complement, inform, and 
predict potential outcomes of in vivo studies by reducing the complexity of interactions 
the cells encounter while minimizing cost of multiple animal studies. Results from these 
studies thereby fuel knowledge of how therapeutically implanted cells might facilitate 
repair and regeneration [360, 361]. To provide relevant platforms for evaluating 
regenerative medicine therapies, such in vitro systems should mimic niche environments 
of a 3D tissue as closely as possible by allowing for dynamic cell-cell interactions, given 
that cellular responses can vary substantially depending on the surrounding 
microenvironment [61, 159]. 




 Portions of this Chapter are adapted from Hammoudi, TM, Rivet, CA, Kemp, ML, Lu, H, and Temenoff, 
JS. 3D In Vitro Tri-Culture Platform to Investigate Effects of Crosstalk between Mesenchymal Stem Cells, 
Osteoblasts and Adipocytes. Tissue Engineering A (2012). Epub Ahead of Print. 
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 Toward this end, use of biomaterials may provide a way to recreate these 3D 
environments, while allowing the study of complex cellular interactions. This includes 
the application of methods for high-throughput, multivariate analyses of high-content 
data (e.g. from gene microarrays, suspension arrays, TOF-mass spectrometry, and 
microscopy images) [62, 63, 312, 322, 327] that yield system-level information of 
complex cellular processes at or close to a single-cell level. However, innovative 
strategies that more closely mimic in vivo microenvironments need to be further coupled 
with the sophisticated methods outlined above [306].  Moreover, use of primary human 
cells (rather than immortalized mammalian cell lines), co-culture systems containing two 
or more cell types to permit better simulation of interactions within realistic 
microenvironments, and tissue-scale 3D-culture systems, have the potential to yield 
further progress toward making regenerative medicine a reality. Therefore, in these 
studies we employed an extension of novel photopatterning techniques (previously 
developed in our laboratory [362]) to generate and assemble 3D laminated hydrogel 
modules of  three different primary human cell types (mesenchymal stem cells, 
osteoblasts, and adipocytes) into millimeter-scale co- and tri-culture constructs. 
 These cell types reside in close proximity within the same bone marrow niche, 
motivating their use in this platform as a model of interactions between them. 
Mesenchymal stem cells (MSCs), which are endowed with the ability to differentiate into 
many elements of the skeletal system [37], have been used clinically for cytotherapies 
both for musculoskeletal and other disorders [42]. The MSC differentiation programs of 
adipogenesis and osteogenesis are reciprocally regulated in cultures of MSCs: both 
RUNX2 and PPARγ master transcriptional regulators are present in low levels in 
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undifferentiated cells, and differentiation towards one lineage completely suppresses 
genes associated with the other lineage [10, 18]. This phenomenon has been exploited in 
past work to evaluate how cell shape [67], substrate stiffness [60], and the 3D biomaterial 
network structure [64] differentially regulate MSC fate under defined media conditions. 
Differentiation towards either pathway is also regulated by a complex set of paracrine 
signals [10, 18] derived from or regulated by cells in the neighboring bone marrow niche 
environment including osteoblasts, adipocytes, HSCs, and endothelial cells [10, 47]. 
Conditioned media and 2D co-culture studies have provided some insight into how one 
cell type (osteoblasts or adipocytes) affects the function and differentiation of MSCs 
[296, 299, 363]. However, these experiments only model static, one-way interactions and 
there is currently no systematic means to examine the effects of multi-directional and 
dynamic crosstalk over time between multiple cell types simultaneously in 3D culture in 
a way that better mimics interactions that occur in vivo. 
 To address these limitations, we encapsulated primary human MSCs, osteoblasts, 
and adipocytes into tissue-scale co- and tri-culture constructs, as described above. In 
particular for this study, we employed poly(ethylene glycol)-based hydrogels that 
maximized diffusion of soluble factors between cell types, and that were cultured in 
media without exogenously added differentiation cues. We hypothesized that this would 
enable us to specifically evaluate effects of soluble paracrine signals derived solely from 
the encapsulated cells. As a proof-of-principle experiment, we evaluated two co-culture 
configurations (MSCs flanked by adipocytes or osteoblasts on both sides) and a tri-
culture configuration (one module each of osteoblasts, MSCs, and adipocytes; see Figure 
4.1). We hypothesized that each culture environment would uniquely affect the 
differentiation of encapsulated MSCs and functional responses of osteoblasts and 
adipocytes as a result of continuous paracrine crosstalk and feedback. After 1, 7, and 18 
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days in culture, whole constructs were either: analyzed using histochemical staining to 
assess osteogenic or adipogenic differentiation, or sectioned with a scalpel to separate 
cell populations for qPCR analysis of mRNA expression for genes from several 
mesenchymal lineages. We further incorporated the relative expression levels of each 
gene assessed at each time point into a series of multivariate analyses. This provided the 
means to ascertain the covariance between genes and to determine how the dynamics of 
these co-variant genes correlate with possible emergent cell phenotypes. 
4.2  Materials and Methods 
4.2.1 Polymer Synthesis and Characterization 
 All chemicals were purchased from Sigma-Aldrich unless otherwise noted. 
Poly(ethylene glycol)-diacrylate (PEG-DA) was prepared as previously described [278] 
from PEG (Mn = 3,400 Da). The resultant polymer had a molecular weight Mn = 3,676 ± 
16 Da with a polydispersity of 1.088 ± 0.015 as determined by gel permeation 




 To allow presentation of adhesive ligands that promote viability of encapsulated 
cells, fibronectin-derived GRGDS (PeproTech) and laminin-derived YIGSR (Anaspec) 
adhesion peptides were conjugated to a 3,400 Da molecular weight Acryl-PEG-
succinimidyl valerate spacer (Acryl-PEG-SVA; Laysan Bio) in NaHCO3 buffer (pH 8.5) 
according to previous protocols [364], dialyzed (1,000 Da MW cutoff), lyophilized, and 
stored at -20 °C until further use. 
4.2.2 Cell Culture and Expansion 
All cell culture reagents were obtained from Mediatech unless otherwise 
specified. Primary human MSCs (hMSCs) were obtained from the laboratory of Dr. 
Darwin Prockop (Texas A&M Health Sciences Center) and expanded according to 
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recommended protocols in Minimal Essential Medium-Alpha (αMEM) with 16.5% fetal 
bovine serum (FBS; Hyclone), 1 g/L glucose, 2 mM L-glutamine, 1% amphotericin B, 
and 0.1% gentamicin and cultured at 37°C with 5% CO2 in a humidified incubator [365]. 
Primary human osteoblasts (hObs; Lonza) were expanded to 7 or 8 population doublings 
according to the manufacturer’s protocol in Dulbecco’s Modified Eagle Medium 
(DMEM) with 10% FBS, 1 g/L glucose, 1% amphotericin B, and 0.1% gentamicin. 
Primary human subcutaneous pre-adipocytes (Lonza) were expanded to 3-4 population 
doublings according to the manufacturer’s protocol in DMEM with 10% FBS, 4.5 g/L 
glucose, 2 mM L-glutamine, 1% amphotericin B, and 0.1% gentamicin. Cultures at 80% 
confluence were differentiated into adipocytes (hAds) for 2 wks in expansion medium 
with 60 µM indomethacin, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 0.5 µM 
dexamethasone, and 1 µM insulin. 
4.2.3 Construct Fabrication and Long-Term 3D Co- and Tri-Culture 
Layering devices were fabricated and employed for cell patterning as described in 
Figure 4.1. Briefly, 1 mm-thick spacers were cut from cured polydimethylsiloxane 
(PDMS; Sylgard 184; Dow Corning) and contact-bonded on each side to glass slides 
(Corning). Each spacer contained a cavity for polymer solution/gels as they were loaded 
and crosslinked. Assembled devices were sterilized by autoclave prior to use for 
encapsulation. 
Hydrogel precursor solutions were formulated with 10% w/w PEG-DA in 
phosphate-buffered saline (PBS) containing 0.05% w/w D-2959 photoinitiator (Ciba) and 
1 mM Acryl-PEG-GRGDS (for hMSCs) or Acryl-PEG-YIGSR (for hAds). Cell 
suspensions were prepared from near-confluent cultures using 0.05% Trypsin/0.53 mM 
EDTA and resuspended in their respective gel precursor solutions at a concentration of 
15 million cells/mL. These solutions were loaded into layering devices and sequentially 
photocrosslinked into laminated 1 mm-thick, 1.5 mm-tall hydrogel strips (Figure 4.1). 
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After each patterning step, residual non-crosslinked material was rinsed out of the device 
with fresh 10% w/w PEG-DA solution using a syringe.[362] An opaque photomask was 
used in subsequent steps to prevent any further UV exposure and crosslinking of the 
existing gels. Single, laminated constructs were extracted from the device and sectioned 
with a scalpel perpendicular to the long axis of the laminate to yield twenty-one 1.5 mm-
wide co- and tri-culture constructs (Figure 4.1). 
 
Figure 4.1. Sample fabrication and study design. Fabrication of co- and tri-culture 
constructs using the techniques outlined in the Methods yield sample sets with well-
segregrated cell populations (Photographs: Sample tri-laminated hydrogel construct 
after reaching equilibrium swelling (left), and confocal image demonstrating hMSCs 
differentially stained with CellTracker Green (bottom) or Orange (top) segregated 
at an interface between modules). Three sample types were examined in this study: 
MSCs in the center module flanked by only one other cell type (co-culture controls) 
or by both osteoblasts and adipocytes (tri-culture). 
Co-culture constructs consisted of hMSCs flanked on both sides by hObs (OMO) 
or hAds (AMA), while tri-culture constructs consisted of hMSCs flanked on one side by 
hObs and hAds on the other (OMA). Constructs were placed in separate wells of 6-well 
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tissue culture plates with 4 mL of co-culture medium [DMEM with 10% FBS, 50 µg/mL 
L-ascorbate-2-phosphate (Sigma), 1 µM insulin, 1% amphotericin B, and 0.1% 
gentamicin; replenished every 2 days] designed by our lab to maintain each cell type in 
culture while eliminating traditional exogenous differentiation cues. Constructs 
containing only hMSCs in each module were fabricated and cultured in osteogenic or 
adipogenic differentiation medium for 21 days as a positive control to verify that 
differentiation was possible in this culture system under a standard set of cues. 
Osteogenic differentiation medium consisted of αMEM with 10% FBS, 50 μM L-
ascorbate-2-phosphate, 20 mM β-glycerophosphate (Sigma), 10 nM dexamethasone, 1% 
amphotericin B, and 0.1% gentamicin. Adipogenic differentiation medium consisted of 
αMEM with 10% FBS, 0.5 mM IBMX, 60 μM indomethacin, 1 μM insulin, 0.5 μM 
dexamethasone, 1% amphotericin B, and 0.1% gentamicin. 
4.2.4 mRNA Isolation and qPCR 
Hydrogel constructs were rinsed in PBS and blocks containing individual cell 
populations were separated from each other using a scalpel for gene expression analysis 
by qPCR after 1, 7, and 18 days in co- or tri-culture. Gel blocks containing the same cell 
type were pooled from 3 constructs of the same culture condition to provide sufficient 
copies of mRNA for quantification. These blocks were homogenized in microcentrifuge 
tubes with pellet grinders, after which mRNA was extracted using a QIAshredder tissue 
homogenizer and RNeasy kit with DNase I digestion (Qiagen).  cDNA was generated 
using SuperScript III Reverse Transcriptase (Invitrogen) with Oligo(dT)15 primers and 
dNTPs (Promega).  Gene expression of each cell type was analyzed for target 
mesenchymal lineage genes using custom-designed primers (Table 4.1) with quantitative 
PCR amplification performed on a StepOnePlus
TM
 Real-Time PCR System (Applied 
Biosystems) in the presence of SYBR Green/ROX master mix (Applied Biosystems).   
RPS18 and ACTB were both used as endogenous controls for normalization through 
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geometric averaging [366], and relative expression (n = 4 per culture type and time point) 
of each target gene was calculated using the formula:      
                
                 
 where Ct 
represents the cycle threshold for amplification. Endogenous controls were evaluated in 
each cell type to ensure that their expression levels were not altered across time or culture 
conditions [367, 368]. 
 
4.2.5 Histological Analysis for Differentiation 
 Following co- or tri-culture, whole constructs (n = 1-2 per culture type and time 
point; same times points as above) were collected for histological staining. Constructs 
were rinsed in PBS and infiltrated by graded concentrations of sucrose in PBS followed 
by graded concentrations of optimal cutting temperature compound (OCT; Sakura 
Finetek) using a technique adapted from the literature (Appendix B, [369]) and 
individually embedded in OCT, flash-frozen in liquid N2, and stored at -80 °C until 
sectioning. Embedded constructs were serially sectioned into 20 µm-thick slices (Microm 
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HM 560 Cryostat; Thermo Scientific), mounted on Superfrost Plus slides (Fisher), and 
stored at -80 °C until staining. Adipogenic differentiation was assessed with an Oil Red O 
stain for triglyceride accumulation in intracellular storage vesicles using standard 
protocols [365] and visualized with brightfield microscopy. Osteogenic differentiation 
was examined by assessing in situ alkaline phosphatase activity (Vector
®
 Red Alkaline 
Phosphatase Substrate Kit; Vector Labs). Briefly, unfixed sections were reacted with an 
alkaline phosphatase substrate in 100 mM Tris buffer (pH 8.5) according to the 
manufacturer’s protocol and counterstained with Hoechst 33258 (0.25 µg/mL in PBS for 
5 min; Molecular Probes), and visualized with epifluorescence microscopy under Texas 
Red and DAPI filters, respectively. 
4.2.6 Statistical Analysis and Multivariate Modeling 
Gene expression results are depicted as mean ± standard deviation unless 
otherwise noted. Prior to statistical analysis, all data were transformed with a Box-Cox 
transformation. Data were analyzed by multi-factor analysis of variance (ANOVA) to 
identify significant factors (cell type, culture type, day) and factor interactions (cell 
type*day, culture type*day) for each target gene assayed. Where significance factors and 
interactions were identified by ANOVA, Tukey’s post hoc test (significance level p < 
0.05) was used to determine significant differences between individual sample groups. 
 Multivariate statistical modeling was performed with the overall goal of 
extracting combinations of time-variant gene expression markers that were the most 
informative for distinguishing differences among cell types and co- or tri-culture 
conditions. All Box-Cox-transformed data were mean-centered and scaled to unit 
variance prior to analysis as a means of normalization to allow all variables to be 
considered equally scaled in the principal components or latent variables [312]. For these 
analyses, the data set (total of 504 data points) was organized into an N×K matrix X that 
denotes the measured gene expression levels with time as well as cell type and culture 
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type. Principal component analysis (PCA) was first performed to discern possible clusters 
of observations and their qualitative similarities among the global data set in an unbiased 
fashion. PCA was performed using SIMCA-P
+
 software (Umetrics) to analyze the X 
matrix and generated linear combinations of the X-variables (target gene and time; K = 
18) that described the sources of maximum variation to cluster them by their 
contributions to the variance of the entire set of X-observations (cell type and culture 
type; N = 28). Using the observed clusters, partial least squares discriminant analysis 
(PLS-DA) was then performed (SIMCA-P
+
) using an additional N×M matrix Y that 
encoded m purported classes of data (e.g. cell type or culture type) to find latent variables 
(linear combinations of the independent X-variables) that served as discriminating 
features to best separate the N observations into M different purported classes designated 
by the dependent Y-variables. In summary, PCA was used to observe the overall 
correlation structure of the gene expression data and understand how it contributed to the 
largest variance among the observations, while PLS-DA aided in separating tight clusters 
of observations and revealing the covariant genes that correlated with each class [370, 
371]. 
To optimize the quality of PCA and PLS-DA models, several pruning procedures 
were performed to remove outlying observations (outside 95% confidence interval) and 
non-influential variables (weight approximately 0 in both components) and enable 
statistical significance-testing of the model and the variables used to generate it [370, 
372]. The quality of each model was summarized by two non-dimensional statistical 
parameters: 1) R
2
X (for PCA) or R
2
Y (for PLS-DA), which quantitatively measure the 
extent to which the model explains the variation in the data matrices and dictate a 
goodness of fit; and 2) Q
2
, which quantitatively measures the extent to which the 
variation of a future experimental data set may be predicted by the model (goodness of 
prediction) [372]. Both of these parameters are analogous to regression statistics, with a 
value ranging from 0 (poor) to 1 (perfect) fit or predictive capability. The appropriate 
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number of principal components or latent variables was determined by cross-validation 
[370, 372]. The results of this procedure were fed into a jack-knifing analysis [370] to 
calculate the standard errors of the regression coefficients (weights), which were then 
converted into 95% confidence intervals via the t-distribution to determine which X-
variables (genes) of high weight have a statistically significant influence (p < 0.05) on 
each class of observations (Y-variables) in each of the PLS-DA models generated (Figs. 
5D and 6D-F). 
4.3 Results 
4.3.1 Gene Expression Dynamics and Histochemical Staining 
We demonstrate that each of the examined mesenchymal lineage genes (Table 1) 
exhibited expression dynamics in each cell type with time that appeared to vary 
depending on the co- or tri-culture condition employed (Figures 4.2-4.4). Certain genes 
were often uniquely variable only within a particular cell type, with MSCs exhibiting 
time-variant changes in most of the genes examined (Figure 4.4), while adipocytes 
(Figure 4.2) and osteoblasts (Figure 4.3) exhibited changes in expression among only two 
or three of the genes evaluated. 
4.3.1.1 Adipocytes 
 Adipocytes co-cultured only with MSCs (AMA configuration) exhibited 
significant decreases in expression of RUNX2 (29-fold), PPARγ2 (15-fold), OCN (11-
fold), and LEP (64-fold) at day 7 (Figure 4.2A). Relative to day 1, RUNX2 expression at 
day 18 was still significantly lower (1.5-fold), OCN expression was significantly higher 
(2.1-fold), and PPARγ2 and LEP were unchanged. Adipocytes from tri-culture (OMA) 
showed a significant decrease in expression of RUNX2 (3.0-fold), PPARγ2 (6.8-fold), and 
LEP (22-fold) at day 7 that persisted through day 18. Relative to AMA adipocytes, 
expression of RUNX2 was significantly lower at each time point and OCN was expressed 
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in higher quantities at day 18. Compared with the osteoblastic and adipocytic genes, 
expression of MYOD and SOX9 remained relatively stable in each cell type over time. 
Over the entire culture period, examination of Oil Red O staining revealed no qualitative 
differences in triglyceride storage vesicles in adipocytes from either culture condition 
(Fig 2B). 
 
Figure 4.2. Co-culture and tri-culture differentially affect expression dynamics of 
osteoblastic (RUNX2 and Osteocalcin) and adipocytic (PPARγ2 and Leptin) genes in 
adipocytes but does not affect triglyceride storage with time. A) Adipocyte 
expression levels of gene regulators of several mesenchymal lineages relative to 
RPS18 and ACTB over 18 days in co- and tri-culture. Values scaled × 10
3
. * = 
Significantly different from another day, same culture type; # = Significantly 
different from another culture type, same day; p < 0.05. B) Oil Red O staining of 
triglyceride storage vesicles (arrows) in adipocytes from AMA and OMA culture 
conditions over time. (Brightfield microscopy, scale bar = 50 μm; Inset scale bar = 
20 μm) 
4.3.1.2 Osteoblasts 
 Osteoblasts co-cultured only with MSCs (OMO) exhibited significant decreases 
in expression of RUNX2 (2.0-fold), OCN (2.1-fold), and SOX9 (7.9-fold) at day 7, and 
RUNX2 decreased further by day 18 (2.7-fold relative to day 1; Figure 4.3A). Osteoblasts 
from tri-culture (OMA) also exhibited significant progressive declines in RUNX2 (1.6- 
and 3.8-fold at day 7 and day 18, respectively, relative to day 1) and OCN (1.5- and 2.8-
fold) through day 18. While RUNX2 and OCN expression were higher in OMA than 
OMO osteoblasts at day 7, both genes exhibited the same expression levels in each 
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culture setting by day 18. Expression of SOX9 in OMA osteoblasts, while much lower 
than OMO osteoblasts on day 1, remained the same by day 7 and significantly decreased 
(48-fold) by day 18. Alkaline phosphatase activity appeared similar in osteoblasts from 
both culture conditions on day 1 (Figure 4.3B). This activity persisted longer in 
osteoblasts from OMO than OMA constructs by day 7. By day 18, no alkaline 
phosphatase activity could be observed in either of the sample types. 
 
Figure 4.3. Co-culture and tri-culture differentially affect expression dynamics of 
osteoblastic (RUNX2 and Osteocalcin) and chondrogenic (SOX9) genes in 
osteoblasts, in addition to alkaline phosphatase activity persistence with time. A) 
Osteoblast expression levels of gene regulators of several mesenchymal lineages 
relative to RPS18 and ACTB over 18 days in co- and tri-culture. Values scaled × 10
3
. 
* = Significantly different from another day, same culture type; # = Significantly 
different from another culture type, same day; p < 0.05. B) In situ alkaline 
phosphatase substrate conversion in osteoblasts from OMO and OMA culture 
conditions over time. (Scale bar = 20 μm; Arrows indicate cells with enzyme 
activity) 
4.3.1.3 Mesenchymal Stem Cells (MSCs) 
 Lineage markers in MSCs exhibited much more diverse and complex expression 
dynamics dependent on their co- or tri-culture setting (Figure 4.4A). RUNX2 expression 
levels persisted through day 7 in MSCs from co-culture settings while declining 
significantly in tri-cultured MSCs by day 7 (1.6-fold). By day 18, RUNX2 expression was 
graded in MSCs depending on the relative amount of osteoblasts present in the co- or tri-
culture construct. Conversely, PPARγ2 expression was dramatically higher in MSCs co-
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cultured with adipocytes (AMA) as early as day 1 and persisted throughout the culture 
period, while OMO MSCs exhibited consistently low levels that did not change. Tri-
cultured MSCs (OMA) exhibited a 14-fold reduction in PPARγ2 expression at day 7, but 
this was upregulated 6.6-fold relative to day 1 after 18 days to an intermediate level 
between AMA and OMO MSCs. Expression of MYOD increased only in MSCs from 
OMO and OMA culture conditions by day 7 (3.6- and 4.1-fold, respectively), and was 
sustained through 18 days in culture. SOX9 expression was only upregulated in MSCs co-
cultured with osteoblasts at day 7 (3.0-fold) before declining to day 1 levels. Genetic 
markers of terminal differentiation towards osteoblasts (OCN) and adipocytes (LEP) were 
not significantly upregulated over time in MSCs from any of the co- or tri-culture 
conditions tested, and this was reflected in our histological analysis. No triglyceride 
storage occurred in MSCs from any culture condition over the entire length of the co-
culture period (Figure 4.4B). Transiently increased, relatively low alkaline phosphatase 
activity was observed only in a small number of MSCs from constructs containing 
osteoblasts (OMO and OMA, day 7) which was absent on day 18 (Figures 4.4C,D). 
Positive control gels containing only MSCs and cultured in osteogenic or adipogenic 
medium exhibited visible alkaline phosphatase activity and triglyceride storage, 
respectively (Figure 4.4D). 
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Figure 4.4. Co- and tri-culture differentially affect expression levels and dynamics of 
several lineage specific transcription factors (but not terminal differentiation 
markers) in MSCs, while only causing scant and transient alkaline phosphatase 
expression in MSCs from osteoblast-containing cultures. A) MSC expression levels 
of gene regulators of several mesenchymal lineages relative to RPS18 and ACTB 
over 18 days in co- and tri-culture. Values scaled × 10
3
. * = Significantly different 
from another day, same culture type; # = Significantly different from another 
culture type, same day; p < 0.05. B) Absence of Oil Red O staining in MSCs (arrows) 
from different co- and tri-culture conditions over time. (Brightfield microscopy, 
scale bar = 50 μm; Inset scale bar = 20 μm) C) In situ alkaline phosphatase substrate 
conversion in MSCs from different co- and tri-culture conditions over time. (Scale 
bar = 20 μm; Arrows indicate cells with enzyme activity). D) MSCs exposed to 
exogenous differentiation cues are able to undergo osteogenesis and adipogenesis 
after encapsulation in this culture platform (monoculture of MSCs only). Left: Oil 
Red O staining of triglyceride storage vesicles (arrows) in MSCs cultured in 
adipogenic medium for 28 days. (Brightfield microscopy, scale bar = 50 μm; Inset 
scale bar = 20 μm). Right: In situ alkaline phosphatase substrate conversion in 
MSCs cultured in osteogenic medium for 28 days. (Scale bar = 20 μm). 
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4.3.2 Multivariate Modeling of Gene Expression Data 
 Given the seemingly complex gene expression responses among different cell 
types placed under different co- and tri-culture conditions, we thought that taking a more 
global view of these factors using multivariate modeling would provide additional 
information; from this analysis, one could potentially extract and examine clusters of cell 
types that exhibit similar responses in gene expression to their culture conditions based 
on covariance of more than one gene. Therefore, we performed principal component 
analysis (PCA) to reduce the dimensionality of all the summarized gene expression data 
based on the sources of maximum variance (Figure 4.5A). Plotting samples in the first 
two principal components (PCs), which captured ~69% of the variability in the data set, 
indicated that MSCs and osteoblasts cluster apart from adipocytes (first PC; 51.1% of 
data set variability). The second PC captured an additional 17.8% of the variance in the 
data and separated MSCs co-cultured with adipocytes (AMA) from osteoblasts and 
MSCs from other culture conditions (OMO and OMA). Plotting the variable loadings in 
the first two PCs indicated that each of the genes evaluated was highly influential in the 
model at one or more time points since each has large weight on one or both PCs (Figure 
4.5B; variables with 0 weight were removed during pruning). In distinguishing the 
different clusters of observations from the score plot, adipocytes from OMA and AMA 
constructs were most distinguishable by PPARγ2 expression, MSCs from AMA 
constructs were most correlated with high PPARγ2 and LEP expression, and osteoblasts 





Figure 4.5. Statistical modeling based on covariance of the expression of several 
mesenchymal lineage genes yields two latent variables that are able to distinguish 
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MSCs from adipocytes and osteoblasts, respectively, and elucidates the correlation 
structure of the gene expression at various time points with each cell type present. 
A) Plot of PCA scores, t1 and t2, separating the observations by two principal 
components (PC) that explain 51.1% and 17.8% of the variance in data, 
respectively. Dashed line represents the 95% confidence limit of the distribution of 
scores. B) Plot of PCA loadings, p1 and p2, that shows the correlation of the gene 
expression data with the sources of maximum variance.  Model quality parameters: 
R
2
X = 0.689, Q
2
 = 0.450. C) Plot of PLS-DA scores, t1 and t2, for observations (cell 
type and culture type) that segregates three distinct cell types by two latent 
variables (LVs). D) Loading plot depicting the correlation structure of the gene 
expression data and the corresponding cell types, indicating: 1) the weights, w*, that 
combine the X-variables (gene expression values at different time points) to form the 
scores, t; and 2) and the weights, c, of the discriminating Y-variables (corresponding 
to each cell type). Gene expression values at specific times (X-variables, triangles) 
that contribute most to the cell type classification (Y-variables, circles) are labeled 
accordingly with the corresponding color scheme. R
2
Y = 0.750, Q
2
 = 0.681. D-F) 
PCA within each cell type demonstrates that more than 80% of the variance 
between samples is explained by differences between co- and tri-culture. A) Model 
discriminating between adipocytes from co- and tri-culture. R
2
X = 0.807, Q
2
 = 0.373. 
B) Model discriminating between osteoblasts from co- and tri-culture. R
2
X = 0.845, 
Q
2
 = 0.400. C) Model discriminating between MSCs from different co- and tri-
culture conditions. R
2
X = 0.812, Q
2
 = 0.547. Figure 4.5 continued. 
 
Several clusters of data by cell type and/or culture type were discernible by the 
PCA results, though they overlapped to an extent. These findings motivated further 
supervised analysis to deconvolve this complex data set into a meaningful set of variables 
that adequately describe the patterns of samples and their gene covariance in the overall 
data set. We first classified the observations into three groups by cell type and generated 
a two-latent variable PLS-DA model with quality parameters R
2
Y = 0.75 and Q
2
 = 0.681. 
The model distinctly classified the scores with the first latent variable describing the 
differences of adipocytes from the other cell types present, and the second latent variable 
describing the differences between MSCs and osteoblasts (Figure 4.5C). Osteoblasts and 
adipocytes constitute smaller clusters on this score plot, while MSCs constitute a much 
larger cluster, owing to differences in heterogeneity between the three cell types. With 
respect to the gene expression dynamics that constitute the latent variables, several genes 
from different mesenchymal lineages overlap in their contribution to discrimination of 
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the different cell types. This can be visualized by their proximities to one another on the 
weight plots in the latent variable space (Figure 4.5D). PPARγ2 (days 1, 7, and 18), 
MYOD (days 1 and 18), LEP (day 1), and RUNX2 (day 18) significantly correlated with 
adipocytes; SOX9 (day 7), LEP (day 7), and OCN (day 1) significantly correlated with 
MSCs; and RUNX2 (day 1) and MYOD (day 7) significantly correlated with osteoblasts. 
In addition, SOX9 (day 18) is significantly correlated with both MSCs and adipocytes, 
and RUNX2 (day 7) and OCN (day 7) are significantly correlated with both MSCs and 
osteoblasts. 
 Within the larger clusters of cell types in our first PLS-DA model (Figure 4.5C), 
we noticed that several observations appeared to also cluster by co- or tri-culture setting. 
After generating several preliminary PCA models, we were able to verify that much of 
the variation within these clusters (> 80%) could be accounted for in PCs that separated 
the observations by co- or tri-culture conditions (Figure 4.5D-F). This motivated the 
development of a separate PLS-DA model for each cell type (Figure 4.6) to further 
classify the observations by culture condition and determine gene expression variables at 
specific times that are highly determinative of cells from each condition. A single-latent 
variable model of adipocytes revealed that expression dynamics of adipocytic (PPARγ2), 
osteoblastic (RUNX2 and OCN), and myogenic (MYOD) genes are important for 
discriminating the cell populations from AMA and OMA culture conditions (Figures 
4.6A,D). A single-latent variable model of osteoblasts discriminates OMO and OMA 
populations largely by their expression dynamics of osteogenic (RUNX2 and OCN) and 
chondrogenic (SOX9) markers (Figures 4.6B,E). Further, a two-latent variable model of 
MSCs discriminates cell populations from all three culture conditions (Figures 4.6C,F) on 
the basis of several mesenchymal lineage markers unique to each population. AMA 
MSCs are most significantly correlated with expression of adipogenic marker PPARγ2 on 
days 1 and 7, while OMO MSCs are characterized by osteogenic markers RUNX2 (day 
18) and OCN (day 1). Interestingly, we observed that unlike co-cultured MSCs, tri-
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cultured MSCs (OMA) correlated strongly with osteogenic (RUNX2, day 1; OCN, day 
18), adipogenic (LEP, day 18), and myogenic (MYOD, days 7 and 18) markers. 
 
 
Figure 4.6. PLS-DA models of single cell types can robustly separate cell samples 
derived from different culture conditions and describe the important gene 
expression variables that correlate with each response to co- or tri-culture. A,D) 
Model discriminating between adipocytes from co- and tri-culture. R
2
Y = 0.898, Q
2
 = 





 = 0.920. C,F) Model discriminating between MSCs from different co- 
and tri-culture conditions. R
2
Y = 0.854, Q
2
 = 0.716. A-C) Score plots of clusters of 
adipocytes (A), osteoblasts (B), and MSCs (C) segregated into distinct groups by one 
(adipocytes, osteoblasts) or two (MSCs) latent variables. Dashed lines represent the 
95% confidence limit of the distribution of scores for the corresponding model. D-F) 
Loading plots depicting the correlation structure of gene expression data and the 
corresponding observation sets for each model. Gene expression values at specific 
times (X-variables) that significantly contribute (p < 0.05) most to the cell type 
classification (Y-variables) are shaded accordingly with the corresponding color 





 This work presents a simple platform for patterning multiple types of cells into 
tissue-scale 3D hydrogel constructs that are permissive for multi-directional paracrine 
signal communication and produce distinct responses in each cell type dependent on the 
co- or tri-culture environment surrounding it. Devices used to generate these platforms 
(Figure 4.1) are easily constructed from inexpensive, sterilizable, and reusable materials, 
making them appropriate and readily adaptable for use in any laboratory environment. 
The size of the PDMS cavity can be readily adapted to contain modules of different sizes 
and thicknesses with some limitations depending on the materials used (e.g. light 
penetration through the entire thickness, efficiency of the crosslinking reaction) [362]. 
The modularity of this hydrogel system, enabled by the sequential crosslinking and 
lamination of these synthetic, chemically tailorable hydrogels, allows for flexibility in the 
configuration of patterned cells and also provides a means for tailoring the 
microenvironmental niche of each cell type (e.g. biomaterials, material stiffness, 
biochemical moieties, and cell density) independently [65, 176]. This feature stems from 
the ability to use a mask for preventing further crosslinking, UV exposure of cells, or 
other modification of a gel module after each step.  
 The data acquired from these proof-of-principle experiments suggest that the 
differential effects of each co- and tri-culture environment on each cell type can result 
from paracrine signaling that occurs between each cell type in the absence of 
proliferation, migration, cell spreading, and direct cell-cell contact. Our hydrogel 
platform is specifically designed to isolate these effects due to its sufficiently small mesh 
size to prevent cell migration and proliferation while allowing the diffusion of soluble 
cues from the small molecule to protein scale [373]. While cell spreading is permissive 
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for and promotes osteogenesis [67], we chose to decouple the effects of cell spreading 
from soluble signals in these experiments to isolate the effects of signaling crosstalk 
alone. 
Fibronectin- and laminin-derived peptides (RGDS and YIGSR, respectively) were 
employed here to promote cell viability of encapsulated hMSCs and adipocytes during 
the culture as this may be adhesion-dependent [198, 374]. During co- and tri-culture, cells 
are coupled via these peptides to the polymer network of the hydrogel and may 
additionally deposit extracellular matrix (ECM).  Consequently, we cannot definitively 
rule out the possibility of intercellular communication via mechanical coupling between 
the cells and the polymer/ECM. However, all of the cells sense the same bulk mechanical 
properties of the gel modules since they are composed of the same gel material. The 
encapsulated cells are likely unable to generate large traction forces (due to lack of cell 
spreading) [67, 375], and mechanical signals would have to propagate over relatively 
long distances for cells from different modules to communicate. Furthermore, the 
synthetic polymer matrix of high crosslink density used here cannot be remodeled to aid 
in mechanical signal propagation (e.g. compared with collagen [376], hyaluronic acid 
[64], ionically crosslinked alginate [60]), and much of the matrix deposition in these 
synthetic, non-degradable gels likely remains confined to a pericellular location [364]. 
Together, these considerations support the likelihood that much of the intercellular 
crosstalk in this system is dominated by soluble paracrine factors. 
Traditional mono- and co-culture experiments with MSCs and their differentiated 
counterparts use exogenous factors to drive and maintain their differentiation and 
terminal function [365], or employ a mixture of differentiation media as a method for 
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providing a permissive environment for differentiation while minimizing bias [60, 64]. 
We formulated our co-culture medium without any exogenous differentiation cues, 
relying instead on the cells themselves to produce the soluble signals necessary to drive 
each other’s responses. While terminal differentiation was not observed, environment-
dependent responses occurred in each cell type. This suggests that the encapsulated cells 
are both producing and responding to soluble signals during the 18-day culture period 
evaluated in this study. Although these signals were not directly measured in these 
experiments, characterizing their roles will be included as a part of future studies with 
this platform. 
 As a direct consequence of being able to readily separate each cell type after the 
co- or tri-culture period by simple gel sectioning, we were able to observe the effects of 
paracrine crosstalk on each cell type independently at the individual gene level (Figures 
4.2-4.4) and more globally through multivariate analysis (Figures 4.5-4.6). While 
controls containing only one encapsulated cell type were not examined in this study, our 
analysis does demonstrate gene expression dynamics and potential histological changes 
that vary with co- and tri-culture conditions and are independent of the effects of time in 
culture. While these culture-dependent effects could be inferred from close examination 
of the data on a gene-by-gene basis (Figures 4.2-4.4), we were able to leverage the power 
of multivariate modeling to examine how distinct our observations were from each other 
given the covariance that existed across the multiple genes we examined. Our high 
quality PLS models (R
2
 ≥ 0.75 and Q
2
 ≥ 0.68) [370] confirmed many of the findings 
present in our preliminary inspection of the data, such that: i) adipocytes could be clearly 
distinguished from the other cell types, ii) AMA MSCs could be represented as a distinct 
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cluster from other MSCs,  iii) similarities in osteoblasts and MSCs from OMO and OMA 
samples could be mapped, and iv) a reduced set of genes that dynamically contribute to 
different emerging phenotypes of each cell type from the different co- and tri-culture 
conditions could be clearly distinguished.  
Our analysis showed that adipocytes in co- and tri-culture differentially expressed 
the adipogenic genes PPARγ2 and LEP and (surprisingly) osteogenic genes RUNX2 and 
OCN, though this did not appear to affect their triglyceride storage (Figures 4.2 and 
4.6D). The presence of MSCs (with or without adipocytes) affected osteoblastic (RUNX2 
and OCN) and chondrogenic (SOX9) markers in osteoblasts (Figures 4.3 and 4.6B,E). 
Interestingly, alkaline phosphatase activity appeared to persist longer in co-cultured than 
tri-cultured osteoblasts (Figure 4.3B). Taken together, our results suggest that adipocytes 
and osteoblasts in co- and tri-culture maintain some of their major functions or 
phenotypic markers. However, there may be subtle and previously unreported differences 
in the functional capacities of adipocytes and osteoblasts depending on neighboring cell 
types, based on the differential expression of genes regulating each lineage. Conversely, 
these findings may suggest that the culture environment (soluble cues, the presence of 
MSCs, or the hydrogel scaffold) or the pre-culture of primary cells may need further 
optimization to promote sustained functions associated with terminal differentiation.  
These potentially novel phenotypes and their determinants, including intercellular signals 
and potential artifacts of the in vitro microenvironment, could be more closely evaluated 
further in future studies. 
The analytical techniques applied here were particularly useful in clearly 
discerning population-level differences among MSCs from different co- and tri-culture 
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settings. We selected transcription factors for multiple MSC lineages, since their 
plasticity and level of lineage commitment are attributable to the simultaneous expression 
of these markers in their undifferentiated state that are progressively down-regulated as 
the cells commit [77]. All lineage-specific transcription factors in these cells were 
affected to some extent by the co- and tri-culture settings. For example, AMA MSCs, the 
most distinct population of MSCs (Figure 4.5A), were most highly correlated with 
increased expression levels of PPARγ2 (Figures 4.4A and 4.6F) and were the only MSCs 
that failed to exhibit alkaline phosphatase activity during the co-culture period (Figure 
S2). Conversely, OMO MSCs correlated with higher expression levels of RUNX2 and 
OCN (Figures 4.4A and 4.6F), clustered with osteoblasts (PCA analysis; Figures 4.5A,B), 
and appeared to exhibit alkaline phosphatase expression in some cells at day 7 (Figure 
4.4B). In contrast, MSCs cultured alone in the same hydrogel formulation, but using 
standard differentiation media, exhibited marked histological signs of differentiation 
(Figure S3). This finding suggests that the lack of significant staining in co- or tri-culture 
for either differentiation marker in MSCs (as well as other cell types) may not be an 
artifact of the culture system, but rather a sign that the signaling cues from neighboring 
cell types is not sufficient to induce terminal differentiation. Taken together, this suggests 
that co-cultured MSCs, while not terminally differentiated, may be biased towards 
differentiation toward the cell type with which they were co-cultured, in agreement with 
previously published data from other groups [296, 299, 363]. Tri-cultured (OMA) MSCs, 
while closely related to osteoblasts and OMO MSCs in their gene expression and 
apparent alkaline phosphatase expression (Figures 4.4A,B and 4.5A,B), correlated with a 
broader set of mesenchymal lineage genes, including MYOD (Figure 4.6F). This might 
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suggest a much more heterogeneous population of cells that emerged from tri-culture or a 
different bias in lineage commitment, each of which merit further study given the paucity 
of literature describing the combined effects of osteoblast- and adipocyte-derived soluble 
signals on MSCs. Additionally, this validates the relevance of this tri-culture system for 
future efforts to re-capitulate the bone marrow niche and to model bone marrow 
pathologies [10]. 
4.5 Conclusions 
 In this study, we develop a simply fabricated, photopatternable 3D culture system 
that enabled observation of distinct gene expression dynamics resulting from dynamic 
paracrine interactions between MSCs, osteoblasts, and adipocytes. This may result in 
distinct phenotypes for both the stem and terminally differentiated cells, representing 
changes in their lineage plasticity and physiological function, respectively. Importantly, 
our versatile platform can be applied in the collection of rich data that could not have 
been elucidated with traditional co-culture systems that examine interactions between 
only two cell types. These findings suggest that this system provides a powerful platform 
to study the cell fate and potential healing functions of MSCs and how they are affected 
by the types of cells surrounding them. Similarly, the system allows assessment of the 
effects of MSCs on cells from their surrounding niche in mediating normal physiological 




MESENCHYMAL STEM CELLS DISPLAY UNIQUE GENETIC 
AND PHENOTYPIC RESPONSES TO GLUCOSE PERTURBATION 
UNDER DIFFERENT MONO-, CO-, AND TRI-CULTURE 
CONDITIONS 
5.1  Introduction 
 Within multicellular organisms, functional interdependencies exist between a 
myriad of cell types, tissues, and organ systems that serve to regulate homeostatic 
processes and responses to disease states. Most cellular components exert their functions 
not just within cells, but across neighboring cell types and distant organs via a multitude 
of crosstalk mechanisms, including: direct cell-cell contact, soluble autocrine, paracrine, 
and endocrine signaling molecules, mechanical forces, neuronal signaling, and 
extracellular matrix interactions [61, 159]. These mechanisms form the components of 
dense cell-cell, cell-tissue, and cell-organ interaction networks that are rich in the 
complexity of their response to normal and pathophysiological perturbations [377, 378]. 
 Much of our understanding of these networks is derived from studies of model 
organisms and in vitro studies using model cell lines [379-381], and most of our attention 
has been focused on molecular-level interactions either within single cells or globally at 
the organismal level with the advent of “omics” technologies [382-386]. However, owing 
to heavy reliance on high-throughput techniques and assays of intracellular networks and 
the inability to reduce the complexity of in vivo model systems, knowledge regarding 
effects of perturbing interacting systems of multiple cells, tissues, organs is significantly 
lacking. In response, we have developed a biomaterial-based platform with the goal of 
recreating complex 3D microenvironments and allowing the study of complex 
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intercellular interactions (detailed in Chapters 3 and 4; [362, 387]). When coupled with 
multivariate analysis techniques, this novel platform enabled observation of distinct gene 
expression dynamics resulting from paracrine crosstalk between co- and tri-cultured 
MSCs, osteoblasts, and adipocytes that may have produced distinct cell phenotypes for 
both the stem and terminally differentiated cells [387]. 
 More recently, increasing attention has been concentrated on mapping and 
correlating interaction networks with physiologic and disease phenotypes, operating on 
the notion that interactions of these networks reflect underlying molecular interactions 
between different cell types and tissues [388-390]. Under normal homeostatic conditions, 
MSCs, osteoblasts, and adipocytes have emerged as key co-regulators of bone 
remodeling and energy metabolism [19, 20]. MSCs in the bone marrow differentiate into 
populations of adipocytes and osteoblasts, and this lineage-allocation is reciprocally 
regulated [10, 18]. Mature osteoblasts secrete osteocalcin that decreases fat mass, 
promotes adiponectin production and insulin sensitivity in adipocytes, and increases 
numbers of pancreatic β-cells and insulin secretion [21, 25]. Adipocytes secrete leptin 
that (acting via the hypothalamus and the sympathetic nervous system) decreases 
osteoblast activity and bone formation, and may also have putative direct anabolic effects 
on osteoblasts [26, 27]. Additionally, they produce adiponectin in response to osteocalcin 
and insulin stimulation that leads to increased insulin sensitivity and osteoblast activity 
[25, 391]. Insulin signaling has also been demonstrated to stimulate osteoblast 
differentiation, osteocalcin expression and release from bone matrix, and bone resorption 
(via decreased osteoprotegrin) [392, 393]. 
 Conversely, dysregulation of glucose metabolism as a consequence of diabetes 
mellitus (DM) has adverse orthopaedic consequences and often leads to secondary 
osteopenia and osteoporosis. Both Type I and Type II diabetes mellitus (T1DM and 
T2DM; respectively) are associated with an increased risk of osteoporotic fractures [121-
123]. Bone formation and osteoblast function are impaired with patients with T1DM, 
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while bone mineral density is increased but bone quality is reduced in patients with 
T2DM. This is coupled with an increased infiltration of fat in the bone marrow cavity [7]. 
Together, these consequences are worsened in patients with poorer glycemic control and 
chronic hyperglycemia [124]. Additionally, pharmacological treatments of T2DM that 
are designed to enhance insulin sensitivity and restore normal glucose homeostasis also 
differentially affect the balance of osteogenesis versus adipogenesis by targeting RUNX2 
and PPARγ2, respectively [125]. Further, gestational diabetes during pregnancy in 
expectant mothers leads to profound bouts of hyperglycemia and hyperinsulinemia in 
developing fetuses that leads to large amounts of peripheral fat deposition and hypoxia 
prenatally and poor skeletal growth and bone mineral quality postnatally [126-128]. 
 A mechanistic understanding of why these sequelae inevitably occur in DM 
remains poor since research has focused only on a few in vitro studies and correlation 
with serum biomarkers [125]. Multiple cell types and pathways may be involved. With 
respect to the balance and extent of osteogenesis and adipogenesis, elevated levels of 
glucose induce apoptosis and replicative senescence in MSCs and reduce their colony 
formation and osteogenic capacity [129-132]. Exposure of immortalized osteoblast cell 
lines to high glucose decreases proliferative capacity, mineralization and osteocalcin 
responses to parathyroid hormone and Vitamin D administration, dysregulates collagen I 
synthesis, and leads to decreased expression of differentiation markers [133-136]. In 
murine 3T3-L1 adipocytes, high glucose administration leads to decreased insulin 
sensitivity, triglyceride storage dysregulation, production of reactive oxygen species 
(ROS) and pro-inflammatory cytokines, and decreased adiponectin secretion [137-139]. 
However, these experiments were conducted on single, often non-primary and non-
human, cell types; there are currently no systematic means to simultaneously examine 
these cell types as a multicellular system with multidirectional and dynamic crosstalk. 
How glucose levels modulate the responses of MSCs, osteoblasts, and adipocytes to each 
other remain an open question. 
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 To address this knowledge gap and the limitations of current in vitro 
methodologies in tackling these open questions, we encapsulated primary human MSCs 
(hMSCs), osteoblasts (hObs), and adipocytes (hAds) into tissue-scale mono-, co-, and tri-
culture constructs as described previously (Chapter 4 and [387]). In particular for this 
study, we applied non-degradable PEG-based hydrogels (which facilitate maximum 
diffusion of soluble cues between cell populations), and we introduced PEG-based 
hydrogels with a collagenase-sensitive degradable peptide crosslinker [218, 394] that 
allowed for recovery of cell populations after the culture period for functional assays. To 
validate the utility of this platform for addressing complex intercellular responses to a 
systemic perturbation in a normal and pathophysiological state, we evaluated three mono-
culture configurations (all hMSCs, hObs, or hAds), two co-culture configurations 
(hMSCs flanked by hObs or hAds on both sides), and a tri-culture configuration (one 
module each of hMSCs, hObs, and hAds; see Figure 5.1) coupled with either 
normoglycemic or hyperglycemic media conditions for 1 week (Figure 5.2). Cell viability 
of each cell type under each condition was monitored over time, and gene expression, 
clonogenicity (hMSCs), markers of differentiation (alkaline phosphatase activity, 
osteogenesis; triglyceride storage, adipogenesis), and secreted factors were determined as 
measures of cellular response to culture type and glucose condition. We hypothesized 
that each culture environment would produce a unique response by each cell type to 
glucose perturbation, and in particular that cultures containing adipocytes would produce 
the most detrimental outcomes in cell viability and clonogenicity since they produce pro-
inflammatory cytokines and oxidative stress in response to hyperglycemia.  
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5.2  Materials and Methods 
5.2.1 Polymer Synthesis and Characterization 
 All chemicals were purchased from Sigma-Aldrich unless otherwise noted. 
Poly(ethylene glycol)-diacrylate (PEG-DA) was prepared as previously described [278] 
from PEG (Mn = 8,000 Da). Briefly, 24 g PEG was dissolved in 25 mL distilled 
dichloromethane (DCM) to create a 0.12 M solution, then reacted at a 2:1 molar ratio 
with acryloyl chloride (AcCl; added dropwise) and at a 1:1 molar ratio with 
triethanolamine (TEA) under nitrogen overnight. Purification was performed by reaction 
with 2 M K2CO3 (Fisher) at a 2:1 K2CO3:AcCl molar ratio and separation into aqueous 
and organic phases. This was followed by drying the solution with anhydrous MgSO4 
(Fisher) and precipitating the polymer in ethyl ether (Fisher). This product was filtered, 
vacuum dried and frozen at -20ºC until further use. 
 To allow presentation of adhesive ligands that promote viability of encapsulated 
cells, fibronectin-derived GRGDS (Bachem) and laminin-derived YIGSR (Anaspec) 
adhesion peptides were separately reacted as previously described [218, 364, 387, 395] in 
a 1:2 molar ratio with a 3,400 Da MW Acryl-PEG-succinimidyl valerate spacer (Acryl-
PEG-SVA; Laysan Bio) in 50 mM NaHCO3 buffer (pH 8.5; Fisher) at room temperature 
with gentle stirring for 3 h, dialyzed (1,000 Da MW cutoff) for 60 h, lyophilized for 72 h, 
and stored at -20 °C until further use. Similarly, to create enzymatically-degradable PEG, 
the unmodified peptide, Gly-Gly-Gly-Leu-Gly-Pro-Ala-Gly-Gly-Lys (GGGLGPAGGK, 
MW 769.84 Da; Aapptec), was reacted with Acrl-PEG- SVA at a 1:2.2 peptide:Acrl-
PEG-SVA molar ratio in 50 mM NaHCO3 buffer at pH 8.5 for 3 h. The resulting solution 
containing Acrl-PEG-GGGLGPAGGK-PEG-Acrl (enzymatically-degradable PEG) was 
then purified as described above. Preliminary evaluation of this and other potential 
enzymatically sensitive peptide candidates are detailed in Appendix A. 
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5.2.2 Cell Culture and Expansion 
All cell culture reagents were obtained from Mediatech unless otherwise 
specified. Primary human MSCs (hMSCs) were obtained from the laboratory of Dr. 
Darwin Prockop (Texas A&M Health Sciences Center) and expanded according to 
recommended protocols in Minimal Essential Medium-Alpha (αMEM) with 16.5% fetal 
bovine serum (FBS; Hyclone), 1 g/L glucose, 2 mM L-glutamine, 1% amphotericin B, 
and 0.1% gentamicin and cultured at 37°C with 5% CO2 in a humidified incubator [365]. 
Primary human osteoblasts (hObs; Lonza) were expanded to 4 population doublings in 
OGM Osteoblast Growth Medium (Lonza) containing 10% FBS, ascorbic acid 
(concentration proprietary), 50 μg/mL gentamicin, and 37 ng/mL amphotericin B. 
Primary human subcutaneous pre-adipocytes (Lonza) were expanded to 1-2 population 
doublings according to the manufacturer’s protocol in PGM-2 Basal Medium (Lonza) 
containing 10% FBS, 2 mM L-glutamine, 50 μg/mL gentamicin, and 37 ng/mL 
amphotericin B. Cultures at 80% confluence were differentiated into adipocytes (hAds) 
for 9 days in Dulbecco’s Modified Eagle Medium (DMEM) with 10% FBS, 1 g/L 
glucose, 60 µM indomethacin, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 0.5 µM 
dexamethasone, and 45 pM insulin. 
5.2.3 Crosslinking Device Design and Construct Fabrication 
Layering devices were fabricated and employed for cell patterning as described in 
Figure 4.1. Briefly, 1 mm-thick spacers were cut from cured polydimethylsiloxane 
(PDMS, Sylgard 184, 10:1 ratio base to curing agent; Dow Corning) and bonded with O2 
plasma to a 25 × 75 mm glass slide (VWR). This slide was contact bonded with another 
coated with fluorinated ethylene propylene film (Bytac FEP; U.S. Plastic Corp) to form a 
cavity for polymer solution/gels as they were loaded and crosslinked. The use of FEP 
film prevented adhesion of crosslinked gels to glass that could result in ripping following 
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device disassembly. Devices were sterilized by autoclave prior to assembly and use for 
encapsulation. 
Hydrogel precursor solutions were formulated with 10% w/w 8K PEG-DA (for 
hObs and hAds) or 10% w/w Acrl-PEG-GGGLGPAGGK-PEG-Acrl enzyme-sensitive 
polymer (for hMSCs) in phosphate-buffered saline (PBS) containing 0.05% w/w D-2959 
photoinitiator (Ciba) and 1 mM Acryl-PEG-GRGDS (for hMSCs and hObs) or Acryl-
PEG-YIGSR (for hAds). Cell suspensions were prepared from near-confluent cultures 
using 0.05% Trypsin/0.53 mM EDTA and resuspended in their respective gel precursor 
solutions at a concentration of 15 million cells/mL. These solutions were loaded into 
layering devices and sequentially photocrosslinked (365 nm light, 10.5 mW/cm
2
, 12 min) 
into laminated 1 mm-thick, 1.5 mm-tall hydrogel strips as described in Figure 5.1. After 
each patterning step, residual non-crosslinked material was rinsed out of the device with 
fresh 10% w/w PEG-DA solution using a syringe [362]. An opaque photomask was used 
in subsequent steps to prevent any further UV light exposure and crosslinking of the 
existing gels. Whole, laminated constructs were extracted from the device and sectioned 
with a scalpel perpendicular to the long axis of the laminate to yield up to eighteen 1.5 




Figure 5.1. Sample Fabrication and Construct Design. Fabrication of mono-, co-, 
and tri-culture constructs using the techniques outlined in Section 5.2.3 yield sample 
sets with well-segregated cell populations. Six sample types (overall dimensions 4.5 × 
1.5 × 1 mm) were examined in this study: Mono-cultures of hMSCs (MMM), hAds 
(AAA), and hObs (OOO); Co-cultures of hMSCs in the center module (2.25 × 1.5 × 
1 mm) flanked on both sides by only one other cell type (hAds or hObs; 1.125 × 1.5 × 
1 mm per module); and Tri-cultures with hMSCs flanked on either side by hObs or 
hAds (each module is 1.5 × 1.5 × 1 mm). 
5.2.4 Construct Culture Conditions 
Constructs were placed in separate wells of 12-well tissue culture plates with 2 
mL of tri-culture medium for 24 h [DMEM with 10% FBS, 1.0 g/L glucose (5.5 mM; 
normal fasting serum glucose), 2 mM L-glutamine, 70 µM L-ascorbate (normal serum 
concentration; Sigma), 45 pM insulin (normal fasting serum insulin; Sigma), 1% 
amphotericin B, and 0.1% gentamicin. After this period (day 1), which allowed the 
hydrogel constructs to reach equilibrium swelling, half were replenished with medium 
containing 1 g/L glucose, and the other half were switched to 4.1 g/L glucose (22.3 mM; 
hyperglycemic). All constructs were then cultured for a total of 7 days with an additional 
media change at Day 4 (Figure 5.2). Levels of glucose and insulin were selected for this 
experiment based on the Homeostasis Model Assessment (HOMA-2). Insulin levels were 
kept consistent between the two experimental conditions and represent a normal fasting 
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level of serum insulin. Using HOMA-2, the normal glucose concentration used (1.0 g/L), 
when coupled with this insulin level, corresponds to 100% insulin sensitivity, 77.4% beta 
cell activity, and no insulin resistance. The high glucose concentration used (4.1 g/L) 
corresponds to 20.2% insulin sensitivity (5-fold reduction), 7.7% beta cell activity (10-
fold reduction), and a 5-fold increase in insulin resistance. 
 
Figure 5.2. Study Design. Mono-, co-, and tri- constructs were cultured in separate 
wells of a 12-well TCPS plate for up to 7 days. Media changes were performed at 1 
and 4 days. After 1 day in culture, half of the constructs were switched to high 
glucose medium for the remainder of the study. Outcome measures analyzed in this 
study included cell viability (Live/Dead staining and confocal microscopy, n = 3), 
mRNA expression (qPCR, n = 5), and colony formation (CFU-F assay after gel 
digestion, re-plating, and culture for 14 days, n = 3) at the time points depicted. 
5.2.5 Cell Viability Assessment and Image Analysis 
 Hydrogel constructs (n = 3) were analyzed on Days 1 and 7 of mono-, co-, or tri-
culture using a LIVE/DEAD assay (Invitrogen) as a qualitative indicator of cell viability 
(Figure 5.2). The kit uses calcein AM (ex/em: 495/515 nm), which is conjugated by 
active cytosolic esterases to remain within the cell membrane and label live cells, and 
ethidium homodimer-1 (EthD-1; ex/em: 495/635 nm), which can only enter permeable 
nuclear membranes and binds to DNA to indicate dead or dying cells. Constructs were 
rinsed in sterile PBS at 37 °C for 30 minutes and subsequently incubated in staining 





) for 45 minutes at 37 °C. After a second PBS rinse for 15 minutes to remove excess 
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dye, stained constructs were imaged with confocal microscopy (10x objective, LSM 700; 
Zeiss). For each construct, 1 image stack was collected for each cell type present 
(dimensions: 693 × 693 μm; stack depth = 0 – 800 µm with 10-µm intervals). 
 Image stacks were analyzed using ImageJ software (version 1.46a; NIH). Each 
stack was split into green (calcein) and red (EthD-1) channels. The red channel 
containing dead cells was then projected onto a single plane using a maximum intensity 
projection algorithm. A threshold (pixel intensity > 20; scale of 0-255) was then applied 
to each projection image to convert it to a binary image. Particles greater than 12 μm
2
 in 
size were counted using the built-in Particle Analysis macro and recorded for further 
statistical analysis. 
5.2.6 mRNA Isolation and qPCR 
Hydrogel constructs (n = 5) were rinsed in PBS and blocks containing individual 
cell populations were separated from each other using a scalpel for gene expression 
analysis by qPCR after 1 and 7 days in mono-, co-, or tri-culture (Figure 5.2). Gel blocks 
containing the same cell type were pooled from 2 co-culture constructs or 3 tri-culture 
constructs of the same culture type and glucose condition to provide sufficient and 
equivalent amounts of mRNA for quantification. These blocks were homogenized in 
microcentrifuge tubes with pellet grinders (Kontes), after which mRNA was extracted 
using a QIAshredder tissue homogenizer and RNeasy kit with DNase I digestion 
(Qiagen).  cDNA was generated using SuperScript III Reverse Transcriptase (Invitrogen) 
with Oligo(dT)15 primers and dNTPs (Promega). Gene expression of each cell type was 
analyzed for several target genes using custom-designed primers (Table 5.1; Invitrogen) 
with quantitative PCR amplification performed on a StepOnePlus
TM
 Real-Time PCR 
System (Applied Biosystems) in the presence of SYBR Green/ROX master mix (Applied 
Biosystems). 
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To analyze PCR amplification data, the raw fluorescence data was processed 
using LinRegPCR (v12.11; http://www.hartfaalcentrum.nl) [368]. This software 
estimates individual well baselines by reconstructing the log-linear portion of the 
amplification curve, and then calculates individual PCR efficiencies (E) for each reaction. 
This is followed by computing a mean efficiency (  ) for the amplicon of interest and 
computes a starting amplicon number (N0) based on a universally applied cycle threshold 
(Ct) using the formula        
   .  Starting amplicon numbers of each target gene were 
normalized to a geometric mean of the starting amplicon numbers of two housekeeping 
genes – ribosomal protein-S18 (RPS18) and β-actin (ACTB) – to obtain relative 
expression values [366]. Endogenous controls were evaluated in each cell type to ensure 
that their expression levels were not altered across time or culture conditions [367, 368]. 





















































 Targets were on the basis of corresponding with genes unique to each mesenchymal lineage, or that have 
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been shown to be responsive to hyperglycemia in previous experiments with MSCs, osteoblasts, or 
adipocytes (termed ‘glucose-responsive’ [129-139]). 
Table 5.1 Continued. 
5.2.7 Gel Digestion, Cell Recovery, and Colony Formation Analysis 
 After 7 days in mono-, co-, or tri-culture, hydrogel constructs containing hMSCs 
(n = 3) were each placed in 500 μL of hMSC expansion medium (as described in Section 
5.3.2) containing 1,100 U/mL collagenase type II (Gibco), and the degradable hydrogel 
block (Acrl-PEG-GGGLGPAGGK-PEG-Acrl) was digested for 1 hour on a shaker table 
to extract the hMSCs (Figure 5.2). Fractions of the media containing the recovered cells 
(100 μL for MMM, 200 μL for OMO and AMA, and 300 μL for OMA; used to seed an 
approximately similar number of cells for each construct type at ~ 1-2 cells/cm
2
) were 
immediately plated into 15-cm TCPS dishes (Corning) containing 20 mL of hMSC 
expansion medium. Media changes were performed 1 day after seeding and every 3 days 
subsequently. After colonies were allowed to form for 14 days, the dishes were washed 




, stained with 3% crystal violet (Sigma) in 100% 
methanol for 10 min, and rinsed thoroughly with tap water. Stained colonies greater than 
2 mm in size were counted [50]. 
5.2.8 Statistical Analysis and Multivariate Modeling 
 Gene expression results are depicted as mean ± standard deviation unless 
otherwise noted. Prior to statistical analysis, all data were transformed with a Box-Cox 
transformation [396, 397]. Data were analyzed by multi-factor analysis of variance 
(ANOVA) to identify significant factors (culture type, glucose, day) and factor 
interactions (culture type*glucose, culture type*day, glucose*day, and culture 
type*glucose*day) for each target gene assayed. Where significant factors and 
interactions were identified by ANOVA, Tukey’s post hoc test (significance level p < 
0.05) was used to generate pairwise comparisons between means of individual sample 
groups and determine statistically significant differences. 
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 Multivariate statistical modeling was performed with the overall goal of 
extracting combinations of time-variant gene expression markers that were the most 
informative for distinguishing different responses among culture types and glucose 
conditions. All Box-Cox-transformed data were mean-centered and scaled to unit 
variance prior to analysis as a means of normalization to allow all variables to be 
considered equally scaled in the principal components or latent variables [312]. For these 
analyses, the data set (total of 1600 data points) was organized into an N×K matrix X that 
denotes the measured gene expression levels with time (variables/responses) as well as 
culture type and glucose conditions (observations/treatments). Principal component 
analysis (PCA) was first performed to discern possible clusters of observations and their 
qualitative similarities among the global data set in an unbiased fashion. PCA was 
performed using SIMCA software (v13; Umetrics) to analyze the X matrix and generated 
linear combinations of the X-variables (target gene and time; K = 20) that described the 
sources of maximum variation to cluster them by their contributions to the variance of the 
entire set of X-observations (cell type and culture type; N = 80). Using the observed 
clusters, partial least squares discriminant analysis (PLS-DA) was then performed 
(SIMCA) using an additional N×M matrix Y that encoded m purported classes of data 
(e.g. culture type or glucose condition) to find latent variables (linear combinations of the 
independent X-variables) that served as discriminating features to best separate the N 
observations into M different purported classes designated by the dependent Y-variables. 
A separate set of models were constructed using partial least squares projections to latent 
structures (PLS) to ascertain whether functional outcomes (e.g. cell viability, colony 
number) encoded as Y-variables (in lieu of purported classes) correlated significantly 
with the X-variables. In summary, PCA was used to observe the overall correlation 
structure of the gene expression data and understand how it contributed to the largest 
variance among the observations. PLS-DA aided in separating tight clusters of 
observations and revealing the covariant genes that correlated with each class, and PLS 
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aided in correlating time variant gene expression data with functional outcomes [370, 
371].  
To optimize the quality of each model, several pruning procedures were 
performed to remove outlying observations (outside 95% confidence interval) and non-
influential variables (weight approximately 0 in both components) and to enable 
statistical significance-testing of the model and the variables used to generate it [398, 
399]. The quality of each model was summarized by two non-dimensional statistical 
parameters: 1) R
2
X (for PCA) or R
2
Y (for PLS-DA and PLS), which quantitatively 
measure the extent to which the model explains the variation in the data matrices and 
dictate a goodness of fit; and 2) Q
2
, which quantitatively measures the extent to which the 
variation of a future experimental data set may be predicted by the model (goodness of 
prediction) [372]. Both of these parameters are analogous to regression statistics, with a 
value ranging from 0 (poor) to 1 (perfect) fit or predictive capability. The appropriate 
number of principal components or latent variables was determined by cross-validation 
[400]. The results of this procedure were fed into a jack-knifing analysis [401] to 
calculate the standard errors of the regression coefficients (weights), which were then 
converted into 95% confidence intervals via the t-distribution to determine which X-
variables (genes) of high weight have a statistically significant influence (p < 0.05) on 
each class of observations (Y-variables) in each of the PLS-DA and PLS models 
generated. Further definitions, parameters, and model details are outlined in Appendix C. 
5.3 Results 
5.3.1 Mesenchymal Stem Cell Viability 
 Live/Dead cell viability staining demonstrates that hMSCs remained largely 
viable after the week-long culture period (Figure 5.3A). Considerable amounts of cell 
spreading occur in co- and tri-cultured hMSCs under both glucose conditions by Day 7. 
There were no statistically significant differences in the number of dead cells per image 
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stack in quantified confocal images at Day 1 regardless of culture type (Figure 5.3B). 
Only hMSCs from AMA and OMO co-cultures exposed to high glucose demonstrated a 
statistically significant increase in the number of dead cells at Day 7 versus the same 
culture type and glucose condition on Day 1 (68.8% and 50.5%, respectively). 
 
 
Figure 5.3. Cell Viability of hMSCs in Mono-, Co-, and Tri-Culture under Different 
Glucose Conditions. A) Representative images of hMSCs stained with Live/Dead 
reagents taken from confocal laser scanning microscopy image stacks after 7 days. 
Cells remain largely viable at Day 7 regardless of culture condition. Considerable 
cell spreading was observed in hMSCs from co- and tri-culture constructs under 
both glucose conditions. B) Number of dead cells per image stack (n = 3 per culture 
type and glucose condition) remain relatively similar over 7 days in culture, with the 
exception of hMSCs from AMA and OMO constructs cultured in high glucose 
medium. (* = Significantly different from same culture type and glucose condition 
on Day 1; p < 0.05) 
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5.3.2 Gene Expression Dynamics of hMSCs 
 Many of the genes expressed in hMSCs showed differential expression patterns 
dependent on the culture type (mono-, co-, or tri-culture), glucose condition (normal or 
high), and time (Figures 5.4 and 5.5). Genes that varied the most with time include JUN, 
OCN, and RUNX2, while FOXO1 appeared to vary more by culture type and NFKB1 and 
ADIPOQ varied significantly with both culture type and time. Significant factor 
interaction effects were observed for culture type and day (FOXO1, NFKB1, ADIPOQ, 
LEP, OCN, and RUNX2), culture type and glucose (FOXO1, NFKB1, and RUNX2), 
glucose and day (OCN), and all three factors (JUN, NFKB1, OCN, and RUNX2). 
Furthermore, ATF2, CEBPB, and OPG failed to show any statistically significant 
differences among any of the sample types. Notably, adipocytic master transcriptional 
regulator PPARG2 failed to amplify in any samples, and CEBPB, LEP, and ADIPOQ 





Figure 5.4. Varying glucose content differentially modulates gene expression 
responses in hMSCs from each culture type. Gene expression relative to RPS18 and 
ACTB is depicted over time for A) mono-cultured (MMM; green), B,C) co-cultured 
(AMA, red; OMO, blue; respectively) and D) tri-cultured (OMA; purple) hMSCs 
exposed to different glucose concentrations (1 g/L, dark shade; 4.1 g/L, light shade). 
Values scaled × 10
4
.  * = significantly different than same culture type and glucose 
concentration on Day 1. † = significantly different from a different glucose 
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concentration with the same culture type on same day. [Note: The same data is 
reorganized by glucose condition in Figure 5.5]Figure 5.4 continued. 
 
5.3.2.1 Gene Expression Dynamics with Normal Glucose 
 hMSCs cultured alone (MMM) under normal glucose conditions (Figure 5.4A; 
dark green) maintained relatively stable expression of many of the genes evaluated, with 
only slight changes exhibited in JUN (2-fold decrease), OCN (1.8-fold increase), and 
ADIPOQ (2.2-fold increase) expression by Day 7.  
When co-culturing hMSCs with hAds (AMA) under normal glucose conditions 
(Figure 5.4B; dark red), decreases in NFKB1 (2.4-fold), ADIPOQ (7.7-fold), and OCN 
(1.7-fold) were observed by Day 7. Compared with MMM hMSCs, ADIPOQ expression 
was 11.4-fold higher on Day 1, but returned to comparable levels by Day 7. OCN 
expression was similar on Day 1, but was 2.2-fold lower by Day 7 (Figure 5.5A). When 
compared with OMO hMSCs under normal glucose, AMA hMSCs expressed lower 
levels of FOXO1 (2.2-fold), NFKB1 (1.8-fold), and OCN (1.5-fold) on Day 7 (Figure 
5.5A). ADIPOQ expression was 6.4-fold higher than in OMO hMSCs on Day 1 but 
returned to comparable levels by Day 7. When compared with OMA hMSCs under 
normal glucose, AMA hMSCs expressed lower levels of JUN than on Day 1 (1.9-fold; 
difference abrogated by Day 7) and consistently lower levels of NFKB1 (1.5-fold on Day 
1, 2.3-fold on Day 7; Figure 5.5A). Expression of OCN was 1.9-fold lower than in OMA 
hMSCs on Day 1 but was similar by Day 7. 
hMSCs co-cultured with hObs (OMO) under normal glucose conditions (Figure 
5.4C; dark blue) maintained similar levels of gene expression over 7 days, with the 
exception of decreases in JUN (2.4-fold), NFKB1 (1.4-fold), RUNX2 (1.6-fold), and OCN 
(2.3-fold). In comparison with MMM hMSCs under normal glucose, OCN expression 
was higher on Day 1 (2.1-fold; 2-fold lower by Day 7), while RUNX2 was similar on Day 
1 but 2.2-fold lower on Day 7 (Figure 5.5A). Gene expression was relatively similar to 
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OMA hMSCs under normal glucose, with the exception of consistently lower RUNX2 
(1.6-fold on both days) and lower JUN (2.3-fold) by Day 7 (Figure 5.5A). 
Tri-culturing hMSCs with hObs and hAds (OMA) under normal glucose 
conditions (Figure 5.4D; dark purple) produced consistent gene expression levels 
between 1 and 7 days, with the exception of lower levels of NFKB1 (1.6-fold), RUNX2 
(1.7-fold), and OCN (2.4-fold). Compared with MMM hMSCs with normal glucose, 
OCN expression was 2.6-fold higher on Day 1 (changed to 1.6-fold lower by Day 7; 
Figure 5.5A). RUNX2 expression was 1.4-fold lower on Day 7, while JUN expression 
was 2.1-fold higher. 
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5.3.2.2 Gene Expression Dynamics with High Glucose 
Culturing hMSCs alone (MMM) under high glucose conditions (Figure 5.4A; 
light green) did not produce a change in JUN expression (as with normal glucose), but 
did lead to a significant decrease in RUNX2 (1.5-fold) after 7 days and lower OCN 
expression relative to hMSCs (1.6-fold) under normal glucose at Day 7. 
  AMA hMSCs cultured with high glucose (Figure 5.4B; light red) showed 
significant declines in several genes by Day 7 when compared with Day 1 (FOXO1 – 1.3-
fold; LEP – 3.1-fold; ADIPOQ – 37-fold; RUNX2 – 1.7-fold; OCN – 2.6-fold). When 
compared with MMM hMSCs under high glucose, gene expression levels were similar on 
Day 1 with the exception of ADIPOQ (11-fold higher; 7.8-fold lower by Day 7; Figure 
5.5B). After 7 days, expression levels of several other genes were significantly lower than 
MMM hMSCs, including NFKB1 (2.1-fold), LEP (3-fold), RUNX2 (2-fold) and OCN 
(1.8-fold). When compared with OMO hMSCs under high glucose, gene expression 
levels were similar on Day 1 with the exception of ADIPOQ (6.8-fold higher; no 
difference by Day 7; Figure 5.5B). Expression levels of several genes at Day 7 were 
significantly lower than OMO hMSCs, including NFKB1 (2.8-fold), FOXO1 (9.6-fold), 
LEP (5.1-fold), RUNX2 (1.6-fold), and OCN (1.7-fold). When compared with OMA 
hMSCs under high glucose, gene expression levels were similar on Day 1 with the 
exception of JUN (1.8-fold lower; no difference at Day 7), NFKB1 (2.1-fold lower; no 
difference at Day 7), and OCN (1.8-fold lower; 1.6-fold lower at Day 7), and were 
otherwise similar on Day 7 with the exception of ADIPOQ (5.9-fold lower; Figure 5.5B). 
hMSCs co-cultured with hObs (OMO) under high glucose conditions (Figure 
5.4C; light blue) showed increased levels of FOXO1 (3.8-fold) and NFKB1 (1.5-fold; 2-
fold higher relative to OMO hMSCs with normal glucose) coupled with decreased OCN 
(1.9-fold) after 7 days. Additionally, RUNX2 was 1.5-fold higher on Day 7 compared 
with OMO hMSCs cultured with normal glucose. Compared with MMM hMSCs exposed 
to high glucose, OMO hMSCs showed 1.7-fold higher OCN expression at Day 1, but this 
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difference did not persist after 7 days (Figure 5.5B). Relative to OMA hMSCs exposed to 
high glucose, ADIPOQ expression on Day 1 was 6-fold lower (similar by Day 7), and 
FOXO1 and NFKB1 were significantly higher (4.4-fold and 2.3-fold, respectively) at Day 
7 (Figure 5.5B). 
Tri-culturing hMSCs with hObs and hAds (OMA) under high glucose conditions 
(Figure 5.4D; light purple) produced decreases in JUN (2.5-fold), NFKB1 (2.3-fold), 
ADIPOQ (5.5-fold), RUNX2 (1.9-fold), and OCN (2.9-fold) by Day 7. Relative to MMM 
hMSCs cultured with high glucose, ADIPOQ and OCN expression were higher at Day 1 
(9.9-fold and 2.4-fold, respectively; levels comparable by Day 7), while RUNX2 was 1.6-




Figure 5.5. Mono-, Co-, and Tri-Culture Differentially Modulate hMSC Gene 
Expression of Mesenchymal Lineage Markers and Glucose-Responsive 
Transcription Factors in Response to Varying Glucose Content. Gene expression 
relative to RPS18 and ACTB is depicted over time for A) MSCs exposed to normal 
glucose levels (1 g/L), and B) MSCs exposed to elevated glucose (4.1 g/L). # = 
significantly different from another culture type on the same day with the same 
glucose concentration. [Note: This figure is a reorganization of Figure 5.4 to allow 
for comparisons across culture types.] 
 
5.3.3 Colony Formation of hMSCs Recovered from Hydrogels 
 Encapsulation of hMSC in hydrogel modules composed of Acrl-PEG-
GGGLGPAGGK-PEG-Acrl successfully enabled digestion of the hydrogel with 
collagenase after 7 days of culture. The resulting supernatant contained enough pre-
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cultured hMSCs that could be collected and directly plated into TCPS dishes at clonal 
density. Following 2 weeks of culture in hMSC expansion medium, MSCs from all 
sample types were still able to form colonies to different degrees (Figure 5.6A; stained 
with crystal violet). Analysis showed that both culture type and glucose condition 
influenced hMSC clonogenicity. Significant declines in colony-forming capacity were 
observed in hMSCs from MMM and OMO samples (33% and 76%, respectively; Figure 
5.6B). hMSCs co-cultured with adipocytes retained their colony-forming capacity 
regardless of glucose condition. A declining trend was observed for tri-cultured (OMA) 
hMSCs (though not statistically significant), and the high glucose treatment still produced 
as many colonies as MMM hMSCs under normal glucose. 
 
Figure 5.6 Mono-, Co-, and Tri-Culture Interact with Glucose Condition to Alter 
Clonogenicity of hMSCs. A) Representative photographs of hMSC colonies stained 
with crystal violet 14 days after construct digestion and cell recovery. Noticeable 
differences were observed in colony formation among the different culture types 
and glucose conditions. B) Enumerated colony-forming units > 2 mm in diameter 
per dish (n = 3). MMM and OMO hMSCs cultured under high glucose conditions 
for 7 days exhibited significant decreases in colony formation. (* = Significantly 
different from same culture type; p < 0.05) 
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5.3.4 Multivariate Modeling of Gene Expression and Colony Formation Data 
5.3.4.1 Modeling of Gene Expression Data with Principle Component Analysis (PCA) to 
Assess Sources of Maximum Variance 
 Principle component analysis was performed to further interpret the complex gene 
expression responses observed (Figures 5.4 and 5.5) by leveraging the covariance of 
more than one gene and to ascertain their correlation with each other and the different 
sample groups tested in this experiment. PCA reduced the dimensionality of all the 
summarized gene expression data based on the sources of maximum variance within the 
entire data set and optimally produced three principle components (Figure 5.7; first two 
components depicted). The first principle component (accounting for 42.2% of the 
variance in the data) appears primarily to distinguish hMSCs co-cultured with adipocytes 
(AMA) from hMSCs from mono-culture (MMM), while the second principle component 
(accounting for an additional 20.4% of the variance in the data set) appears to more 
clearly separate the tri-cultured hMSCs (OMA) from the other sample groups. An overall 
examination of the scores indicates that much of the variance in the overall gene 
expression data set arises from differences between culture conditions (Figure 5.7A, 
different shapes), with a more moderate effect of glucose condition (Figure 5.7A, dark vs. 
light shades). Plotting the variable loadings in the first two principle components 
indicated that all of the genes (with the notable exception of ADIPOQ and CEBPB, the 
genes with the lowest expression in the entire data set) were highly influential in the 
model at one or both time points since each has a large weight on one or both principle 
components (Figure 5.7B; variables with near 0 weight were removed during pruning). In 
distinguishing the different clusters of observations from the score plot, hMSCs from 
AMA co-cultures were most distinguishable by being strongly anti-correlated with all of 
the genes in the model, while MMM hMSCs were strongly correlated with these genes. 
OCN on Day 1 did not have a large weight in the first component. Tri-cultured hMSCs 
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were strongly correlated with OCN, NFKB1, ATF2, and RUNX2 (all on Day 1), and 
strongly anti-correlated with the same variables on Day 7. OPG and LEP did not have 
strong weight along the second component. 
Figure 5.7. Statistical modeling based on maximum variance of the gene expression 
data set yields three principle components that indicate most of the variance arises 
from differences in culture type and elucidates the correlation structure of the gene 
expression at various time points. A) Plot of PCA scores, t1 and t2, separating the 
observations by the first two principal components (PC) that explain 42.2% and 
20.4% of the variance in data, respectively. Dashed line represents the 95% 
confidence limit of the distribution of scores. B) Plot of PCA loadings, p1 and p2, 
that shows the correlation of the gene expression data with the sources of maximum 
variance.  Overall model quality parameters: R
2
X = 0.784, Q
2
 = 0.403. 
5.3.4.2 Multivariate Modeling of Gene Expression Data with PLS Discriminant Analysis 
(PLS-DA) to Correlate Gene Expression with Culture Type 
Several clusters of data by culture type were discernible in the PCA results, 
though they overlapped to an extent. These findings motivated further supervised analysis 
to deconvolve this complex data set into a meaningful set of variables that adequately 
describe the patterns of samples and their gene covariance in the overall data set. The 
observations first were classified into four groups by culture type and generated a five-
latent variable PLS-DA model with quality parameters R
2
Y = 0.842 and Q
2
 = 0.649, with 
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the first three being reasonably sufficient to distinguish all four culture types 
(cumulatively having R
2
Y = 0.728 and Q
2
 = 0.632). The model distinctly classified the 
observations with the first latent variable describing the differences between AMA- and 
MMM-derived hMSCs, the second latent variable delineating the OMA-derived hMSCs, 
and the third latent variable distinguishing the OMO-derived hMSCs from all the other 
culture types (Figure 5.8A,C). OMA-derived hMSCs constitute the tightest cluster in all 
of the first three latent variables, owing to their relative homogeneity between samples 
compared with the other culture types. With respect to the gene expression dynamics that 
constitute the latent variables, several genes overlap in their contribution to 
discrimination of the different culture types. This can be visualized by their proximities to 
one another on the weight plots in the latent variable space (Figure 5.8B,D). Genes that 
correlated with MMM hMSCs in one or more latent variables included OCN (Day 7), 
CEBPB, RUNX2, NFKB1, OPG, ADIPOQ, ATF2, and LEP. AMA hMSCs were 
correlated with LEP, RUNX2, and ADIPOQ (all on Day 1). OMA hMSCs were correlated 
with OCN, FOXO1, JUN, LEP, RUNX2, and ADIPOQ (all on Day 1). OMO hMSCs were 




Figure 5.8. Statistical modeling based on covariance of the gene expression data 
yields three latent variables that distinguish hMSCs from each culture type and 
elucidates its correlation structure with gene expression at various time points. A,C) 
Plots of PLS-DA scores, t1 and t2 (A) and t2 and t3 (C), for observations (culture type 
and glucose condition) that segregates four distinct culture types by three latent 
variables (LVs). B,D) Weight plots depicting the correlation structure of the gene 
expression data and the corresponding culture types, indicating: 1) the weights, w*, 
that combine the X-variables (gene expression values at different time points) to 
form the scores, t; and 2) and the weights, c, of the discriminating Y-variables 
(corresponding to each culture type). Gene expression values at specific times (X-
variables) that contribute most to the culture type classification (Y-variables) are 
shaded accordingly with the corresponding color scheme. R
2
Y = 0.842, Q
2
 = 0.649. 
 
5.3.4.3 Modeling of Gene Expression Data with PCA to Assess Sources of Maximum 
Variance within Culture Types 
 Within the larger clusters of cell types in our first PLS-DA model (Fig. 5.8A,C), 
several observations appeared to also cluster by glucose condition. The first three latent 
variables in this model only account for 58.6% of the variance in the X-variables (genes 
at different time points; R
2
X = 0.586), and the addition of two more latent variables 
account for an additional 11.4 and 12.1% of the variance in the X- and Y-variables, 
respectively. This observation appeared to indicate that an additional source of variance 
was present, and it was hypothesized that variance caused by changes in glucose were 
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masked by larger variances attributable to culture type in the global data set. To test this 
hypothesis, a set of PCA sub-models that split the data by culture type were constructed 
to look at the sources of variance within each culture type (Figure 5.9). Using one or 
more principle components, each model was able to sort the observations by glucose 
condition within each culture type to varying degrees. Approximately 70% or more of the 
variance could potentially account for differences in gene expression due to glucose 
condition within hMSCs from mono- (Figure 5.9A) and co-culture (AMA, Figure 5.9B; 
OMO, Figure 5.9C) with 50% or greater predictive capability. Variations in glucose 
appeared to only account for 60% of the variance within the OMA hMSC data set with 




Figure 5.9. PCA within each culture type demonstrates that more than 60% of the 
variance between samples may be explained by differences from exposure to normal 
or high glucose. A-D) Score plots for each sub model. A) Model discriminating 
between MMM hMSCs exposed to normal or high glucose. R
2
X = 0.852, Q
2
 = 0.564. 
B) Model discriminating between AMA hMSCs exposed to normal or high glucose. 
R
2
X = 0.669, Q
2
 = 0.475. C) Model discriminating between OMO hMSCs exposed to 
normal or high glucose. R
2
X = 0.698, Q
2
 = 0.481. D) Model discriminating between 
OMA hMSCs exposed to normal or high glucose. R
2
X = 0.603, Q
2
 = 0.3. 
 
5.3.4.4 Modeling of Gene Expression Data with PLS-DA to Correlate Gene Expression 
with Glucose Condition within Culture Type 
 After generating several preliminary PCA models, we were able to verify that a 
reasonable portion of the variation within these clusters (> 60%) could be accounted for 
in PCs that separated the observations by glucose condition. This motivated the 
development of a separate PLS-DA model for each culture type to further classify the 
observations by glucose condition and determine gene expression variables at specific 
times that are highly determinative of hMSCs from each condition (Figure 5.10). A two-
latent variable model for MMM hMSCs revealed that expression dynamics of RUNX2, 
OCN, OPG, JUN, and NFKB1 were important for discriminating between normal and 
high glucose conditions (Figure 5.10A,B). A two-latent variable model for AMA hMSCs 
discriminates normal- from high-glucose samples by expression levels of NFKB1, LEP, 
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ADIPOQ, OCN, and RUNX2 (Figure 5.10C,D). A single-latent variable model 
discriminates OMO hMSCs cultured in the presence of normal or high glucose by 
expression of JUN, ATF2, NFKB1, RUNX2, and OPG (Figure 5.10E,F). Finally, a two-
latent variable model separates OMA hMSCs from different glucose conditions on the 








Figure 5.10. PLS-DA models of individual culture types can robustly distinguish 
hMSC samples cultured under different glucose conditions and describe the 
important gene expression variables that correlate with response to glucose level. 
A,B) Model discriminating between MMM hMSCs exposed to normal and high 
glucose. R
2
Y = 0.903, Q
2
 = 0.724. C,D) Model discriminating between AMA hMSCs 
exposed to normal and high glucose. R
2
Y = 0.839, Q
2
 = 0.593. E,F) Model 





 = 0.814. G,H) Model discriminating between OMA hMSCs exposed to 
normal and high glucose. R
2
Y = 0.922, Q
2
 = 0.837. A,C,E,G) Score plots of clusters of 
hMSCs segregated into distinct groups by one or more latent variables. Dashed lines 
represent the 95% confidence limit of the distribution of scores for each model. 
B,D,F,H) Weight plots depicting the correlation structure of gene expression data 
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and the corresponding observation sets for each model. Gene expression values at 
specific times (X-variables) that significantly contribute (p < 0.05) most to the 
glucose condition classification (Y-variables) are shaded accordingly with the 
corresponding color scheme. Figure 5.10 continued. 
 
5.3.4.5 Partial Least Squares Projections to Latent Structures (PLS) Modeling to Assess 
Correlation of Gene Expression with Colony Formation 
 Given the availability of data quantifying an hMSC functional outcome, namely 
colony-formation capacity, PLS regression analysis was used to map the variation in 
CFU-F number (Y-variable) with the corresponding variation in gene expression data (X-
variables) from each culture type and glucose condition. A two-latent variable model was 
generated in which the first latent variable separates MMM and OMO hMSCs exposed to 
high glucose from all the other samples and encompasses 56.7% of the variation in the 
gene expression data and 54.2% of the variation in the colony formation data (Figure 
5.11A). The second latent variable accounted for an additional 19% of the variation in the 
gene expression data and 12.7% of the variation in colony formation in separating 
hMSCs from OMA and AMA cultures. Overall, the observations appear to be clustered 
by both culture type and glucose condition. Examination of the weight plot (Figure 
5.11B) reveals that colony formation is positively correlated with JUN expression on Day 
1, highly anti-correlated with FOXO1 on Day 7, and moderately anti-correlated with 
ATF, NFKB1, LEP, and OPG expression on Day 7. 
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Figure 5.11. Statistical modeling based on covariance of hMSC gene expression data 
with colony formation yields two latent variables that are able to distinguish hMSCs 
from different culture types and glucose conditions and elucidates the correlation 
structure of gene expression and colony formation. A) Plot of PLS scores, t1 and t2, 
for observations (culture type and glucose condition) that segregates high-glucose 
OMO and MMM hMSCs (1
st
 LV) and OMA and AMA hMSCs (2
nd
 LV). B) Weight 
plots depicting the correlation structure of gene expression data and colony 
formation capacity. Gene expression values at specific times (X-variables) that 
significantly correlate (p < 0.05) with colony formation (Y-variable) are shaded 





 = 0.569 
 
5.4 Discussion 
 This work demonstrates that human mesenchymal stem cells have unique genetic 
and phenotypic responses to glucose perturbations when cultured alone or with one or 
more differentiated cell types. Using a variety of outcome measures, we were able to 
discern unique effects of mono-, co-, and tri-culture on cell viability, gene expression, 
and clonogenicity of hMSCs in the context of systemically delivered normo- and 
hyperglycemic conditions. Had the changes due to glucose been the overriding influence 
on these outcomes, the utility of this platform for culturing multiple cell types would be 
superfluous and culture of a single cell type would suffice for further exploration. 
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Conversely, if the hMSCs been completely unresponsive to changes in glucose and only 
to the identity of the neighboring cell types, then their relevance in studying the 
pathophysiological consequences of hyperglycemia might be diminished. Neither the 
signaling interactions between the cells themselves nor the global change in glucose 
concentration provided an overwhelmingly dominant influence over gene expression and 
functional responses, signifying that this hydrogel tri-culture platform is uniquely suitable 
for examining both cell-derived and global perturbations to a complex interaction 
network consisting of multiple cell types in a simplified, highly tunable 3D in vitro 
microenvironment. 
5.4.1 Response of hMSCs to Degradable Hydrogel 
 The modularity of this hydrogel system, enabled by the sequential crosslinking 
and lamination of these synthetic, chemically tailorable hydrogels, allows for flexibility 
in the configuration of patterned cells and also provides a means for tailoring the 
microenvironmental niche of each cell type (e.g. biomaterials, material stiffness, 
biochemical moieties, and cell density) independently [65, 176]. This feature stems from 
the ability to use a mask for preventing further crosslinking, UV exposure of cells, or 
other modification of a gel module after each step. As a direct result of this modularity, 
we were able to encapsulate hMSCs in an enzyme-sensitive PEG derivative that allowed 
us to retrieve the cells on demand following the conclusion of the 3D culture and evaluate 
their functional characteristics. This experiment provided a proof-of-principle that our 
system can incorporate another mode (in addition to manual dissection) of selectively 
separate cell populations after culture in a specific manner dictated by the sensitivity and 
specificity of the peptide crosslinker used. Additionally, this represents the first time 
enzyme-sensitive hydrogels containing encapsulated cells have been used for this 
purpose. 
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 Fibronectin- and laminin-derived peptides (GRGDS and YIGSR, respectively) 
were employed here to promote cell viability and normal adhesion-dependent function of 
encapsulated hMSCs, osteoblasts, and adipocytes during the culture [196, 198, 374]. 
When coupled with the collagenase-sensitive peptide crosslinker for encapsulation of 
hMSCs, there existed the possibility of cell-mediated degradation of their surrounding 
matrix since the peptide is also sensitive to matrix metalloproteinases MMP-1 and MMP-
2 [394, 402]. Based on previous literature, the expectation was that over the week-long 
course of the experiment, the hydrogel network would not degrade quickly enough to 
induce significant hMSC cell spreading [218], and this was validated prior to the 
experiment by encapsulating each cell type in separate degradable gels and observing 
viability and cell spreading over 1 week (Appendix A). MMM hMSCs did not undergo 
changes in cell spreading over 1 week in culture, regardless of glucose condition (Figure 
5.3A); however, co- and tri-cultured hMSCs under normal and high glucose did spread 
and appear to form some cell-cell contacts. This could be attributed to a high 
concentration of cells localized near the surface of the gels due to settling of cells; the 
hydrogel material was not density matched to each cell type and thus cells were not 
homogeneously distributed within each module. 
 However, despite the unintended effect of cell settling, hMSCs still responded to 
glucose in a context-dependent fashion. This suggests that hMSC MMP activity was 
affected by cues from the differentiated cells, since each cell type alone could not 
degrade the gels and spread within 1 week (Appendix A). Their spreading and/or 
coupling may have in turn affected their response to soluble paracrine signals from other 
cell types or to the glucose condition, since hMSC spreading is permissive for 
osteogenesis [67] and cell density in culture has been shown to correlate with 
proliferative capacity [50]. Additionally, more direct cell-cell contacts exist between the 
hMSCs than the other cell types and thus they are able to generate mechanical forces that 
may signal to other cells. Encapsulated hObs and hAds, while coupled via adhesion 
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peptides to the same network, cannot spread, remodel the PEG network, or generate large 
traction forces, so it remains unclear whether they were able to sense any hMSC-derived 
mechanical cues [67, 375]. Consequently, we cannot definitively rule out the possibility 
of intercellular communication via mechanical coupling between the cells and the 
polymer/cell-secreted extracellular matrix. Given that this PEG-based network readily 
allows for the diffusion of soluble cues from the small molecule to protein scale [373], it 
remains likely that much of the intercellular crosstalk between each cell type is largely 
dominated by soluble paracrine factors. Nevertheless, despite the mode(s) of signaling 
being unclear, hMSC responses specific to both culture type and glucose condition were 
still detectable with high confidence (Section 5.3). To maintain the cell-retrieval 
capability of the system while isolating the effects of soluble signals from other potential 
modes of communication, the enzyme-sensitive peptide sequence could be optimized in 
future experiments to enable on-demand degradability using a non-endogenously 
produced enzyme. 
5.4.2 Cellular Responses to Culture Type and Glucose Condition 
 Much of the variance in the gene expression among the entirety of the samples 
from this experiment could be attributed more to culture type than glucose condition. 
Confirmation of this notion is quite difficult if only examining the statistical significance 
of each factor and their interactions when analyzing each gene separately with ANOVA 
(Section 5.3.2 and Figures 5.4 and 5.5). Much stronger confirmation of the more 
dominant influence of culture type was discernible from PCA and PLS-DA of the entire 
gene expression data set (Figures 5.7 and 5.8). The observations appear to cluster more 
homogeneously within each culture type rather than by applied glucose condition. 
Additionally, the principle components (PCA; Figure 5.7) that separate the observations 
along each axis based almost largely by culture type are determined by the sources of 
maximum variance in the data by definition. Moreover, the PLS-DA (Figure 5.8) 
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confirms that the observations are best classified by latent variables that distinguish 





). Additionally, functional outcomes such as cell viability (Figure 5.3) 
and colony formation (Figure 5.6) were not uniformly affected by glucose condition. 
While the PLS model (Figure 5.11) was able to discern some correlation of clonogenicity 
with the gene expression data, many of the variables we measured were pruned from the 
model and few exhibited strong positive or negative correlation. Together, these results 
demonstrate that while glucose did affect cell gene and functional responses, it did so 
only within the context of the existing crosstalk interactions between the cell types 
present and did not overwhelm their influence on hMSCs. Future experiments would 
benefit from expanding the repertoire of genes and outcome measures to more fully 
elucidate underlying mechanisms of the different responses that emerged in each culture 
system, along with mapping of the network interaction modules that may be differentially 
activated by each system [377, 403] to these functional outcomes through PLS models 
that would benefit from more input data. 
 Evidence exists from the gene expression data that hMSCs sensed and responded 
to their surrounding environment as soon as the first day in culture (Figures 5.4 and 5.5) 
when no change had been made yet to the administered glucose concentration. 
Expression of JUN and NFKB1 were elevated in hMSCs from tri-culture compared with 
those from AMA co-cultures. Additionally, levels of ADIPOQ and OCN (generally 
considered to be secreted by terminally differentiated adipocytes and osteoblasts, 
respectively; [404, 405]) were quite different among the different culture types. ADIPOQ 
was significantly expressed in higher amounts by hMSCs either co- or tri- cultured with 
adipocytes than MMM or OMO hMSCs. OCN was significantly expressed in higher 
amount by constructs containing osteoblasts. These results suggest that after one day in 
culture, hMSCs may have been differentially primed by their surroundings, which could 
later have affected how each responded to the level of glucose administered during 
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subsequent feedings. Notably, by the end of the week-long culture, the expression of each 
gene evaluated in this study responded differently to glucose treatment depending on the 
mono-, co-, or tri-culture condition. 
5.4.2.1 Responses of Mono-Cultured hMSCs 
 Mono-cultured hMSCs (MMM) constituted one of the largest sources of gene 
expression variance in all the samples tested (separated by the first component of global 
PCA; Figure 5.7). When examining their covariance structure with the gene expression 
data (Figure 5.8), they exhibited strong positive correlations with many of the genes 
tested with the exception of JUN, FOXO1, and OCN. Exposure to high glucose did not 
affect their cell viability over time compared with normal glucose (Figure 5.3), but it did 
significantly reduce their colony formation capacity (Figure 5.6). MMM hMSCs under 
high glucose also were highly anti-correlated with JUN on Day 1 (whereas this gene was 
highly correlated with MMM hMSCs under normal glucose; Figure 5.10A,B), a variable 
that positively correlates with colony formation (Figure 5.11). Together, this data may 
reflect glucose-induced replicative senescence as previously documented in the literature 
[129-132], which would be consistent with the negative consequences of gestational 
diabetes for embryonic and neonatal skeletal development [126-128], and for skeletal 
development in patients with T1DM [121-123].  Follow up staining of histological 
sections with β-galactosidase (a marker of senescence, [406]) would aid in verifying this 
hypothesis. Additionally, similar findings were observed in OMO hMSCs but apparently 
not in AMA hMSCs (Section 5.4.2.2), and comparative gene expression and histological 
analysis between these cultures would be useful in further elucidating a potential 
mechanism for this apparent senescence. 
5.4.2.2 Responses of hMSCs Co-Cultured with Adipocytes 
 Examining the culture types overall, hMSCs from AMA co-cultures exhibited the 
largest variance in gene expression data (largest separation on the first component of 
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global PCA; Figure 5.7). Interestingly, their gene expression was almost entirely anti-
correlated with that of any of the other culture types (Figures 5.7 and 5.8), suggesting that 
they may be phenotypically the most different from hMSCs from any of the other culture 
types and that their behavior would be very different. Indeed, when exposed to high 
glucose, they showed increased numbers of dead cells by Day 7, but once extracted, the 
viable hMSCs remaining showed the same colony formation capacity as AMA hMSCs 
under normal glucose conditions (Figure 5.6), leading us to refine our original hypothesis 
since the effects of AMA co-culture were more nuanced than originally conjectured. This 
may result from the ability of adipocytes in co-culture that can accommodate and store 
the extra glucose, which may serve as an acute compensatory mechanism. Despite similar 
clonogenicity, the gene expression of AMA hMSCs is quite different under normal and 
high glucose (Figure 5.10C,D); AMA hMSCs exposed to high glucose are highly 
correlated with NFKB1, a potent transcription factor in eliciting production of pro-
inflammatory cytokines that could have led to increased cell death [137, 139]; and they 
are anti-correlated with ADIPOQ, LEP, and OCN, all of which serve to maintain glucose 
homeostasis [25]. Together, these results suggest there may be phenotypic traits other 
than cell death and colony formation worth probing in future experiments (e.g. changes in 
lineage allocation [129, 132], or in ability to modulate inflammation and ROS [137, 
139]). Histological evidence of increased triglyceride storage would support the notion 
that adipocytes provide a buffering capacity to the co-culture system, while analysis of 
conditioned medium could yield insight into the degree of inflammatory molecules and 
ROS produced. Should this evidence be lacking, an alternative hypothesis may be that 
hMSCs have the capacity to moderate negative effects of adipocytes in the face of 
hyperglycemia by counteracting the oxidative stress and modulating inflammation, both 
known properties of hMSCs in other regenerative contexts [61, 407-409]. 
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5.4.2.3 Responses of hMSCs Co-Cultured with Osteoblasts 
 hMSCs co-cultured with osteoblasts (OMO) did not contribute nearly as much 
variance to the overall gene expression data. Like AMA hMSCs exposed to high glucose, 
OMO hMSCs were also characterized by reduced cell viability (Figure 5.3). However, 
this was instead coupled with vastly reduced colony-forming capacity (Figure 5.6), 
constituting the largest decline compared with its normal glucose counterpart. Since 
hMSCs and hObs do not have nearly the glucose absorption capacitance of adipocytes, it 
is possible that the hyperosmotic stress caused by excess extracellular glucose leads to 
ROS production that upregulates FOXO1 as a protective mechanism, but can also lead to 
NFKB1 expression if it persists for too long [134, 410]. Both of these genes were found 
to be upregulated in high glucose-exposed OMO hMSCs (Figures 5.4 and 5.5), and 
strongly correlated with them in PLS-DA models (Figure 5.10E,F). Similarly to high 
glucose-treated MMM hMSCs, these cells were also negatively correlated with JUN on 
Day 1. Both of these gene correlations are in good agreement with the PLS model, which 
shows that the same genes co-vary in the same ways with CFU number (Figure 5.11), 
lending strength to the potential role of these genes in regulating hMSC clonogenicity. 
The finding that co-culture setting differentially regulates hMSC clonogenicity while 
having similar effects on cell viability is both striking and unexpected, since dysregulated 
adipogenesis correlates with poorer skeletal health and inflammatory adipokines are 
thought to play a significant role in reducing bone quality [7, 9, 11]. However, hMSCs 
and osteoblasts do not have the glucose absorptive capacity of adipocytes, thus leading to 
potential hyperosmotic shock as previously described in the literature [133-135]. This 
lends strength to the hypothesis that the accumulation of excess marrow fat may be a 
compensatory mechanism to counteract the effects of hyperglycemia, though this may 
become detrimental in the long term. 
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5.4.2.4 Responses of Tri-Cultured hMSCs 
 Tri-cultured hMSCs (OMA) provided a moderate source of variability in the gene 
expression data set (distinguished by the second principle component in the global PCA; 
Figure 5.7A). Examination of this culture type with a PCA sub-model (Figures 5.8D) 
revealed that these observations were tightly clustered and difficult to separate into high 
and normal glucose conditions, owing to their low intrinsic variability (R
2
X = 0.603 and 
Q
2
 = 0.3). When attempting to model this sample set with PLS-DA to try and 
discriminate between glucose conditions, two latent variables were required when one 
that distinguished between normal and  high glucose conditions would have sufficed, 
suggesting the presence of variability in the data that could not be accounted for by 
glucose alone. The scores in this model still placed the observations near the origin, 
which indicates that the latent variables are separating a tightly clustered data set, again 
suggesting that the gene expression is not that variable between the two glucose 
conditions (Figure 5.10G,H). Taken together, this suggests that the variance within this 
sample group could not be primarily attributed to differences in response to glucose. This 
provided a striking correlation with their functional outcomes, in which no statistically 
significant differences were observed in cell viability or colony formation (Figures 5.3 
and 5.6). One possible interpretation of these results then is that the data in this sample 
set is particularly noisy because of multiple confounding processes within the system; 
however, this appears unlikely as the variance in this sample set when examining gene 
expression or functional outcomes is no larger than any other culture type. Therefore, this 
likely indicates that the tri-culture system as a whole is robust to glucose perturbations 
and maintains a relatively stable state over the 1-week culture period. Conceivably, the 
compensatory mechanisms of all three cell types lead to stability where those present in 
the mono- and co-culture settings are insufficient, suggesting that a proper balance and 
regulation of all three  cell types is needed to maintain adequate skeletal health in the 
context of diabetes. As outlined above, histological and conditioned medium assays and 
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comparison of these with mono- and co-cultures may yield insights into the degree of 
compensation and the key players in maintaining a relatively stable state. 
5.4.3 Limitations and Future Directions 
  Further data acquisition and examination is necessary to more fully characterize 
the system-level responses of the cell types in our platform in response to mono-, co-, and 
tri-culture in response to glucose perturbations. Insight into the interplay between culture 
type and glucose condition on the osteoblasts and adipocytes from these mono-, co-, and 
tri-cultures would provide further evidence to support the hypothesis surrounding the 
behavioral responses of the hMSCs in this system outlined above. This data would 
include cell viability quantification of osteoblasts and adipocytes, collecting their gene 
expression data and expanding the repertoire of genes evaluated, and protein expression 
of glucose-regulating hormones and remaining glucose content from media samples. 
Together, these would strengthen our multivariate models to elucidate the correlation 
structure between all of these outcomes and provide further opportunities to test our 
hypotheses and generate new ones. Future experimentation to evaluate potential lineage 
restriction of hMSCs through clonal selection, assays for senescence, and assessment of 
osteoblast and adipocyte function (e.g. ability to mineralize or store and release 
triglycerides, respectively) would provide even more comprehensive insight into the 
complex behavior elicited in this study. Quantitative analysis of soluble factors within the 
conditioned media (e.g. residual glucose content, free fatty acids, inflammatory 
cytokines, growth factors, and hormones), when combined with comparative analysis 
using our multivariate techniques across culture types and glucose conditions would 
readily enable discovery of key mediators of the cell fate processes observed. Previous 
work detailed in Chapter 4 demonstrates that longer term mono-, co-, and tri-cultures are 
feasible and would enable further elucidation of the consequences of prolonged exposure 
to hyperglycemia that may align more with clinical observations and previously 
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generated hypotheses [9-11, 106, 118]. Nonetheless, the preliminary data collected solely 
from examination of the hMSC outcomes from this study validates this platform for use 
in examining the complex interplay between bone remodeling and energy metabolism in 
homeostasis and disease states. 
 Since the culture systems studied herein respond to a systemic perturbation in a 
complex, context-dependent way, this motivates further exploration of responses of these 
systems to the addition of drugs used to treat diabetes, since often these coexist with and 
modulate hyperglycemia and insulin resistance in clinical settings [125]. Metformin 
stimulates osteoblast differentiation through the transactivation of Runx2 [411-415]. 
Glitazones activate PPARγ which might shift precursor cells towards the adipocytic 
lineage at the cost of osteoblast formation [416-421]. However, as with glucose, these 
medications may produce counterintuitive and perhaps counterproductive effects when 
applied to systems of cells such as those studied in these experiments. Additionally, their 
interactions with fluctuations in glucose levels have yet to be studied in such a controlled 
environment like the one offered by this platform.  Studying these networks and their 
dynamic responses to these perturbations may reveal new modes of treatment that target 
networks rather than individual proteins or genes [377, 378, 422-424], as was recently 
illustrated by Lee et al who successfully increased the susceptibility of non-drug-
responsive breast cancer tumors to attack by time- and order-dependent drug 
combinations that progressively rewired cellular signaling networks within the tumor 
[425]. 
5.5 Conclusions 
 In this study, we have leveraged our 3D tri-culture platform developed in Chapter 
4 to enable observation context-dependent interactions between hMSCs, osteoblasts, and 
adipocytes in response to different amounts of systemically administered glucose to 
mimic poorly controlled diabetes. hMSCs from each culture type displayed distinct gene 
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expression, viability and colony formation after one week of culture, suggesting that both 
cell- non-cell autonomous mechanisms drive their responses to high glucose levels. 
Together, these data suggest a more complex pathophysiology surrounding diabetes than 
previously hypothesized and that the mechanisms of disease progression are likely a 
function of more than just the sum of individual cell type-responses to hyperglycemia 
that have been studied more extensively in the literature. Indeed hMSCs respond in 
unpredictable ways when in co- and tri-culture, suggesting that clinical correlates such as 
excess marrow fat may have both positive and negative effects and that the entire marrow 
microenvironment needs to be studied as a system to fully elucidate the mechanisms 
underpinning skeletal pathology in this disease. In fact, data from tri-culture suggests that 
all three cell types are potentially needed to satisfactorily maintain skeletal health by 
preserving hMSC clonogenicity and preventing cell death. These findings suggest that 
this biomaterial platform provides a powerful systems biology tool to map and correlate 
complex stem and native cell-cell interaction networks with physiologic and disease 
phenotypes. When complemented with differential network analysis and combinations of 
systemic perturbations with biomolecules and/or drugs, this platform could lead to 
discovery of new mechanisms of skeletal disease in diabetes and allow advancement of 




CONCLUSIONS AND FUTURE DIRECTIONS 
6.1  Summary 
In addition to offering the potential to replace and restore function to injured 
tissues, tissue engineering provides researchers with the ability to generate improved, 
highly controlled and tailorable in vitro model systems to better understand mechanisms 
of homeostasis, disease, and healing and regeneration. Model systems that allow 
assembly of modules of MSCs, osteoblasts, and adipocytes in a number of configurations 
to engage in signaling crosstalk offer the potential to study integrative physiological 
aspects and complex interactions in the face of changes in local and systemic 
microenvironments. Each of these aspects will more readily enable prediction and 
understanding of cell and tissue behaviors in vivo with respect to skeletal remodeling and 
energy metabolism and facilitate design of novel and integrated molecular and cellular 
therapies to combat skeletal and metabolic diseases. The overall goal of this dissertation 
was to examine integrative physiological aspects between multiple cell types that exist 
within the marrow microenvironment, namely: MSCs, osteoblasts, and adipocytes using a 
novel in vitro model system. Specifically, a method was developed to 
photolithographically pattern and assemble cell-laden PEG-based hydrogels with high 
spatial fidelity and tissue-scale thickness for long-term three-dimensional co-culture of 
multiple cell types [362]. These photopatterning and lamination techniques were then 
adapted to produce an enabling platform to investigate effects of crosstalk between 
MSCs, osteoblasts and adipocytes on expression dynamics of mesenchymal lineage genes 
and histological markers of differentiation [387]. Finally, the same platform was used as 
a model to examine how the responses of MSCs to systemic perturbations in glucose 
concentration was affected by mono-, co-, and tri-culture with these same cell types as a 
model of pathogenesis of skeletal disease in diabetes. Together, these studies provided 
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valuable insight into unique and differential effects of signaling crosstalk between all 
three cell types and how this crosstalk may be affected during a pathological state, 
demonstrating a valuable model system for further study of integrative physiological 
interactions between mesenchymal lineage cells. 
In Chapter 3, fluidic and photolithography techniques were combined under an 
oxygen-depleted environment to enable photopatterning of hydrogels into well-defined 
shaped at tissue scale thickness (1-2 mm) [362]. Shape and size of hydrogel spatial 
features within each construct may be tuned and controlled through simple alterations in 
the photomask and implementation of an N2 atmosphere during the crosslinking 
procedure. This was accomplished without altering concentrations of cytotoxic free 
radical photoinitiators or altering base polymer structure to increase crosslink density and 
generating oxygen free radicals, all of which would have been detrimental to cell 
viability. This photolithographic scheme was sequentially employed in the generation of 
multiple laminated, spatially defined hydrogel domains that consistently remained 
adherent at their interfaces and segregated multiple cell types in the same laminated 
construct. These templated constructs enable tissue-scale co-culture between two or more 
cell types in defined spatial locales with preserved viability over at least 2 weeks and 
provided a platform with which to study signaling interactions between these cell types in 
Chapters 4 and 5. 
In Chapter 4, a simplified version of the platform developed in Chapter 3 was 
employed for co- and tri-culture of MSCs, osteoblasts, and adipocytes to evaluate effects 
of paracrine signaling on markers of differentiation in each cell type [387]. Each gel 
module containing a different cell type was specifically designed to prevent cell 
migration, cell-cell contacts, proliferation, and cell spreading to isolate the effects of 
paracrine signaling. Gene expression and histological analysis over 18 days in culture 
demonstrated that each cell type was able to respond to signals from its neighbors in a 
context specific way. Gene expression indicated that MSCs appeared to exhibit some 
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levels of lineage commitment in cell types that they were co-cultured with but failed to 
show definitive histological markers of terminal differentiation when compared with 
mono-culture positive controls cultured in defined differentiation media for osteogenesis 
or adipogenesis. Tri-cultured MSCs retained gene expression markers for multiple 
mesenchymal lineages. Multivariate analysis incorporating the global gene expression 
data set confirmed that MSCs as a whole remained a distinct population from osteoblasts 
and adipocytes, but revealed that all three cell types responded in a context-dependent 
manner to their co- and tri-culture environments since they could be discriminated with 
specifically defined, statistically meaningful latent variables. Together, these data showed 
that distinct phenotypes for both the stem and differentiated cells may have developed as 
a result of intercellular soluble signaling, which may represent changes in their lineage 
plasticity and physiological function, respectively. Additionally, these results validated 
the relevance of this platform for further efforts to re-capitulate the bone marrow niche 
and model related pathologies, as described in Chapter 5. 
In Chapter 5, the same platform from Chapter 4 was used to evaluate potential 
differences in MSC response to normal and pathologically elevated levels of systemically 
administered glucose that were governed by their mono-, co-, or tri-culture setting over 1 
week. This platform was adapted to include an enzymatically degradable hydrogel 
module for the MSCs to separate and re-plate the cells to assess their residual 
clonogenicity after these experimental treatments. Several outcome measures, including 
cell viability, gene expression, and clonogenicity were used to assess the degree to which 
responses differed between culture types and glucose conditions. Mono-cultured MSCs 
maintained cell viability under high glucose, but exhibited differences in RUNX2, OCN, 
and JUN expression and lower colony-forming capacity, suggesting possible cellular 
senescence. MSCs co-cultured with osteoblasts exhibited decreases in both cell viability 
and colony formation under high glucose conditions accompanied with changes in 
expression of RUNX2, JUN, and NFKB1. Conversely, while MSCs co-cultured with 
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adipocytes displayed changes in cell viability and gene expression of NFKB1, ADIPOQ, 
LEP, and RUNX2, their colony forming capacity was maintained and illustrated a striking 
difference between the two co-culture settings that suggested that adipocytes may be 
protective of MSC clonogenicity to some degree. Tri-cultured MSCs displayed the most 
stable cell viability, gene expression and clonogenicity in response to different levels of 
glucose, illustrating a potential balance of compensatory mechanisms and an overall 
ability to buffer each others’ responses to a perturbation that was more overwhelming in 
other mono- and co-culture contexts. These experiments demonstrated that MSC 
response to glucose was context-dependent and governed by cell- and non-cell 
autonomous mechanisms and validated this platform as a model system for future 
mechanistic studies and evaluating different treatments for the skeletal and metabolic 
consequences of diabetes. 
Together, the findings presented in this dissertation suggested that intercellular 
signaling within the niche environment of MSCs and their terminally differentiated 
progeny plays an important role in priming and governing cellular responses to local and 
systemic factors and that the modular 3D tri-culture platform developed herein provides a 
novel and unique in vitro modality for investigating homeostatic and pathological 
crosstalk between each cell type in the construct. 
6.2  Conclusions 
 The research presented in this dissertation advances understanding of the roles of 
context-dependent cues within the stem cell niche and between niche components and 
other less proximal cells and tissue compartments. Interactions of the MSCs, osteoblasts, 
and adipocytes examined herein together demonstrate a physiologically relevant 
subsystem with a larger role in homeostatic and disease processes. Neighboring cell types 
in combination with various media conditions over different time scales were shown to 
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affect the response of each cell type within the 3D laminated hydrogel constructs in 
different and detectable ways. 
A broad overview of the transcriptional and phenotypic data that the following 
conclusions were drawn from reveals a non-trivial amount of noise in gene expression 
(Figures 4.2-4.4, and 5.4-5.5), cell viability (Figure 5.3), and clonogenicity (Figure 5.7). 
Conducting a post-hoc power analysis revealed that sample sizes used in these 
experiments were sufficient to detect near 1.6 to 1.8-fold differences in gene expression 
and 1.8-fold differences in clonogenicity and 2.5-fold differences in cell viability. This 
suggests that our data is inherently noisy and there are multiple possible reasons for such 
variability. Our platform analyzes cell populations as a whole, and sample to sample 
variation, stochastic variation in gene expression, and spatial heterogeneity within a 
construct on the length scale of hundreds of cells could all produce variance in collected 
data [426-430]. Despite this level of noise, the multivariate analysis techniques that we 
employed in these studies (Chapters 4 and 5) aided in discriminating our different sample 
groups much more cleanly, particularly with gene expression data since within a single 
sample, genes tended to co-vary the same way as in other samples from the same group. 
This allowed us to truly determine whether experimental treatments (culture type and/or 
glucose condition) caused observable differences in cellular responses. With respect to 
phenotypic data, sample size likely played a much larger role in our diminished ability to 
distinguish differences among some sample groups, even when incorporating PLS 
analysis methods. Nevertheless, these results demonstrate that combining our novel 
culture platforms with multivariate modeling techniques yields a powerful tool for 
discriminating context-dependent responses of cells and systems of cells to each other 
and to systemic perturbations (Section 6.3). 
 This platform fills a sizeable gap between in vitro models culturing one or two 
cell types in monolayer or transwell format and in vivo models composed of numerous 
interacting cells, tissues, and organ systems. Tissue-scale laminated hydrogel constructs 
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containing two or more cell types retain a higher degree of complexity than traditional in 
vitro models while simplifying and eliminating confounding factors present in animal 
models by isolating and allowing the study of specific subsystems. Responses within 
each of these subsystems (i.e. mono-, co-, and tri-culture) are governed by cell-
autonomous (observable in mono-culture; Chapter 5) and non-cell-autonomous 
mechanisms (observable in co- and tri-culture; Chapters 4 and 5) [323, 324, 427, 431, 
432]. Gene expression data and multivariate models formulated in each of these chapters 
demonstrates that a unique intercellular communication network, likely composed of 
numerous network motifs (e.g. feedback and feed-forward loops, uni- and multi-
directional signaling), is formed in each setting depending on the cells used. Whether 
these effects are different from those that would be observed in 2D monolayer models is 
difficult to discern, particularly with tri-culture, since adipocytes tend to become non-
adherent with increasing differentiation and 2D in vitro tri-culture models are 
extraordinarily difficult to prepare and then separate to examine cell-type specific effects 
[294, 296, 297, 299-304, 363]. Rather the platform developed here is easily fabricated 
and modified, and in combination with these multivariate analysis techniques, enables the 
study of complex interactions between multiple cell types in an uncomplicated way. 
 Gene expression data of transcriptional regulators from Day 1 after encapsulation 
(Chapter 4, Figures 4.2A, 4.3A, 4.4A; and Chapter 5, Figure 5.4) suggests that these 
communication networks may be set up over relatively short time scales (hours) 
compared to the overall length of the experimental culture period. Importantly, these 
transcriptional regulators are key mediators of differentiation (Chapter 4) and cellular 
metabolism (Chapter 5), and that they are so quickly modulated shows that key cellular 
processes are already potentially undergoing significant changes. Additionally, the genes 
selected for analysis in both these series of experiments represent a tiny fraction of the 
entire transcriptome. That detectable changes were observed in such a small sampling of 
potential transcripts suggests that other cellular transcriptional pathways and functional 
 131 
modules may have been activated or repressed according to the cellular context of these 
cultures (Section 6.3). 
 Over 18 days in culture, MSCs in co-culture and tri-culture with osteoblasts or 
adipocytes (Chapter 4) displayed graded expression of master transcriptional regulators 
of osteo- and adipogenesis (RUNX2 and PPARG2, respectively; Figure 4.4) correlating 
with which neighboring cells were present in the co- or tri-culture [387]. As expected, 
this behavior was not observable over a week-long timescale examined in Chapter 5 
(Figures 5.4 and 5.5); rather cells never expressed PPARG2 (Section 5.3.2) and did not 
exhibit the same patterns in RUNX2 expression over the week in culture (Figures 5.4 and 
5.5). Prior work in the literature has suggested that MSCs are primed toward and even 
differentiate into the lineages that they are cultured with over a 2-3 week time span, 
providing conflicting results [294, 297, 299, 300, 303, 363]. These can be reconciled on 
closer examination of the previous literature, which performed these co-cultures in the 
presence of media formulations that induce differentiation. A better interpretation of 
those prior experimental results would be that co-culture enhanced or permitted faster 
differentiation toward osteoblastic or adipocytic lineages than when cultured alone, 
which is much more in line with what was observed in Chapter 4 (Figures 4.4 and 4.6). 
 While more permanent changes in clonogenic phenotype were observed in the 
MSCs examined in Chapter 5, data from Chapter 4 suggest that this may not be at the 
expense of plasticity in lineage allocation of MSCs, or even their differentiated progeny. 
Evidence of any lineage commitment in MSCs was scant by Day 7 in co- and tri-cultures 
from Chapter 4 (Figure 4.4), with the possible exception of PPARG2 expression in AMA 
co-cultures (though this never materialized in terms of enhanced triglyceride storage). 
Even alkaline phosphatase activity was transiently upregulated at Day 7 (Figure 4.4C) 
and disappeared by Day 18. Meanwhile adipocytes from co- and tri-culture dynamically 
expressed levels of osteogenic markers RUNX2 and OCN (Figure 4.2), and osteoblasts 
displayed altered levels of adipogenic marker PPARG2 and chondrogenic marker SOX9 
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that suggested these mesenchymal cells may be exhibiting context-dependent plasticity in 
their level of differentiation. Interestingly, MSCs from different culture settings 
expressed measureable levels of OCN, LEP, ADIPOQ, and OPG transcripts (Figures 4.4 
and 5.4-5.5), which have been traditionally associated with hormones that are produced 
by their terminally differentiated progeny. These expression levels were comparably 
lower than levels expressed by osteoblasts and adipocytes evaluated in Chapter 4, and 
need to be further evaluated in Chapter 5. 
 Evidence from Chapter 5 demonstrates that system components (i.e. the cells 
types within each construct), when properly configured as in the tri-culture setup, can 
produce a network that is robust (stable) to a systemic perturbation where other 
configurations (mono- and co-cultures) are not [323, 324, 433-437]. An alternative 
network property to consider is adaptability (flexibility), which was displayed by cultures 
containing adipocytes [438-440]. While MSCs from these cultures differed under high 
glucose (Figures 5.9 and 5.10), clonogenicity was preserved (Figure 5.6) suggesting that 
the presence of adipocytes in culture confers the property of adaptability to the network 
that was formed during the week long culture period. To some degree however, this 
network did exhibit a degree of fragility (vulnerability) since MSC death increased under 
conditions of high glucose [434, 435, 441, 442]. This network fragility was much more 
pronounced when MSCs were cultured alone or with osteoblasts, since colony formation 
was significantly affected in both settings and this was coupled with increased cell death 
in co-culture. The finding that adipocytes and osteoblasts provide different degrees of 
network fragility and adaptability while together conferring robustness is a unique one 
that could only have been elucidated when examining systems of these cells as was 
performed in the studies in Chapter 5. Each of the network properties represents an 
important consideration and should continue to be scrutinized when considering systems 
of interacting cells and tissues in the design of implantable tissues or combination 
therapies targeted for regenerative medicine [377, 378, 442-444] (see also Section 6.3). 
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 These systemic properties are in turn able to confer relatively stable properties on 
each of their cellular components. In Chapter 5, after a week-long period in mono-, co-, 
or tri-culture under conditions of normal or high glucose, MSCs were extracted from their 
hydrogel modules using enzymatic digestion (analogous to trypsinization or removal of a 
transwell insert) and re-plated at clonal density to evaluate their ability to generate colony 
forming units. During this time, they were no longer exposed to the same cellular or 
media context that existed over the week of encapsulation and instead were switched to 
media optimized for colony formation for a full two weeks (Section 5.2.7). Staining of 
colony formation after this culture period revealed different amounts of colony formation 
depending on the culture type and glucose treatment (Figure 5.6). This provides a proof-
of principle demonstration of how degradable modules that allow retrieval of cell 
populations can be leveraged to provide further phenotypic data that could not be 
obtained while the cells were still encapsulated. Furthermore, these results demonstrated 
that the intercellular communication networks imparted phenotypic characteristics on the 
MSCs encapsulated within them that may last long after a stimulus is removed [426, 445-
449]. Translated to an in vivo context, this lends insight into how pathological insults, 
both acute and chronic, can transform stem cell niches (e.g. in the bone marrow) and the 
stem cells themselves in a permanent fashion to affect their ability to self-renew, 
participate in normal homeostatic remodeling of tissues, and respond in the face of 
physiological insults [73, 426, 439, 450, 451]. 
 Both iterations of the 3D co- and tri-culture platforms (flow-driven delivery and 
photolithography in Chapter 3, and layer-by-layer deposition in Chapters 4 and 5) 
importantly are designed to build laminated constructs in a modular fashion due to the 
sequential crosslinking steps during fabrication. This key feature means that each gel 
module containing a different cell type can be tuned to have no biofunctionality, (Chapter 
3), or to include adhesive ligands (Chapters 4 and 5), and/or degradable moieties 
(Chapter 5). Consequently, different cellular behaviors were permitted in Chapters 4 
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(adhesion) and 5 (adhesion, spreading, cell-cell contacts, and potentially proliferation). 
Results from Chapter 4 detected differential responses to co- or tri-culture in the absence 
of cell spreading, which conclusively showed that cells were able to respond to soluble 
cues derived from other cells (Figure 4.6). In contrast, context-dependent effects were 
detected in Chapter 5 (Figures 5.6–5.8) while allowing MSCs to spread and form contacts 
due to their high density (Figure 5.3). Whether these effects differ substantially from 
those that would have occurred without spreading cannot be deconvolved from the data 
collected, though it is possible that allowing spreading did modulate behavior. Since 
these cells are often spread within the marrow microenvironment, which model system is 
more appropriate for study is an open question. To properly deconvolve soluble and other 
types of signals, the degradable sequence would need to be redesigned to be sensitive 
only to a non-endogenous enzyme. 
 The laminated hydrogel co- and tri-culture platforms presented in this dissertation 
therefore provide highly controlled and tunable systems to study a variety of signals 
within stem cell microenvironments. These platforms were shown to facilitate 
intercellular communication within constructs of tissue scale, produce unique culture 
type-specific responses in stem and terminally differentiated cells encapsulated within 
them, and respond in context-dependent ways to systemic perturbations that mimicked 
the pathological environment observed in diabetes. Therefore, this platform constitutes a 
valuable tool to investigate a diverse array of signaling cues in directing stem cell 
differentiation and interaction with terminally differentiated cells to mimic tissue 
microenvironments observed in vivo, and additional material and biological 
functionalities can be engineered into this unique biomaterial system to modulate this 
environment in probing behavior of complex biological systems and leveraging those 
behaviors to designing novel treatments for disease. 
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6.3 Future Directions 
The findings presented in this dissertation provide significant insights into the 
interactions between MSCs, osteoblasts, and adipocytes, the effects of those interactions 
on potential cell phenotypes, and the formation of intercellular communication networks 
that respond in a context-dependent way to glucose perturbations. All of these findings 
were made possible through the design of a modular, laminated, tissue-scale tri-culture 
platform that permitted intercellular signaling events to occur over days to weeks in 
culture to effect changes in each cell type. Future work can utilize the insights gained 
from this dissertation as a foundation for studies that apply and further refine this model 
platform for elucidating modes of interaction, mechanisms underlying multicellular 
behavior, and methods of perturbing the complex networks that emerge from these 
interactions to better understand how bone and energy metabolism are linked in healthy 
and disease states and to design targeted treatments. 
Future cell- and molecular-based therapies designed to treat diseases of bone 
remodeling must effectively integrate into a stable, homeostatically controlled marrow 
microenvironment that supports continued bone remodeling through internal and external 
regulation by both neural and hormonal cues. Both undifferentiated and differentiated 
MSCs, as well as the osteoblasts and adipocytes that they interact with, must: 1) 
appropriately regulate each others’ functions through the secretion of peripherally acting 
hormones, and 2) simultaneously retain their functional susceptibility to external 
regulatory feedback through hormonal and neural mechanisms. MSCs must be able to 
supply sufficient and appropriate numbers of osteoblasts to deposit mineralized matrix 
and adipocytes needed to support this energy intensive process. How co- and tri-culture 
of MSCs with osteoblasts and/or adipocytes affects production of bone deposition- and 
resorption-promoting factors and energy storage- and release-promoting factors from 
each cell type and the susceptibility of each cell type to neural and hormonal regulation 
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with time is an open question that needs to be addressed to provide fully integrative and 
restorative therapeutic options. 
To accomplish this, secretome analysis may be performed on conditioned media 
samples from several culture configurations to enable performance of differential 
network analysis [325, 403] and discovery of soluble mediators that affect MSC, 
osteoblast, and adipocyte phenotypes and responses in the context of healthy, 
pathological, and therapeutic microenvironments imparted by biomaterials and media 
supplements. This system would readily enable this analysis, which has previously only 
been possible with non-adherent cells [325] since it is often difficult to separate adherent 
cells from each other or extract them from 3D biomaterials. Additionally, our ability to 
cryosection hydrogels as if they were tissues (Appendix B) would readily enable us to 
stain for reporters of signaling gradients as well as expression of paracrine, neural, and 
hormonal receptors that would provide insight into susceptibility to both intra-systemic 
and external regulation and responsiveness. Furthermore, leveraging the ability of the 
platform to separate and isolate specific cell populations would offer the benefit of 
enabling further study of functional responses (e.g. mineralization, triglyceride storage) 
to stimulation with a plethora of neural and endocrine mediators implicated in regulating 
this subsystem in vivo [22, 88, 89, 147]. 
The hypothesis that lineage allocation and clonogenicity of MSCs are affected by 
pathological states such as anorexia, obesity, diabetes, and osteoporosis remains one 
based on correlation of biomarkers, imaging, and histological findings with clinical 
findings [7-11, 18, 78, 80, 84, 86]. Through limited gene expression analysis, we have 
demonstrated that MSC lineage priming and allocation may be affected in a context-
dependent way [387]. Further studies combining our cell retrieval techniques with clonal 
selection and differentiation assays [35, 428, 452] would aid in revealing the extent to 
which MSC heterogeneity, lineage commitment, differentiation, and plasticity are 
modulated as a result of exposure to one or more terminally differentiated cell types in 
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the absence of exogenous differentiation cues [426]. Because this system may be used to 
model developmental, homeostatic, and disease microenvironments, we can in turn 
observe how each of these properties is potentially modulated in the face of local 
(intercellular) and systemic (exogenously administered) microenvironmental cues. Using 
the same analysis techniques outlined above, we can additionally perform mechanistic 
studies that can be further tested in animal models [453, 454]. 
The different culture systems examined in this dissertation confer the ability to 
study mechanisms of stability imparted by crosstalk interactions between each of the 
cellular components in a controlled way, another property that emerges from the 
modularity of this platform [323, 324]. For example, one can test the degree to which 
adipocytes are able to provide compensatory responses to increased levels of glucose 
before detrimental processes such as inflammatory adipokine and oxidative stress begin 
to impose a negative stress on the entire subsystem. Additionally, the degree to which 
MSCs are able to respond to perturbations and dysfunction in neighboring osteoblastic 
and adipocytic populations by regulating their lineage allocation before they themselves 
become overwhelmed by the detrimental effects of high glucose, e.g., would provide 
important knowledge regarding how MSCs respond to their microenvironments.  There is 
currently a paucity of techniques other than comparative gene expression analysis to 
discern the source of soluble signals in co- and tri-culture settings. Were such techniques 
to come to fruition, these data demonstrate that examining the roles of MSCs in 
participating in hormonal crosstalk between bone and energy metabolism may be 
worthwhile. Further phenotypic information from clonal selection and differentiation 
studies in MSCs, mineralization capabilities in osteoblasts, and triglyceride storage in 
adipocytes gained from utilizing our degradable hydrogel modules would lend insight to 
the degree of differentiation plasticity in each of these cell types [10, 18, 455-457]. 
To ensure that the model system developed herein is truly representative of in 
vivo cellular behavior and interactions, further refinement of the hydrogel biomaterials 
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used that compose each module of cells will need to be performed. As discussed in 
Section 6.2, the modularity of this system enables us to tune the microenvironment in a 
manner specific for each cell type – a function that derives both from the patternability of 
the system as well as the orthogonal chemistries that may be used to independently 
incorporate numerous factors [458-460]. The functionalities are not just limited to 
adhesiveness and cell-mediated degradation, but also tethering of ECM molecules that 
can provide substrates for migration and cellular remodeling [195, 265, 460-464], add 
mechanical stiffness [465] or that tune the spatial range of soluble signals by providing 
added charge density, as is observed in vivo with heparan sulfate proteoglycans [466], 
other glycosaminoglycans [467-470], and in previous work from our laboratory [445, 
471]. Additionally, bioactive factors such as drugs, growth factors, cytokines, and 
hormones may be tethered to the polymer network, released in a controlled fashion from 
embedded particles that act as sources, sequestered by particles that act as sinks, or may 
interact with embedded ECM to potentiate or suppress bioactivity [164, 174, 235, 468, 
470, 471]. The specific factors, their combinations, and dosages may be specifically 
incorporated and continuously refined based on knowledge gained from in vivo models to 
further refine and better mimic the true microenvironment for each cell type. In these 
ways, this model platform can be made to tailor a specific niche for each encapsulated 
cell type that represents its normal in vivo environment, a pathological one, or even an 
environment that is specifically designed to tune cell responsiveness to signals from other 
cell types or systemically administered to the culture [65, 176, 472]. 
Taking advantage of photolithography developed as part of this dissertation as 
well as other micropatterning techniques would enable patterning of many of the 
molecular features described above [65, 176]. Additionally, the patterning techniques 
adapted to patterning hydrogels in this dissertation are also scalable with aspect ratio, and 
could be used to generate larger constructs with incorporated channels to overcome 
transport limitations and modulate signal transport, as the bone marrow niche consists of 
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an intricate and complex reticular network of blood vessels [289, 290]. This would 
additionally allow incorporation of endothelial cells and microvasculature, which 
constitute another physiologically relevant component of the niche for MSCs and their 
progeny within the marrow. Conversely, the platform could be scaled down to generate 
microscale constructs containing single cell types that could be encapsulated within a 
larger bulk. This would bring different cell types in closer proximity while still retaining 
the ability to isolate and separate them after degrading the bulk gel, since these cells are 
not often physiologically separated a large rectangular blocks like the proof-of-principle 
constructs evaluated in this dissertation. Combination of microfluidic sheet or droplet 
fabrication techniques in combination with step-growth or ionic crosslinking mechanisms 
to avoid free-radical toxicity could enable higher throughput fabrication of multicellular 
micro-tissue models (e.g. Janus particles) [280, 291]. This would enable greater 
experimental throughput with the ability to generate more samples for analysis. Scaling 
the platform down would also allow for the creation of much more complex geometries, 
such as concentric spheres that would readily enable the study of cell-generated 
morphogen gradients due to transport constraints imposed by the geometry. Smaller 
constructs would necessitate a modified set of analysis techniques with the added benefits 
of providing richer, high content data in a high-throughput manner [62, 63, 312, 322, 
327]. Examples might include digital PCR for gene expression [322] and suspension 
arrays for assay of proteins [473, 474], and such constructs would be more amenable to 
techniques such as image cytometry that provide high content imaging data from multiple 
samples at once [63, 327]. The merging of these novel techniques would more readily 
yield a compendium of data that would permit detailed inquiry into the behavior of 
complex systems of cells. 
These adaptations or additions to this platform would aid in isolating and 
characterizing potential sources of noise in the data. The degradable modules designed in 
this dissertation allow recovery of cells, and when coupled with single cell analysis 
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techniques such as digital PCR or limiting dilution and clonal selection would allow us to 
quantify the population level noise. Alternatively, with broader knowledge of which 
transcription factors were highly variable within a group of samples and different across 
culture types, immunohistochemical staining could be performed on histological sections 
of whole constructs to examine if signaling gradient-induced spatial heterogeneities were 
formed. Further studies assaying a larger repertoire of genes and phenotypic outcomes 
would strengthen our multivariate models (PCA, PLS-DA, and PLS) by revealing a more 
detailed and stronger correlation between the phenotypic states acquired by each cell type 
as they are exposed to other cells in this model microenvironment and less noisy gene 
transcripts that more accurately distinguish differences between cell types and cultures 
[306, 309, 311-315, 325, 475]. Furthermore, this would lend insight into how each 
subsystem studied is primed towards detecting a response to one or more systemic 
perturbations, such as altered glucose or other soluble factors. 
In addition to adding and modulating niche components within each module of 
the assembled hydrogel construct detailed in this dissertation, we successfully 
demonstrated that the entire system could be perturbed by and exhibit unique responses 
to exogenous stimuli added to the media. However, the hyperglycemia that is 
representative of poorly controlled diabetes mellitus is but one of many systemic 
perturbations that could be imposed to mimic a pathological state. Over time these cells, 
within and outside the marrow microenvironment, are exposed to advanced glycation 
products, reactive oxygen species, changes in extracellular redox potential, 
hyperlipidemia, inflammatory cytokines, hypoxia, and a whole host of other chemical and 
biomolecular insults representative of a wide range of metabolic, immune, oncologic, and 
other diseases [476]. This platform is amenable to exposure to any one or a combination 
of these perturbations to examine changes in cell fate and function that mediate or result 
from a number of disease states, which would in turn make this a novel in vitro model 
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system within which to evaluate treatments and predict therapeutic efficacy prior to 
testing in expensive and much more complex animal models. 
By introducing these capabilities and demonstrating their feasibility, the 
advancements in 3D co-culture detailed in this dissertation may also be used to induce 
specific cellular states and prime them in defined, controllable ways for further in vitro or 
in vivo experimentation or eventually for delivery as an optimized therapeutic product to 
a patient. Further refinement of the degradable modules to include moieties that are not 
amenable to cell-mediated degradation would allow on-demand isolation of cells 
exhibiting a specific stable state. Alternatively, modules of cells can be disassembled 
using interfaces made from degradable hydrogels and then reassembled into new 
configurations [477]; or they may be primed in isolated modules under specific 
conditions prior to assembly. In this fashion, analogous pieces of a LEGO
®
 set, modules 
could be primed to different stages and assembled in different configurations to yield new 
emergent complex system-level behaviors [434, 435, 478, 479]. Additionally, these 
modules could be combined with modules of cells acquired ex vivo from animal models 
of disease states. Together, these prospective advancements would offer temporal control 
of cell state transitions and process optimization for biological characterization and 
therapeutic development and evaluation [323, 324]. 
 Future work can expand on the various principles presented in this dissertation to 
develop precisely controlled, highly tunable, complex, physiologically representative 
microenvironments with modules of multiple cell types and enable study of their 
emergent behavior in the presence and absence of systemic perturbations. Additionally, 
while this dissertation was focused on interactions of MSCs, osteoblasts, and adipocytes 
with respect to their reciprocally regulated differentiation programs and in the context of 
their interactions in regulating bone and energy metabolism, the technology developed 
within is readily extensible to creating models of other cell-cell interactions and 
subsystems, including but not limited to other solid organs, the immune system, neuronal 
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interfaces, and tumors. The research presented in this dissertation demonstrated the need 
and utility for more advanced co-culture systems of multiple cell types, and provided 
valuable insights into the contributions of MSCs, osteoblasts, and adipocytes to 
intrinsically regulating each others’ fate, function, and coordinated responses in the face 
of systemic perturbations. Furthermore, these findings improve understanding of the role 
of intercellular communication networks and the cellular composition of the stem cell 




DESIGN AND SCREENING OF CONJUGATED POLYMERS FOR 
HYDROGEL DEGRADABILITY, CYTOCOMPATIBILITY, AND 
CELL SPREADING 
A1.  Introduction 
Poly(ethylene glycol) (PEG) is a non-adhesive synthetic material that is highly 
resistant to protein adsorption, making it an especially attractive material for allowing 
freely diffusing cell-derived signals to be transported between encapsulated cells [191-
193]. PEG’s mechanical and biochemical properties can be easily modified for a variety 
of tissue engineering applications [194-196]. As such, PEG-based materials provide a 
template upon which additional bioactive functionality can be specifically tailored into 
the hydrogel formulation. Functional peptides such as the adhesive peptides glycine-
arginine-glycine-aspartic acid-serine (GRGDS) and tyrosine-isoleucine-glycine-serine-
arginine (YIGSR) and growth factors including TGF-β, bFGF, and VEGF have been 
tethered into PEG networks to modulate cell response [197-201]. PEG hydrogels have 
been extensively investigated for bone, cartilage, vascular, and neural engineering [196, 
201-207]. Collectively, these studies have demonstrated the ability of biofunctionalized 
PEG hydrogels to support viability, spreading, proliferation and ECM deposition by 
multiple cell types, directed differentiation of stem cells, and more complex functions 
such as endothelial tubulogenesis, vascular infiltration, and neurite extension. 
 Biodegradable hydrogels have been favored for biomedical applications since 
they degrade in clinically relevant time-scales under relatively mild conditions, thus 
eliminating the need for additional surgeries to recover implanted gels and allowing for 
progressive replacement of the biomaterial by native or regenerated tissue [165, 186, 208, 
209]. They are advantageous for in vitro applications because they facilitate cell 
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spreading, proliferation, migration and deposition of extracellular matrix to better mimic 
native tissue environments [209, 210]. Currently, the fabrication and modeling of 
hydrolytically degradable hydrogels [209, 211, 212] are well developed and the synthesis 
and utilization of synthetic gels incorporating biological moieties for enzymatic 
degradation are under investigation [209, 213, 214]. While hydrogels made from natural 
polymers are often enzymatically degraded, synthetic hydrogels containing biological 
moieties often offer more controlled degradation rates due to their tunable 
physicochemical properties [164]. Hydrolytically labile components have been added into 
PEG networks to control degradation [203, 215], and enzymatically degradable peptides 
have also been incorporated within PEG hydrogels for cell-mediated degradation [216-
218]. More recently, novel photodegradable groups have been investigated as a means to 
degrade PEG networks on demand in the presence of ultraviolet (UV) light [219-221]. 
These methods have been designed with the ability to elicit a cellular response (e.g. 
migration, spreading, and proliferation) in vitro or to eventually fully degrade via 
hydrolysis or cell-mediated enzymes in an in vivo setting to promote regeneration. None 
have been employed thus far for cell retrieval. 
 To address the need for enabling cell retrieval from bulk hydrogels in our tri-
culture platform in Chapter 5, we screened the literature for peptide and enzyme 
combinations that allowed for specific enzyme-substrate reactions to occur and avoid the 
potential for exogenously added enzymes to degrade any ECM components or cell 
surface proteins or to diminish cell viability. We then synthesized PEG-peptide-PEG 
conjugates using standard NHS chemistry (see Section 5.2.1) and evaluated the time to 
achieve bulk degradation. Additionally, alginate gels derived from non-endogenous 
polysaccharides were evaluated [60, 178, 184, 280, 289, 480-482]. Hydrogel 
formulations that achieved bulk degradation in 2 hours or less were then used to 
encapsulate hMSCs, osteoblasts, and adipocytes to screen for any detrimental effects on 
cell viability and whether cells were able to locally degrade the hydrogel network. 
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A2.  Materials and Methods 
A2.1 Selection of Candidate Peptides 
 Candidate peptides were collected initially from the literature reviewing currently 
available fusion tags for recombinant protein purification [483-487], since these enzyme-
peptide combinations are known for their highly specific cleavage while leaving 
recombinant proteins intact. Data detailing enzyme characteristics and known substrate 
cleavage events was collected from MEROPS (http://merops.sanger.ac.uk/), a database of 
peptidases compiled and curated from the literature. UniProt identification numbers of 
proteins containing the purported cleavage substrate used in the fusion tag were then 
collected and stored. This information was then imported into SitePrediction 
(http://www.dmbr.ugent.be/prx/bioit2-public/SitePrediction/index.php), an online tool for 
identifying potential cleavage sites within a protein. SitePrediction then cross-referenced 
these proteins with known substrate cleavage sites of extracellular enzymes (e.g. matrix 
metalloproteinases (MMPs) and cathepsins) to assess the likelihood that these cell-
secreted enzymes could degrade the peptide of interest based on MEROPS data for each 
cell-secreted enzyme. 
 Substrates that demonstrated a low likelihood of cleavage by the cell-secreted 
enzymes were then assessed for their molecular properties to determine if they were 
amenable to PEG-conjugation with NHS chemistry [218, 364, 387, 395]. These criteria 
are summarized below in Table A1. Additionally, peptides were selected that would 
demonstrate neutral charge at pH 7 to prevent limitation of charged molecule transport 





Table A1. Peptide Criteria for Successful Conjugation and Gelation Using Free-
Radical Polymerization 
Peptide isoelectric point less than 8.5 
[Ensures that all amines are de-protonated to enable efficient conjugation with NHS] 
No primary amines except at N-terminus and at terminal lysine 
[Ensures site-specific conjugation of Acrl-PEG-SVA] 
Percentage of hydrophobic residues < 30%, and hydrophilic and polar residues > 30% 
[Ensures solubility of peptide during conjugation reaction] 
Number of aromatic residues less than 2, and no tryptophan residues 
[Ensures that free-radical crosslinking reaction is not quenched by peptide] 
A2.2 Polymer Synthesis and Characterization 
 To allow presentation of adhesive ligands that promote viability of encapsulated 
cells, fibronectin-derived GRGDS (Bachem) and laminin-derived YIGSR (Anaspec) 
adhesion peptides were separately reacted as previously described [218, 364, 387, 395] in 
a 1:2 molar ratio with a 3,400 Da MW Acryl-PEG-succinimidyl valerate spacer (Acryl-
PEG-SVA; Laysan Bio) in 50 mM NaHCO3 buffer (pH 8.5; Fisher) at room temperature 
with gentle stirring for 3 h, dialyzed (1,000 Da MW cutoff) for 60 h, lyophilized for 72 h, 
and stored at -20 °C until further use. 
Similarly, to create enzymatically-degradable PEG, the unmodified peptides 
selected from our screen (Table A2), were reacted with Acrl-PEG- SVA at a 1:2.2 
peptide:Acrl-PEG-SVA molar ratio in 50 mM NaHCO3 buffer at pH 8.5 for 3 h. The 
resulting solution containing Acrl-PEG-Peptide-PEG-Acrl (enzymatically-degradable 
PEG) was then purified as described above. 
 Alginate was conjugated with double bonds as previously described [481, 482]. 
Briefly, low molecular weight sodium alginate (2 g; Pronova UP VLVG, Novamatrix) 
was dissolved in a buffer solution (1% w/v, pH 6.5) of 50 mm 2-
morpholinoethanesulfonic acid (MES, Sigma) containing 0.5 M NaCl. N-
hydroxysuccinimide (NHS, 0.53 g) and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
hydrochloride (EDC, 1.75 g) (molar ratio of NHS:EDC = 1:2) were added to the mixture 
 147 
to activate the carboxylic acid groups of the alginate. After 5 min, 3-
aminopropylmethacrylamide  (APMAm) (molar ratio of NHS:EDC:APMAm = 1:2:1) 
was added to the product and the reaction was maintained at room temperature for 24 h. 
The mixture was precipitated with the addition of excess of acetone, dried under reduced 
pressure, and rehydrated to a 1% w/v solution in ultrapure deionized water (diH2O) for 
further purification. The methacrylated alginate was purified by dialysis against diH2O 
(MWCO 3500; Spectrum Laboratories) for 3 days, filtered (0.22 μm filter), and 
lyophilized. 
Table A2. Summary of Peptides Chosen for Conjugation 
Peptides: GGENLYFQSGGK GGIEGRIVEGGK GGGLGPAGGK
* 
UniProt ID P04517 P00735 P02452 
Enzyme Tobacco Etch Virus 
Protease 
Factor Xa Collagenase, MMPs 
No. of Amino Acids 12 12 10 
Molecular Weight 1256.33 1171.31 769.85 
Isoelectric Point 
(pI) 
6.34 6.51 9.69 
Charge at pH 7.4 0 0 +1 
Charge at pH 8.5 -0.5 -0.5 +0.75 
% Hydrophobic 25 25 30 
% Hydrophilic 17 33 10 
% Polar, 
Uncharged 
25 0 0 
Aromatic Residues 0 0 0 
* This peptide sequence was included on the basis of previous work that demonstrated 
successful conjugation, relatively slow cleavage over 7 days in culture (the length of the 
experimental period in Chapter 5), and amenability to cell retrieval in our lab [218, 364, 
387, 395, 488]. This was not evaluated at part of the screen outlined in A2.1. Also note 
that once conjugated, the charge of this peptide at pH 7.4 is neutral since both the N-
terminal and lysyl amines are conjugated. 
 
A2.3 Assessment of Bulk Gel Degradability 
 Gel samples were formed as described in Section 5.2.3, with the following 
exceptions: TEV- and Factor Xa-sensitive gels consisted of 7.5 w/w% polymer; alginate 
gels consisted of 2.5% w/w polymer; collagenase-sensitive gels were crosslinked for 12 
 148 
minutes, while all other gels were crosslinked for 10 minutes. After allowing the gels to 
reach equilibrium swelling overnight in PBS, gels were placed in 500 μL of buffer 
containing their respective enzymes and incubated at 37 °C on a shaker table until the 
hydrogel was no longer visible. Collagenase-sensitive gels were degraded in hMSC 
expansion medium (as described in Section 5.3.2) containing 1,100 U/mL collagenase 
type II (Gibco). TEV protease-sensitive gels were degraded in 20 mM Tris-HCl with 200 
mM NaCl, 5 mM citrate, 3 mM reduced glutathione, 0.3 mM oxidized glutathione and 
containing 15 Units of TEV-protease (ProTEV; Promega). Factor Xa-sensitive gels were 
degraded in serum-free αMEM. Alginate gels were degraded in PBS containing 10 
Units/mL of alginate lyase (Sigma). 
A2.4 Cell Culture and Expansion 
All cell culture reagents were obtained from Mediatech unless otherwise 
specified. Primary human MSCs (hMSCs) were obtained from the laboratory of Dr. 
Darwin Prockop (Texas A&M Health Sciences Center) and expanded according to 
recommended protocols in Minimal Essential Medium-Alpha (αMEM) with 16.5% fetal 
bovine serum (FBS; Hyclone), 1 g/L glucose, 2 mM L-glutamine, 1% amphotericin B, 
and 0.1% gentamicin and cultured at 37°C with 5% CO2 in a humidified incubator [365]. 
Primary human osteoblasts (hObs; Lonza) were expanded to 4 population doublings in 
OGM Osteoblast Growth Medium (Lonza) containing 10% FBS, ascorbic acid 
(concentration proprietary), 50 μg/mL gentamicin, and 37 ng/mL amphotericin B. 
Primary human subcutaneous pre-adipocytes (Lonza) were expanded to 1-2 population 
doublings according to the manufacturer’s protocol in PGM-2 Basal Medium (Lonza) 
containing 10% FBS, 2 mM L-glutamine, 50 μg/mL gentamicin, and 37 ng/mL 
amphotericin B. Cultures at 80% confluence were differentiated into adipocytes (hAds) 
for 9 days in Dulbecco’s Modified Eagle Medium (DMEM) with 10% FBS, 4.5 g/L 
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glucose, 60 µM indomethacin, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 0.5 µM 
dexamethasone, and 1 μM insulin. 
A2.5 Crosslinking Device Design and Construct Fabrication 
Layering devices were fabricated and employed for cell patterning as described in 
Figure 4.1. Briefly, 1 mm-thick spacers were cut from cured polydimethylsiloxane 
(PDMS, Sylgard 184, 10:1 ratio base to curing agent; Dow Corning) and bonded with O2 
plasma to a 25 × 75 mm glass slide (VWR). This slide was contact bonded with another 
coated with fluorinated ethylene propylene film (Bytac FEP; U.S. Plastic Corp) to form a 
cavity for polymer solution/gels as they were loaded and crosslinked. The use of FEP 
film prevented adhesion of crosslinked gels to glass that could result in ripping following 
device disassembly. Devices were sterilized by autoclave prior to assembly and use for 
encapsulation. 
Hydrogel precursor solutions were formulated as described in Section 5.2.3 with 1 
mM Acryl-PEG-GRGDS (for hMSCs and hObs) or Acryl-PEG-YIGSR (for hAds). Cell 
suspensions were prepared from near-confluent cultures using 0.05% Trypsin/0.53 mM 
EDTA and resuspended in their respective gel precursor solutions at a concentration of 
10 million cells/mL. These solutions were loaded into layering devices and 
photocrosslinked (as described in Section A2.3) into 1 mm-thick, 4.5 mm-tall hydrogel 
constructs as described in Figure 5.1 (mono-culture). Whole constructs were extracted 
from the device and sectioned with a scalpel to yield up to twelve 1.5 mm-wide mono-
culture constructs (Figure 5.1). 
A2.6 Construct Culture Conditions 
Constructs were placed in separate wells of 12-well tissue culture plates with 2 
mL of tri-culture medium for 24 h [DMEM with 10% FBS, 1.0 g/L glucose (5.5 mM; 
normal fasting serum glucose), 2 mM L-glutamine, 50 µg/mL L-ascorbate-2-phosphate 
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(Sigma), 1 μM insulin (Sigma), 1% amphotericin B, and 0.1% gentamicin. All constructs 
were then cultured for a total of 7 days with media changea at Days 1 and 4. 
A2.7 Cell Viability Assessment and Image Analysis 
 Hydrogel constructs (n = 3) were analyzed on Days 1 and 7 using a LIVE/DEAD 
assay (Invitrogen) as a qualitative indicator of cell viability. The kit uses calcein AM 
(ex/em: 495/515 nm), which is conjugated by active cytosolic esterases to remain within 
the cell membrane and label live cells, and ethidium homodimer-1 (EthD-1; ex/em: 
495/635 nm), which can only enter permeable nuclear membranes and binds to DNA to 
indicate dead or dying cells. Constructs were rinsed in sterile PBS at 37 °C for 30 
minutes and subsequently incubated in staining solution (1 µM calcein AM, 1 µM 




) for 45 minutes at 37 °C. After 
a second PBS rinse for 15 minutes to remove excess dye, stained constructs were imaged 
with confocal microscopy (10x objective, LSM 700; Zeiss). For each construct, 1 image 
stack was collected for each cell type present (dimensions: 693 × 693 μm; stack depth = 0 
– 800 µm with 10-µm intervals). Each image stack was qualitatively assessed for cell 
viability and the degree of cell spreading visualized by cytoplasmic calcein staining. 
A3. Results and Discussion 
A3.1 Bulk Hydrogel Degradation 
 As expected from previous work, collagenase-sensitive gels completely degraded 
within 1 hour. Alginate gels completely degraded within 10 minutes, likely because the 
base polymer contains multiple cleavage sites and due to the high efficiency of the 
alginate lyase. Factor Xa gels completely degraded within 2 hours. TEV-protease 
sensitive gels degraded within 36-48 hours. Both of these enzyme sensitive gels were 
highly crosslinked and required lowering the initial polymer content from the typical 10% 
w/w described throughout this dissertation to 7.5 % w/w. This could be attributable to a 
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much more efficient conjugation of these gels since both starting peptides are fully de-
protonated in the conjugation reaction conditions. Further optimization of both gels 
would likely entail lengthening the peptide chains with additional endogenous amino 
acids (within the limits of the above described criteria in Section A2.1) to enhance 
enzyme substrate binding and reaction or with additional glycine spacers to prevent steric 
hindrance of enzyme transport throughout the hydrogel bulk and accessibility of the 
target peptide to the enzyme. Additionally enzyme buffer formulations may need to be 
further optimized to ensure that enzyme activity is maximized and prolonged. On the 
basis of these results, all gels except the TEV-protease sensitive gels were further 
evaluated for cytocompatibility and cell spreading in subsequent experiments.  
A3.2 Cell Viability and Cell Spreading 
 
Figure A1. Alginate and Factor Xa-sensitive gels are cytocompatible but 
demonstrate differences in MSC cell spreading over 7 days in culture. 
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 Alginate gels demonstrate gels demonstrate high cell viability after 1 week in 
culture and a complete absence of cell spreading. This is readily attributable to the 
inability of MSCs to produce alginate lyase that can cleave the polysaccharide matrix. 
Factor Xa gels demonstrated comparable cytocompatibility. However, MSCs exhibited 
significant cell spreading after 7 days in culture, suggesting that the peptide crosslinker 
used in these gels is sensitive to an enzyme that is endogenously produced by MSCs and 
which remains to be identified. 
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Figure A2. Mono-cultured adipocytes, osteoblasts, and MSCs demonstrate adequate 
cell viability when encapsulated in collagenase-sensitive gels and no observable cell 
spreading after 7 days in culture. 
 In contrast to Factor Xa-sensitive gels, all three cell types are unable to cleave the 
hydrogel network over the first 7 days in culture. This suggests that while each cell type 
may produces enzymes that have the ability to cleave the network their activity over the 
first 7 days in culture negligibly affects cell spreading within these constructs under 
mono-culture conditions.  
A4. Conclusions 
 Each of the hydrogel materials evaluated in this series of experiments represents a 
tunable system that offers unique capabilities when used as modular materials within our 
tri-culture platform (see Chapter 6). Alginate and TEV protease-sensitive gels are not 
sensitive to degradation by endogenously produced enzymes, while Factor Xa- and 
collagenase-sensitive gels do exhibit this property with different time scales. Each of the 
proteolytically sensitive hydrogels has a neutral charge density due to the lack of charged 
amino acid residues in their respective peptide sequences, while alginate gels contain a 
carboxyl moiety on each disaccharide unit along the polymer chain. This charge may 
interact with positively charged growth factors [445, 466-471], thus limiting transport of 
these molecules between cell types over the length scales of our tri-culture platform. On 
the basis of these findings and conclusions, we selected the collagenase-sensitive 




ADAPTED METHOD FOR CRYOPRESERVATION AND 
CRYOSECTIONING OF HYDROGELS 
Purpose: 
To effectively cryopreserve poly(ethylene glycol)-based hydrogels and improve 
sectioning and mounting using a Microm HM-560 cryomicrotome. This protocol is 
intended to prevent ice crystal formation in samples with high water content, enhance 
penetration of embedding medium in the gel sample, and increase the quality of sections 
by altering the embedding medium composition to match the mechanical properties and 
refreezing rate of the modified sample. Technique for cryosectioning, including knife and 
sample temperature, orientation of sample, use of the roll-up preventing glass plate and 
sample transfer to slides is also described. Please see the following references for further 




 Sucrose (crystalline, VWR: EM-SX1075-3) 
 Phosphate-buffered saline (use PBS with Ca2+ and Mg2+ to preserve cell 
morphology) 
 Sakura Finetek O.C.T. (Optimal Cutting Temperature) Compound 4583 
 Liquid nitrogen (alternatively isopentane in liquid nitrogen or dry ice in acetone 
may be used) 
Materials: 
 Conical tubes or bottles (solution storage) 
 Spatula and/or forceps (for manipulating gels) 
 Cryomolds of desired size 
 12-well plates 
Equipment: 
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 Vacuum capable of -20 in Hg pressure 
 
Methods: 
Processing: Cryoprotection with sucrose and infiltration with OCT compound 
1. Make up a solution of 50% (w/v) sucrose in PBS by dissolving 50 g per 100 mL. 
Using this concentrated solution, make up the following working solutions: 
a. 5% sucrose in PBS 
b. 20% sucrose in PBS 
c. 20% sucrose : OCT (4:1 ratio by volume) 
d. 20% sucrose : OCT (3:1 ratio by volume) 
e. 20% sucrose : OCT (2:1 ratio by volume) 
f. 20% sucrose : OCT (1:1 ratio by volume) 
g. 20% sucrose : OCT (1:2 ratio by volume) 
Note: For solutions of sucrose in PBS, long term storage is improved with sterile 
filtration of the sucrose stock solution. For solutions containing sucrose mixed 
with OCT, these must be prepared with vigorous shaking to ensure complete 
mixing of sucrose solution with OCT. This will result in the formation of air 
bubbles within the solution that may be removed by placing the solution under 
vacuum or allowing the solution to sit capped at room temperature overnight. 
2. Sucrose serves as a cryoprotectant by allowing vitrification (freezing of water 
without the formation of ice crystals). OCT acts as a space filler that allows the 
sample and surrounding embedding medium to refreeze at similar rates after 
sectioning with a cryotome blade. Gradual infiltration of each of these substances 
is needed since highly concentrated solutions are substantially more viscous than 
the fluid in the interior of the hydrogel. The presence of a vacuum environment 
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aids in penetration of the embedding medium. To achieve optimal sucrose and 
OCT infiltration, the following steps are recommended: 
a. Begin by placing the gel in 1-2 mL of 5% sucrose and vacuum infiltrate 
(20 in Hg) for 0.5 hour 
b. Place the sample in 1-2 mL of 10% sucrose infiltrate for 30 min. 
c. Place the sample in 1-2 mL of 15% sucrose infiltrate for 30 min. 
d. Place the sample in 1-2 mL of 20% sucrose infiltrate for 30 min. 
e. Move gel to 4:1 sucrose:OCT solution, vacuum infiltrate for 1 hour. 
f. Move gel to 3:1 sucrose:OCT solution, vacuum infiltrate for 1 hour. 
g. Move gel to 2:1 sucrose:OCT solution, vacuum infiltrate for 1 hour. 
h. Move gel to 1:1 sucrose:OCT solution, vacuum infiltrate for 1 hour. 
i. Move gel to 1:2 sucrose:OCT solution, vacuum infiltrate overnight (or 
minimum 4 hours). 
j. Optional: Use 1:2 sucrose:OCT solution for 1 hour, followed by OCT 
overnight (or minimum 4 hours). This is likely more useful for gels of 
higher stiffness (e.g. somewhat mineralized or with higher crosslink 
density). 
Note: The times denoted above are minimum times for each step. Longer 
infiltration times are not necessarily detrimental, and may be used depending on 
the time available to the sample preparer. 
 
Embedding and Cryopreservation 
3. Label the peel-away cryomold with the sample information, and make sure to 
label the orientation and approximate location of the sample to be embedded. 
4. Place a layer of 1:2 sucrose:OCT solution in bottom of cryomold to the 
approximate height desired for the hydrogel sample.  
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5. Place the hydrogel sample on top of the unfrozen layer, making sure it is parallel 
with the eventual cutting surface. Cover in 1:2 sucrose:OCT solution to desired 
block thickness and re-orient sample if necessary. 
6. Flash freeze the entire sample by submerging ¾ of the cryomold into the liquid 
nitrogen. Using liquid nitrogen in addition to sucrose minimizes the size of ice 
crystals that may form during the freezing process that could damage the sample. 
The sample will freeze from the outside toward the center. Care should be taken 
not to completely freeze the sample because it is likely to crack. Only submerge 
in liquid nitrogen until ¼ of the top layer of embedding medium remains 
unfrozen, and then place the sample in a -80°C freezer to complete freezing. Note: 
If a loud popping sound is heard, the sample is likely cracked and will need to be 
thawed and refrozen. Cracked blocks will not remain fixed on the sample holder 
in the cryostat, and there is a risk of cracking the specimen as well. Alternatively, 
isopentane in liquid nitrogen or ethanol/acetone on dry ice may be used to help 
avoid cracking. 
7. Samples may be stored at -80°C until ready to be sectioned. 
 
Cryosectioning 
8. Set the ambient/sample temperature in the cryostat to -23 to -25°C. Insert a 
cryotomy blade into the blade holder, and set the knife temperature to -23 to -
25°C. (The sample and knife temperatures should match). Allow 10-15 minutes 
for the blade to cool down to this temperature. 
9. Extract embedded sample from the peel-away cryomold and fix to sample holder 
with a moderate amount of OCT compound. Allow the OCT to freeze, bonding 
the sample to the sample holder, and then mount and secure the sample holder in 
the specimen block. Orient the sample so that its cross section is parallel to the 
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blade, and so that it is diamond shaped. Having a diamond-shaped cross section 
minimizes roll-up during sectioning. 
10. Trim the sample block at 50-µm intervals until the hydrogel sample becomes 
barely visible, then switch to 20 µm fine setting to acquire sections. It’s best to 
leave a small portion of the section hanging on the sample block to keep the 
section in place while trying to mount onto slides. NOTE: When sectioning, be 
sure that there is no frost or residual OCT on the blade, roll-up preventing glass 
plate, or stainless steel plate by brushing away. Residual material in any of these 
locations will wrinkle, roll up, or damage the sample as it comes off the blade. 
Gently use a cotton swab to unroll the sample if necessary. 
11. Mount each section onto a frosted slide (Superfrost + slides or similar are best), 
making sure to mount on the sides that are frosted and labeled with a plus sign. 
Hydrogel samples stick best to these slides during staining. 
 
FINAL NOTE: With this procedure, serial sections ≥ 20 µm may be acquired with 
relative ease. Thinner sections still detach from the OCT and fold up. Suggested 
modifications to achieve thinner sections would include deriving a custom formulation 
for an embedding medium and sectioning with a much colder knife and larger 
temperature differential between the knife and sample (see Cocco et al and Ferri et al 
references for guidance).  
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APPENDIX C 
GUIDE TO MULTIVARIATE MODELING 
Purpose: To provide an introduction to the modeling techniques outlined in this 
dissertation. For further reference, please see [370, 371, 494]. 
 
Introduction: Why use multivariate modeling? 
 Works well for modeling soft biological data; multiple types of data can be used 
(gene/protein expression, image quantification, mechanical/material properties, 
functional outcomes from in vitro or in vivo studies, etc). 
 Since observations are considered in a multivariate way, noise in the data is much 
more easily accounted for by a within each model 
 Works for both explorative (hypothesis-generating) and confirmative (hypothesis-
testing) analysis 
 Reveals dominant structures in one data table X 
 Reveals the relevant structures within and between two data tables X and Y 
 Predicts one set of variables Y from another set of variables X, even in new samples 
 Handles cases with far more X-variables than samples, in contrast to many traditional 
methods 
 Allows collinear redundancies in the input data and actively utilize these in the 
modeling 
 Allows errors in both X and Y 
 Allows different error levels in different input variables in X and in Y 
 Handles a few missing data points in a simple and robust way 
 Provides compact graphical overviews and statistical details, as chosen by the user 
 Gives automatic warnings for outliers and gross mistakes 
 Gives understandable statistical assessment of the validity of the model: predictive 
ability and model parameter stability 
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 Is compatible with contemporary statistics, but incorporates experiences from other 
fields 
 Works for classification and discrimination issues 
 Can address experiment-to-experiment variation and be used for quality assessment 
 Is available in several commercial program packages with documentation and support 
 
Principle Component Analysis (PCA): 
 Utility 
o Extracts and displays systematic variation in data matrix X with N 
observations (rows) and K variables (columns) 
o Represent a multivariate data table as a low dimensional plane such that an 
overview is obtained. May reveal groups of observations, trends, and outliers. 
o Uncovers relationships between observations and variables, and between 
variables themselves 
 Under the hood 
o Statistically, PCA finds orthogonal lines, planes, and hyperplanes in K-
dimensional space that approximate the data in the least squares sense.  
o PCA is governed by maximum variance least squares projection of X; in other 
words information is depicted according to the sources of most variance in the 
data and can reveal the observations/factors that contribute to that maximum 
variance. Each principle component includes a non-overlapping amount of 
variance in the sample set, with the first component describing the most 
variance, the second describing the next most, and so on. A data set can be 
completely described if the number of components matches the number of 
variables (i.e. 100% fit), but those are not the “best” models (see below). 
o Overall model:               
   = vector mean of all X-variables 
 T = matrix of scores for X (values of observations on principle 
component axes) 
 P = matrix of loadings for X (weights assigned to variables) 
 E = matrix of residuals for X 
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o Performs cross-validation and jack-knifing to assess model quality and 
optimize number of principle components 
 Entering data into the model (pre-processing) 
o Trim (remove) or Winsorize (re-scale) non-sensical data or egregious outliers 
(Note: if possible, leave as many perceived outlying data points in as possible 
and allow the model to prune these out later. An outlier from univariate 
analyses such as ANOVA is not necessarily an outlier in multivariate analysis 
where you are analyzing all variables for a given observation.) 
o Perform necessary transformations of data to achieve normality (e.g. Box-
Cox, log, etc.) 
o Data need to be scaled to unit variance (i.e. σ2 = 1) so that all variables are 
equally important in the resulting model 
o Data need to be mean centered (i.e.   = 1) so that all variables are centered on 
the origin in the resulting model space and do not skew the model 
 Outputs and diagnostics (P denotes that this parameter can be used to “prune” the 
model) 
o R2X: explained variation of the model determined for X; indicates overall fit, 
ideal is > 0.7 
o Q2: predictive capacity of the model determined for X; indicates ability of 
model to account for future observations, ideal is > 0.5 
o Cross-validation: model optimization to achieve a number of principle 




. Groups of observations are eliminated 
and the model is re-fit to examine the sensitivity of the scores and loadings. 
o Jack-knifing: results from cross-validation are used to evaluate variable 
sensitivity in the model and calculate the standard errors of the regression 
coefficients (weights), which can then be converted to 95% confidence 
intervals (via t-distribution) to determine which X-variables have statistically 
significant influence (p < 0.05) in one or more principle components. 
o Score plot (t1 vs. t2, etc.): ta represents each principle component a found in 
the model; observations are projected onto these principle components. 
o Loading plot (p1 vs. p2, etc.): pa represent the weight assigned to each 
variable contained in X for each principle component a; variables are 
projected onto these plots 
o P Hotelling’s T2: multivariate generalization of Student’s t-test; provides 
check for observations adhering to multivariate normality) => indicates 
 162 
STRONG outliers, used in conjunction with score plot (default = 95% 
confidence) 
o P Distance to model in X-space (DModX): Examination of residuals (matrix 
E); MODERATE outlying observations have DModX values > Dcrit (critical 
distance, determine by number of observations) 
o P R2VX and Q2VX: explained variation of a X-variable; allows ability to look 
at extent to which each variable is accounted for by the model 
 Interpretation: 
o Does the model fit the data well? If not, then no interpretation of the score and 
loading plots can be performed. No exceptions! 
o Do the observation scores cluster according to known independent variables? 
o How do the loadings correlate with the observations? The loading plot can 
essentially be overlayed with the score plot to assess this. 
o Which observations contribute to the maximum variance (i.e. high score on 
one or more components, or furthest from the center of the model)? 
o Which variables contribute to the maximum variance (i.e. high loading on one 
or more components, or furthest from the center of the model)? 
o Are there outlying observations in the data (Hotelling’s T2 and/or DModX)? 
o Which observations and variables are statistically significant in one or more 
components (use results from cross-validation and jack-knifing to generate 
confidence intervals)? 
 
Partial Least Squares Projections to Latent Structures (PLS): 
 Utility 
o Used to connect information in two blocks of variables, X and Y, to each 
other; effectively multivariate linear regression to elucidate how X determines 
Y 
o Precision improves with increasing number of relevant X-variables 
 Under the hood 
o Same pre-processing methods as with PCA 
 163 
o Maximum covariance model of relationship between X and Y. This 
constitutes the main difference between PLS and PCA. The observations are 
modeled based on how Y maximally covaries with X, rather than how they 
are distributed by the maximum variance in X. If Y is the source of the 
maximum variance in X (i.e. describes the variance in X 100%), then the PLS 
and PCA scores and loadings will be exactly the same. 
o Overall Model:               ;                
                           
   = vector mean of all observations 
 U = matrix of scores for Y (values of observations on principle 
component axes) 
 C = matrix of weights for Y 
 F = matrix of residuals for Y 
 W*C = PLS weights 
o Performs cross-validation and jack-knifing to assess model quality and 
optimize number of principle components 
 Entering data into the model (pre-processing) 
o Same as for PCA; also perform for individual Y-variables 
 Outputs and diagnostics 
o R2X: explained variation of the model determined for X; indicates overall fit, 
ideal is > 0.7 
o R2Y: explained variation of the model determined for Y; indicates overall fit, 
ideal is > 0.7 
o Q2: predictive capacity of the model determined for Y; indicates ability of 
model to account for future observations, ideal is > 0.5 
o Cross-validation: model optimization to achieve a number of principle 






. Groups of observations are 
eliminated and the model is re-fit to examine the sensitivity of the scores and 
loadings. 
o Jack-knifing: results from cross-validation are used to evaluate variable 
sensitivity in the model and calculate the standard errors of the regression 
coefficients (weights), which can then be converted to 95% confidence 
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intervals (via t-distribution) to determine which X-variables have statistically 
significant influence (p < 0.05) on Y-variables in the model. 
o Score plot for X (t1 vs. t2, etc.): ta represents each principle component a 
found in the model for the X-variables; observations are projected onto these 
principle components. 
o Score plot for Y (u1 vs. u2, etc.): ua represents each principle component a 
found in the model for the Y-variables; observations are projected onto these 
principle components. 
o Regression plot of scores: (u1 vs. t1, etc.): shows the regression of the Y-
scores u with respect to the X-scores t; akin to linear regression to see how the 
principle components in Y are explained by the principle components in X 
o Weight plot: combined plot of weights for X- and Y-variables (similar to 
loading plot for PCA); gives information on what X yields Y or how to “set” 
X to get a desired Y (i.e. correlation structure) 
o PLS regression coefficients (CoeffCS): column plot for each Y-variable vs. 
X-variables of w
*
c; one vector of concise model information per response Y 
(correlation structure is lost); useful when a model contains multiple Y-
variables 
o P Hotelling’s T2: multivariate generalization of Student’s t-test; provides 
check for observations adhering to multivariate normality) => indicates 
STRONG outliers, used in conjunction with score plot (default = 95% 
confidence) 
o P Distance to model in X-space (DModX) and in Y-space (DModY): 
Examination of residuals (matrices E and F); MODERATE outlying 
observations have DModX values > Dcrit (critical distance, determine by 
number of observations); no Dcrit for DModY 
o P Variable influence on projection (VIP): weighted sum of squares of PLS 
weights, w
*
, that summarizes importance of each X-variable in the model 
o R2VY and Q2VY: explained variation of a Y-variable; allows ability to look 
at extent to which each Y-variable is accounted for by the model 
 Interpretation: 
o Does the model fit the data well? If not, then no interpretation of the score and 
loading plots can be performed. No exceptions! 
o Ask same questions as PCA, and also… 
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o How well do the Y-principle components regress onto the X-principle 
components? (Use u vs. t plots. This will help you determine what the 
principle components actually separate, or what their ‘meaning’ might be.) 
o Which X-variables most significantly determine the Y-variables (use 
regression coefficients or w*c weights with results from cross-validation and 
jack-knifing)? 
 
Classification and Discrimination of Clusters of Observations: 
 Partial Least Squares Discriminant Analysis (PLS-DA): 
o Utility 
 Necessary vs. PCA because not always the case that maximum 
variation directions coincide with the maximum separation directions 
among the classes 
 May be that other directions are more pertinent for discriminating 
among classes of observations 
 Works best with 2-5 classes of observations. May have to split into 
separate sub-models if more classes exist in the data. 
 When some classes are not “tight” (e.g. because of lack of 
homogeneity and similarity), discriminant analysis fails and must use 
SIMCA 
o Under the hood 
 Accomplishes a rotation of the projection to give latent variables that 
focus on class separation  (“discrimination”) 
 Encodes a class identity using a data matrix of “dummy” Y-variables 
that describes the class membership of each observation of a training 
set with a discrete numerical value (0 or 1) 
 Otherwise, same as PLS 
o Diagnostics: same as PLS 
o Interpretation: same as PLS 
 Soft Independent Modeling of Class Analogy (SIMCA, or PCA-Class): 
 Utility 
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o Approximates data observed on a class of similar observations, often with 
fewer components 
o Overview of training data set with PCA gives indications of class separation, 
trends, and outliers 
o Data should be selected such that each class of observations contains 
“homogeneous” data material 
 Under the hood 
o Effectively running a local PCA of each class; useful for identifying new 
observations 
 Diagnostics: very similar to PCA, and may also include: 
o DModX using training and prediction sets (generates classification and 
misclassification lists) 
Cooman’s plot: DModX’s for two classes are plotted against each other in a scatter plot 
that includes critical distance for both; used in conjunction with prediction set to identify 
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